EP4125665B1 - Intravascular lithotripsy device with electrical analyzer assembly - Google Patents
Intravascular lithotripsy device with electrical analyzer assembly Download PDFInfo
- Publication number
- EP4125665B1 EP4125665B1 EP21719784.7A EP21719784A EP4125665B1 EP 4125665 B1 EP4125665 B1 EP 4125665B1 EP 21719784 A EP21719784 A EP 21719784A EP 4125665 B1 EP4125665 B1 EP 4125665B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- balloon
- electrode
- catheter
- catheter system
- energy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000012530 fluid Substances 0.000 claims description 95
- 238000004891 communication Methods 0.000 claims description 56
- 239000008280 blood Substances 0.000 claims description 17
- 210000004369 blood Anatomy 0.000 claims description 17
- 210000003709 heart valve Anatomy 0.000 claims description 5
- 238000013461 design Methods 0.000 description 39
- 230000003287 optical effect Effects 0.000 description 17
- 231100000216 vascular lesion Toxicity 0.000 description 17
- 230000015572 biosynthetic process Effects 0.000 description 14
- 239000002872 contrast media Substances 0.000 description 13
- 238000000034 method Methods 0.000 description 13
- 239000003795 chemical substances by application Substances 0.000 description 9
- 229910019655 synthetic inorganic crystalline material Inorganic materials 0.000 description 9
- 210000005166 vasculature Anatomy 0.000 description 9
- 230000002411 adverse Effects 0.000 description 8
- 238000004873 anchoring Methods 0.000 description 7
- 239000013307 optical fiber Substances 0.000 description 7
- 230000000717 retained effect Effects 0.000 description 7
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 6
- 229910052740 iodine Inorganic materials 0.000 description 6
- 239000011630 iodine Substances 0.000 description 6
- 230000003902 lesion Effects 0.000 description 6
- JNDMLEXHDPKVFC-UHFFFAOYSA-N aluminum;oxygen(2-);yttrium(3+) Chemical compound [O-2].[O-2].[O-2].[Al+3].[Y+3] JNDMLEXHDPKVFC-UHFFFAOYSA-N 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 230000000670 limiting effect Effects 0.000 description 5
- 239000012811 non-conductive material Substances 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 229910019901 yttrium aluminum garnet Inorganic materials 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000005253 cladding Methods 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 210000002254 renal artery Anatomy 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000001514 detection method Methods 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 230000035939 shock Effects 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 229910052691 Erbium Inorganic materials 0.000 description 2
- 229910052689 Holmium Inorganic materials 0.000 description 2
- 229910052779 Neodymium Inorganic materials 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000002399 angioplasty Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000009172 bursting Effects 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- UYAHIZSMUZPPFV-UHFFFAOYSA-N erbium Chemical compound [Er] UYAHIZSMUZPPFV-UHFFFAOYSA-N 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 231100001261 hazardous Toxicity 0.000 description 2
- KJZYNXUDTRRSPN-UHFFFAOYSA-N holmium atom Chemical compound [Ho] KJZYNXUDTRRSPN-UHFFFAOYSA-N 0.000 description 2
- QEFYFXOXNSNQGX-UHFFFAOYSA-N neodymium atom Chemical compound [Nd] QEFYFXOXNSNQGX-UHFFFAOYSA-N 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- TXEYQDLBPFQVAA-UHFFFAOYSA-N tetrafluoromethane Chemical compound FC(F)(F)F TXEYQDLBPFQVAA-UHFFFAOYSA-N 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 206010051055 Deep vein thrombosis Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- UXIGWFXRQKWHHA-UHFFFAOYSA-N Iotalamic acid Chemical compound CNC(=O)C1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I UXIGWFXRQKWHHA-UHFFFAOYSA-N 0.000 description 1
- AMDBBAQNWSUWGN-UHFFFAOYSA-N Ioversol Chemical compound OCCN(C(=O)CO)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I AMDBBAQNWSUWGN-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 229910052775 Thulium Inorganic materials 0.000 description 1
- 206010047249 Venous thrombosis Diseases 0.000 description 1
- 239000011358 absorbing material Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- YVPYQUNUQOZFHG-UHFFFAOYSA-N amidotrizoic acid Chemical compound CC(=O)NC1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I YVPYQUNUQOZFHG-UHFFFAOYSA-N 0.000 description 1
- 239000004037 angiogenesis inhibitor Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940034982 antineoplastic agent Drugs 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 229940039231 contrast media Drugs 0.000 description 1
- 229960005423 diatrizoate Drugs 0.000 description 1
- 229950010592 dodecafluoropentane Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
- RJOJUSXNYCILHH-UHFFFAOYSA-N gadolinium(3+) Chemical compound [Gd+3] RJOJUSXNYCILHH-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- CPBQJMYROZQQJC-UHFFFAOYSA-N helium neon Chemical compound [He].[Ne] CPBQJMYROZQQJC-UHFFFAOYSA-N 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 229960004359 iodixanol Drugs 0.000 description 1
- NBQNWMBBSKPBAY-UHFFFAOYSA-N iodixanol Chemical compound IC=1C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C(I)C=1N(C(=O)C)CC(O)CN(C(C)=O)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I NBQNWMBBSKPBAY-UHFFFAOYSA-N 0.000 description 1
- 229960001025 iohexol Drugs 0.000 description 1
- NTHXOOBQLCIOLC-UHFFFAOYSA-N iohexol Chemical compound OCC(O)CN(C(=O)C)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I NTHXOOBQLCIOLC-UHFFFAOYSA-N 0.000 description 1
- 229960004647 iopamidol Drugs 0.000 description 1
- XQZXYNRDCRIARQ-LURJTMIESA-N iopamidol Chemical compound C[C@H](O)C(=O)NC1=C(I)C(C(=O)NC(CO)CO)=C(I)C(C(=O)NC(CO)CO)=C1I XQZXYNRDCRIARQ-LURJTMIESA-N 0.000 description 1
- 229960002603 iopromide Drugs 0.000 description 1
- DGAIEPBNLOQYER-UHFFFAOYSA-N iopromide Chemical compound COCC(=O)NC1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)N(C)CC(O)CO)=C1I DGAIEPBNLOQYER-UHFFFAOYSA-N 0.000 description 1
- 229940029378 iothalamate Drugs 0.000 description 1
- 229960004537 ioversol Drugs 0.000 description 1
- 229940029407 ioxaglate Drugs 0.000 description 1
- TYYBFXNZMFNZJT-UHFFFAOYSA-N ioxaglic acid Chemical compound CNC(=O)C1=C(I)C(N(C)C(C)=O)=C(I)C(C(=O)NCC(=O)NC=2C(=C(C(=O)NCCO)C(I)=C(C(O)=O)C=2I)I)=C1I TYYBFXNZMFNZJT-UHFFFAOYSA-N 0.000 description 1
- 229960002611 ioxilan Drugs 0.000 description 1
- UUMLTINZBQPNGF-UHFFFAOYSA-N ioxilan Chemical compound OCC(O)CN(C(=O)C)C1=C(I)C(C(=O)NCCO)=C(I)C(C(=O)NCC(O)CO)=C1I UUMLTINZBQPNGF-UHFFFAOYSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- GGGDNPWHMNJRFN-UHFFFAOYSA-N metrizoic acid Chemical compound CC(=O)N(C)C1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I GGGDNPWHMNJRFN-UHFFFAOYSA-N 0.000 description 1
- 229960004712 metrizoic acid Drugs 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- NJCBUSHGCBERSK-UHFFFAOYSA-N perfluoropentane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F NJCBUSHGCBERSK-UHFFFAOYSA-N 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- -1 polydimethylsiloxane Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 239000011253 protective coating Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B18/22—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
- A61B18/24—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor with a catheter
- A61B18/245—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor with a catheter for removing obstructions in blood vessels or calculi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/042—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating using additional gas becoming plasma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B18/22—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
- A61B18/26—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor for producing a shock wave, e.g. laser lithotripsy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/056—Transvascular endocardial electrode systems
- A61N1/057—Anchoring means; Means for fixing the head inside the heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00022—Sensing or detecting at the treatment site
- A61B2017/00026—Conductivity or impedance, e.g. of tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00022—Sensing or detecting at the treatment site
- A61B2017/00039—Electric or electromagnetic phenomena other than conductivity, e.g. capacity, inductivity, Hall effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00115—Electrical control of surgical instruments with audible or visual output
- A61B2017/00119—Electrical control of surgical instruments with audible or visual output alarm; indicating an abnormal situation
- A61B2017/00123—Electrical control of surgical instruments with audible or visual output alarm; indicating an abnormal situation and automatic shutdown
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00137—Details of operation mode
- A61B2017/00154—Details of operation mode pulsed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00107—Coatings on the energy applicator
- A61B2018/00154—Coatings on the energy applicator containing and delivering drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00166—Multiple lumina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
- A61B2018/0022—Balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00273—Anchoring means for temporary attachment of a device to tissue
- A61B2018/00279—Anchoring means for temporary attachment of a device to tissue deployable
- A61B2018/00285—Balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00351—Heart
- A61B2018/00369—Heart valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00351—Heart
- A61B2018/00386—Coronary vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00404—Blood vessels other than those in or around the heart
- A61B2018/00422—Angioplasty
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00642—Sensing and controlling the application of energy with feedback, i.e. closed loop control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/0066—Sensing and controlling the application of energy without feedback, i.e. open loop control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00696—Controlled or regulated parameters
- A61B2018/00702—Power or energy
- A61B2018/00708—Power or energy switching the power on or off
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00875—Resistance or impedance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00898—Alarms or notifications created in response to an abnormal condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/1213—Generators therefor creating an arc
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B18/22—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
- A61B2018/2205—Characteristics of fibres
- A61B2018/2211—Plurality of fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B18/22—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
- A61B2018/2255—Optical elements at the distal end of probe tips
- A61B2018/2261—Optical elements at the distal end of probe tips with scattering, diffusion or dispersion of light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B18/22—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
- A61B2018/2255—Optical elements at the distal end of probe tips
- A61B2018/2266—Optical elements at the distal end of probe tips with a lens, e.g. ball tipped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B18/22—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
- A61B2018/2255—Optical elements at the distal end of probe tips
- A61B2018/2272—Optical elements at the distal end of probe tips with reflective or refractive surfaces for deflecting the beam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B18/22—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
- A61B18/26—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor for producing a shock wave, e.g. laser lithotripsy
- A61B2018/263—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor for producing a shock wave, e.g. laser lithotripsy the conversion of laser energy into mechanical shockwaves taking place in a liquid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B18/22—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
- A61B18/26—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor for producing a shock wave, e.g. laser lithotripsy
- A61B2018/266—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor for producing a shock wave, e.g. laser lithotripsy the conversion of laser energy into mechanical shockwaves taking place in a part of the probe
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/08—Accessories or related features not otherwise provided for
- A61B2090/0807—Indication means
- A61B2090/0809—Indication of cracks or breakages
Definitions
- Vascular lesions within vessels in the body can be associated with an increased risk for major adverse events, such as myocardial infarction, embolism, deep vein thrombosis, stroke, and the like. Severe vascular lesions can be difficult to treat and achieve patency for a physician in a clinical setting.
- vascular lesions may be treated using interventions such as drug therapy, balloon angioplasty, atherectomy, stent placement, vascular graft bypass, to name a few. Such interventions may not always be ideal or may require subsequent treatment to address the lesion.
- WO-A-2013/169807 discloses a catheter system for treating a treatment site within or adjacent to a vessel wall or heart valve within a body of a patient.
- EP-A-0119296 discloses an impedance based system for detection of balloon rupture.
- the present invention provides a catheter system as defined in claim 1.
- the present invention is directed toward a catheter system used for treating a treatment site within or adjacent to the vessel wall.
- the catheter system includes an energy source, a balloon, an energy guide, and an electrical analyzer assembly.
- the energy source generates energy.
- the balloon is positionable substantially adjacent to the treatment site.
- the balloon has a balloon wall that defines a balloon interior.
- the balloon interior receives a balloon fluid.
- the energy guide is configured to receive energy from the energy source and guide the energy into the balloon interior.
- the electrical analyzer assembly is configured to monitor a balloon condition during use of the catheter system.
- the electrical analyzer assembly includes a first electrode, a second electrode, and an impedance detector that is electrically coupled to the first electrode and the second electrode.
- the impedance detector is configured to detect impedance between the first electrode and the second electrode.
- the electrical analyzer assembly analyzes an electrical signal and determines the balloon condition based at least in part on the electrical signal. For example, in certain such embodiments, the electrical analyzer assembly analyzes the electrical signal and determines a rupture of the balloon based at least in part on the electrical signal.
- the first electrode is positioned in a manner to be in communication with the balloon fluid within the balloon interior; and the second electrode is positioned in a manner to not be in communication with the balloon fluid within the balloon interior. More particularly, the second electrode is positioned in a manner to be in communication with blood of the patient with no nonconductive materials positioned between the second electrode and the blood of the patient.
- the impedance detector generates a detector signal based at least in part on the detected impedance between the first electrode and the second electrode.
- the catheter system further includes a system controller that is electrically coupled to the impedance detector.
- the system controller is configured to receive the detector signal from the impedance detector and to determine the balloon condition based at least in part on the detector signal.
- the impedance detector can be electrically coupled to the system controller via a wired connection, or the impedance detector can be electrically coupled to the system controller via a wireless connection.
- the system controller is configured to recognize a normal balloon condition based at least in part on the detector signal. Additionally, in certain embodiments, the system controller is configured to recognize a potential rupture of the balloon based at least in part on the detector signal. Further, in such embodiments, the system controller can be configured to automatically shut down operation of the catheter system upon recognition of the potential rupture of the balloon.
- the first electrode is positioned within the balloon interior.
- the catheter system further includes an inflation conduit through which the balloon fluid is directed into the balloon interior; and the first electrode can be positioned within the inflation conduit.
- the catheter system further includes a guidewire that is configured to guide positioning of the balloon substantially adjacent to the treatment site; and the second electrode can be positioned substantially adjacent to the guidewire. Still alternatively, in still other embodiments, the catheter system further includes a guidewire that is configured to guide positioning of the balloon substantially adjacent to the treatment site, and a guidewire lumen that is configured to move over the guidewire, the guidewire lumen being coupled to the balloon; and the second electrode can be positioned within the guidewire lumen.
- the energy source generates pulses of energy that are guided along the energy guide into the balloon interior to induce plasma formation in the balloon fluid within the balloon interior.
- the plasma formation can cause rapid bubble formation and imparts pressure waves upon the balloon wall adjacent to the treatment site.
- the energy source is a laser source that provides pulses of laser energy.
- the energy guide includes an optical fiber.
- the energy source is a high voltage energy source that provides pulses of high voltage.
- the energy guide can include an electrode pair including spaced apart electrodes that extend into the balloon interior; and pulses of high voltage from the energy source can be applied to the electrodes and form an electrical arc across the electrodes.
- the present disclosure is also directed toward a non-claimed method for treating a treatment site within or adjacent to a vessel wall within a body of a patient, the method including the steps of generating energy with an energy source; positioning a balloon substantially adjacent to the treatment site, the balloon having a balloon wall that defines a balloon interior that receives a balloon fluid; receiving energy from the energy source with an energy guide; guiding the energy with the energy guide into the balloon interior; and monitoring a balloon condition with an electrical analyzer assembly while energy is being guided into the balloon interior.
- WO 2013/169807 A1 discloses an angioplasty catheter system for treatment of lesions, particularly lesions which have calcified in the wall of an artery.
- the system comprises a balloon arranged about a carrier to receive a fluid that inflates the balloon, and a shock wave generator which forms rapidly expanding and collapsing bubbles which form mechanical shock waves within the balloon. These shock waves travel through the balloon to adjacent tissue, working to break up the calcified plaque.
- the formation of the rapidly expanding and collapsing bubble may include creating an electrical arc within the balloon by an electrical arc generator, or include generating a laser within the balloon.
- US 2018/333043 A1 discloses a balloon endoscope system having a selectively pressurizable interior volume and a selectably inflatable balloon located on an outer surface of the endoscope body and defining a balloon volume which communicates with the interior volume for selectable inflation of the balloon by selectable pressurization of the interior volume.
- the invention includes a balloon inflation/deflation control system which operates to provide automatic leak testing of at least one of the selectively inflatably pressurizable interior volume and selectively inflatable balloon, based on pressure measurements.
- the automatic leak testing may comprise either a positive pressure leak testing mode or a negative pressure leak testing mode.
- US 2016/184023 A1 discloses a device for using laser-induced pressure waves to disrupt vascular blockages, characterised by a catheter comprising a sheath having a lumen, a proximal end and a distal end, one or more layers of optical fibers circumferentially arranged around or adjacent to the lumen, a balloon assembly circumferentially arranged around a portion of the sheath, at least one emitter coupled to the sheath and disposed within the balloon assembly, wherein said emitter is disposed proximate the distal end of the sheath, wherein said emitter is coupled to the one or more layers of optical fibers, and one or more liquid medium ports disposed about the sheath and within the balloon assembly.
- the activation of the at least one emitter within the balloon assembly to emit one or more pulses of light energy causes a reaction with the liquid medium and generates a plurality of propagating pressure waves that cause the balloon assembly to engage and disrupt at least a portion of the vascular obstruction.
- US 2011/257641 A1 discloses an apparatus for facilitating delivery of optical energy to a renal artery of a patient, characterised by a catheter configured for deployment relative to the renal artery, an optical fiber arrangement comprising a coupling for receiving laser light from a laser light source, and an optics arrangement comprising one or more optical elements arranged to receive the laser light and project optical energy to a desired depth within innervated tissue at or proximate an outer wall of the renal artery, the optical energy of sufficient power to ablate innervated tissue at or proximate the outer wall of the renal artery.
- vascular lesions can reduce major adverse events or death in affected subjects.
- a major adverse event is one that can occur anywhere within the body due to the presence of a vascular lesion.
- Major adverse events can include, but are not limited to, major adverse cardiac events, major adverse events in the peripheral or central vasculature, major adverse events in the brain, major adverse events in the musculature, or major adverse events in any of the internal organs.
- the catheter systems and related methods disclosed herein are configured to monitor the performance, reliability and safety of an intravascular lithotripsy catheter.
- the catheter systems of the present invention utilize an energy source, e.g., a light source such as a laser source or another suitable energy source, which provides energy that is guided by an energy guide, e.g., a light guide, to create a localized plasma in a balloon fluid within a balloon interior of an inflatable balloon of the catheter.
- an energy guide e.g., a light guide
- the energy guide can sometimes be referred to as, or can be said to incorporate a "plasma generator" at or near a guide distal end of the energy guide that is positioned within the balloon interior.
- This localized plasma induces a high energy bubble inside the balloon interior to create pressure waves to impart pressure onto and induce fractures in a treatment site, such as a calcified vascular lesion or a fibrous vascular lesion, at a treatment site within or adjacent to a blood vessel wall or a heart valve within a body of a patient.
- a treatment site such as a calcified vascular lesion or a fibrous vascular lesion
- the catheter systems can include a catheter configured to advance to the treatment site within or adjacent a blood vessel or heart valve within the body of the patient.
- the catheter includes a catheter shaft, and a balloon that is coupled and/or secured to the catheter shaft.
- the inflatable balloons herein can include a balloon wall that defines the balloon interior and can be configured to receive the balloon fluid within the balloon interior to expand from a collapsed configuration suitable for advancing the catheter through a patient's vasculature, to an expanded configuration suitable for anchoring the catheter in position relative to the treatment site.
- the catheter systems also include one or more energy guides, e.g., light guides, disposed along the catheter shaft and within the inflatable balloon. Each energy guide can be configured for generating pressure waves within the inflatable balloon for disrupting the treatment sites.
- the catheter systems utilize energy from an energy source, e.g., light energy from a light source, to generate the plasma, i.e. via the plasma generator, within the balloon fluid at or near a guide distal end of the energy guide disposed in the inflatable balloon located at the treatment site.
- the plasma formation can initiate a pressure wave and can initiate the rapid formation of one or more bubbles that can rapidly expand to a maximum size and then dissipate through a cavitation event that can launch a pressure wave upon collapse.
- the rapid expansion of the plasma-induced bubbles can generate one or more pressure waves within the balloon fluid retained within the inflatable balloon and thereby impart pressure waves upon the treatment site.
- the energy source can be configured to provide sub-millisecond pulses of energy, e.g., light energy, from the energy source to initiate plasma formation in the balloon fluid within the inflatable balloon to cause rapid bubble formation and to impart pressure waves upon the balloon wall at the treatment site.
- energy e.g., light energy
- the pressure waves can transfer mechanical energy through an incompressible balloon fluid to the treatment site to impart a fracture force on the vascular lesion.
- intravascular lesion As used herein, the terms "intravascular lesion”, “vascular lesion” and “treatment site” are used interchangeably unless otherwise noted. As such, the intravascular lesions and/or the vascular lesions are sometimes referred to herein simply as “lesions”.
- FIG. 1 a schematic cross-sectional view is shown of a catheter system 100 in accordance with various embodiments herein.
- the catheter system 100 is suitable for imparting pressure to induce fractures in one or more treatment sites within or adjacent a vessel wall of a blood vessel or a heart valve within a body of a patient.
- the catheter system 100 can include one or more of a catheter 102, a light guide bundle 122 including one or more light guides 122A, a source manifold 136, a fluid pump 138, a system console 123 including one or more of a light source 124, a power source 125, a system controller 126, and a graphic user interface 127 (a "GUI"), a handle assembly 128, and an electrical analyzer assembly 142.
- a catheter 102 can include one or more of a catheter 102, a light guide bundle 122 including one or more light guides 122A, a source manifold 136, a fluid pump 138, a system console 123 including one or more of a light source 124, a power source 125, a system controller 126, and a graphic user interface 127 (a "GUI"), a handle assembly 128, and an electrical analyzer assembly 142.
- GUI graphic user interface
- the catheter 102 is configured to move to a treatment site 106 within or adjacent to a blood vessel 108 within a body 107 of a patient 109.
- the treatment site 106 can include one or more vascular lesions such as calcified vascular lesions, for example. Additionally, or in the alternative, the treatment site 106 can include vascular lesions such as fibrous vascular lesions.
- the catheter 102 can include an inflatable balloon 104 (sometimes referred to herein simply as a "balloon"), a catheter shaft 110 and a guidewire 112.
- the inflatable balloon 104 can be coupled to the catheter shaft 110.
- the inflatable balloon 104 can include a balloon proximal end 104P and a balloon distal end 104D.
- the catheter shaft 110 can extend from a proximal portion 114 of the catheter system 100 to a distal portion 116 of the catheter system 100.
- the catheter shaft 110 can include a longitudinal axis 144.
- the catheter shaft 110 can also include a guidewire lumen 118 which is configured to move over the guidewire 112.
- the catheter shaft 110 can further include an inflation lumen (not shown).
- the catheter 102 can have a distal end opening 120 and can accommodate and be tracked over the guidewire 112 as the catheter 102 is moved and positioned at or near the treatment site 106.
- the balloon proximal end 104P can be coupled to the catheter shaft 110, and the balloon distal end 104D can be coupled to the guidewire lumen 118.
- the catheter shaft 110 of the catheter 102 can be coupled to the one or more light guides 122A of the light guide bundle 122 that are in optical communication with the light source 124.
- the light guide(s) 122A can be disposed along the catheter shaft 110 and within the inflatable balloon 104.
- each light guide 122A can be an optical fiber and the light source 124 can be a laser.
- the light source 124 can be in optical communication with the light guides 122A at the proximal portion 114 of the catheter system 100.
- the catheter shaft 110 can be coupled to multiple light guides 122A such as a first light guide, a second light guide, a third light guide, etc., which can be disposed at any suitable positions about the guidewire lumen 118 and/or the catheter shaft 110.
- multiple light guides 122A such as a first light guide, a second light guide, a third light guide, etc., which can be disposed at any suitable positions about the guidewire lumen 118 and/or the catheter shaft 110.
- two light guides 122A can be spaced apart by approximately 180 degrees about the circumference of the guidewire lumen 118 and/or the catheter shaft 110; three light guides 122A can be spaced apart by approximately 120 degrees about the circumference of the guidewire lumen 118 and/or the catheter shaft 110; or four light guides 122A can be spaced apart by approximately 90 degrees about the circumference of the guidewire lumen 118 and/or the catheter shaft 110.
- multiple light guides 122A need not be uniformly spaced apart from one another about the circumference of the guidewire lumen 118 and/or the catheter shaft 110. More particularly, it is further appreciated that the light guides 122A described herein can be disposed uniformly or non-uniformly about the guidewire lumen 118 and/or the catheter shaft 110 to achieve the desired effect in the desired locations.
- the inflatable balloon 104 can include a balloon wall 130 that defines a balloon interior 146, and can be inflated with a balloon fluid 132 to expand from a collapsed configuration suitable for advancing the catheter 102 through a patient's vasculature, to an expanded configuration suitable for anchoring the catheter 102 in position relative to the treatment site 106. Stated in another manner, when the inflatable balloon 104 is in the expanded configuration, the balloon wall 130 of the inflatable balloon 104 is configured to be positioned substantially adjacent to the treatment site 106.
- the light source 124 of the catheter system 100 can be configured to provide sub-millisecond pulses of light from the light source 124, along the light guides 122A, to a location within the balloon interior 146 of the inflatable balloon 104, thereby inducing plasma formation in the balloon fluid 132 within the balloon interior 146 of the inflatable balloon 104.
- the plasma formation causes rapid bubble formation, and imparts pressure waves upon the treatment site 106. Exemplary plasma-induced bubbles are shown as bubbles 134 in Figure 1 .
- the catheter systems 100 illustrated herein are generally described as including a light source 124 and one or more light guides 122A
- the catheter system 100 can alternatively include any suitable energy source and energy guides for purposes of generating the desired plasma in the balloon fluid 132 within the balloon interior 146.
- the energy source 124 can be configured to provide high voltage pulses
- each energy guide 122A can include an electrode pair including spaced apart electrodes that extend into the balloon interior 146.
- each pulse of high voltage is applied to the electrodes and forms an electrical arc across the electrodes, which, in turn, forms the pressure waves within the balloon fluid 132 that are utilized to provide the fracture force onto the treatment site 106.
- the energy source 124 and/or the energy guides 122A can have another suitable design and/or configuration.
- the balloons 104 suitable for use in the catheter systems 100 described in detail herein include those that can be passed through the vasculature of a patient when in the collapsed configuration.
- the balloons 104 herein are made from silicone.
- the balloons 104 herein are made from polydimethylsiloxane (PDMS), polyurethane, polymers such as PEBAX TM material available from Arkema, which has a location at King of Prussia, Pennsylvania, USA, nylon, and the like.
- the balloons 104 can include those having diameters ranging from one millimeter (mm) to 25 mm in diameter.
- the balloons 104 can include those having diameters ranging from at least 1.5 mm to 12 mm in diameter.
- the balloons 104 can include those having diameters ranging from at least one mm to five mm in diameter.
- the balloons 104 herein can include those having a length ranging from at least five mm to 300 mm. More particularly, in some embodiments, the balloons 104 herein can include those having a length ranging from at least eight mm to 200 mm. It is appreciated that balloons 104 of greater length can be positioned adjacent to larger treatment sites 106, and, thus, may be usable for imparting pressure onto and inducing fractures in larger vascular lesions or multiple vascular lesions at precise locations at the treatment site 106.
- the balloons 104 herein can be inflated to inflation pressures of between approximately one atmosphere (atm) and 70 atm. In some embodiments, the balloons 104 herein can be inflated to inflation pressures of from at least 20 atm to 70 atm. In other embodiments, the balloons 104 herein can be inflated to inflation pressures of from at least six atm to 20 atm. In still other embodiments, the balloons 104 herein can be inflated to inflation pressures of from at least three atm to 20 atm. In yet other embodiments, the balloons 104 herein can be inflated to inflation pressures of from at least two atm to ten atm.
- the balloons 104 herein can include those having various shapes, including, but not to be limited to, a conical shape, a square shape, a rectangular shape, a spherical shape, a conical/square shape, a conical/spherical shape, an extended spherical shape, an oval shape, a tapered shape, a bone shape, a stepped diameter shape, an offset shape, or a conical offset shape.
- the balloons 104 herein can include a drug eluting coating or a drug eluting stent structure.
- the drug eluting coating or drug eluting stent can include one or more therapeutic agents including anti-inflammatory agents, anti-neoplastic agents, anti-angiogenic agents, and the like.
- the balloon fluid 132 can be a liquid or a gas.
- Exemplary balloon fluids 132 suitable for use herein can include, but are not limited to one or more of water, saline, contrast medium, fluorocarbons, perfluorocarbons, gases, such as carbon dioxide, and the like.
- the balloon fluids 132 described can be used as base inflation fluids.
- the balloon fluids 132 include a mixture of saline to contrast medium in a volume ratio of 50:50.
- the balloon fluids 132 include a mixture of saline to contrast medium in a volume ratio of 25:75.
- the balloon fluids 132 include a mixture of saline to contrast medium in a volume ratio of 75:25. Additionally, the balloon fluids 132 suitable for use herein can be tailored on the basis of composition, viscosity, and the like in order to manipulate the rate of travel of the pressure waves therein. In certain embodiments, the balloon fluids 132 suitable for use herein are biocompatible. A volume of balloon fluid 132 can be tailored by the chosen light source 124 and the type of balloon fluid 132 used.
- the contrast agents used in the contrast media herein can include, but are not to be limited to, iodine-based contrast agents, such as ionic or non-ionic iodine-based contrast agents.
- ionic iodine-based contrast agents include diatrizoate, metrizoate, iothalamate, and ioxaglate.
- non-ionic iodine-based contrast agents include iopamidol, iohexol, ioxilan, iopromide, iodixanol, and ioversol. In other embodiments, non-iodine based contrast agents can be used.
- Suitable non-iodine containing contrast agents can include gadolinium (III)-based contrast agents.
- Suitable fluorocarbon and perfluorocarbon agents can include, but are not to be limited to, agents such as the perfluorocarbon dodecafluoropentane (DDFP, C5F12).
- the balloon fluids 132 herein can include those that include absorptive agents that can selectively absorb light in the ultraviolet region (e.g., at least ten nanometers (nm) to 400 nm), the visible region (e.g., at least 400 nm to 780 nm), or the near-infrared region (e.g., at least 780 nm to 2.5 ⁇ m) of the electromagnetic spectrum.
- absorptive agents can include those with absorption maxima along the spectrum from at least ten nm to 2.5 ⁇ m.
- the balloon fluids 132 can include those that include absorptive agents that can selectively absorb light in the mid-infrared region (e.g., at least 2.5 ⁇ m to 15 ⁇ m), or the far-infrared region (e.g., at least 15 ⁇ m to one mm) of the electromagnetic spectrum.
- the absorptive agent can be those that have an absorption maximum matched with the emission maximum of the laser used in the catheter system.
- the absorptive agents used herein can be water soluble. In other embodiments, the absorptive agents used herein are not water soluble. In some embodiments, the absorptive agents used in the balloon fluids 132 herein can be tailored to match the peak emission of the light source 124.
- Various light sources 124 having emission wavelengths of at least ten nanometers to one millimeter are discussed elsewhere herein.
- the catheter system 100 and/or the light guide bundle 122 disclosed herein can include any number of light guides 122A in optical communication with the light source 124 at the proximal portion 114, and with the balloon fluid 132 within the balloon interior 146 of the inflatable balloon 104 at the distal portion 116.
- the catheter system 100 and/or the light guide bundle 122 can include from one light guide 122A to five light guides 122A.
- the catheter system 100 and/or the light guide bundle 122 can include from five light guides 122A to fifteen light guides 122A.
- the catheter system 100 and/or the light guide bundle 122 can include from ten light guides 122A to thirty light guides 122A.
- the catheter system 100 and/or the light guide bundle 122 can include greater than 30 light guides 122A.
- the light guides 122A herein can include an optical fiber or flexible light pipe.
- the light guides 122A herein can be thin and flexible and can allow light signals to be sent with very little loss of strength.
- the light guides 122A herein can include a core surrounded by a cladding about its circumference.
- the core can be a cylindrical core or a partially cylindrical core.
- the core and cladding of the light guides 122A can be formed from one or more materials, including but not limited to one or more types of glass, silica, or one or more polymers.
- the light guides 122A may also include a protective coating, such as a polymer. It is appreciated that the index of refraction of the core will be greater than the index of refraction of the cladding.
- Each light guide 122A can guide light along its length from a proximal portion, i.e. a guide proximal end 122P, to a distal portion, i.e. a guide distal end 122D, having at least one optical window (not shown) that is positioned within the balloon interior 146.
- the light guides 122A can create a light path as a portion of an optical network including the light source 124. The light path within the optical network allows light to travel from one part of the network to another. Both the optical fiber and the flexible light pipe can provide a light path within the optical networks herein.
- the light guides 122A herein can assume many configurations about and/or relative to the catheter shaft 110 of the catheters 102 described herein. In some embodiments, the light guides 122A can run parallel to the longitudinal axis 144 of the catheter shaft 110. In some embodiments, the light guides 122A can be physically coupled to the catheter shaft 110. In other embodiments, the light guides 122A can be disposed along a length of an outer diameter of the catheter shaft 110. In yet other embodiments, the light guides 122A herein can be disposed within one or more light guide lumens within the catheter shaft 110.
- the light guides 122A can be disposed at any suitable positions about the circumference of the guidewire lumen 118 and/or the catheter shaft 110, and the guide distal end 122D of each of the light guides 122A can be disposed at any suitable longitudinal position relative to the length of the inflatable balloon 104 and/or relative to the length of the guidewire lumen 118.
- the light guides 122A herein can include one or more photoacoustic transducers 154, where each photoacoustic transducer 154 can be in optical communication with the light guide 122A within which it is disposed.
- the photoacoustic transducers 154 can be in optical communication with the guide distal end 122D of the light guide 122A.
- the photoacoustic transducers 154 can have a shape that corresponds with and/or conforms to the guide distal end 122D of the light guide 122A.
- the photoacoustic transducer 154 is configured to convert light energy into an acoustic wave at or near the guide distal end 122D of the light guide 122A. It is appreciated that the direction of the acoustic wave can be tailored by changing an angle of the guide distal end 122D of the light guide 122A.
- the photoacoustic transducers 154 disposed at the guide distal end 122D of the light guide 122A herein can assume the same shape as the guide distal end 122D of the light guide 122A.
- the photoacoustic transducer 154 and/or the guide distal end 122D can have a conical shape, a convex shape, a concave shape, a bulbous shape, a square shape, a stepped shape, a half-circle shape, an ovoid shape, and the like.
- the light guide 122A can further include additional photoacoustic transducers 154 disposed along one or more side surfaces of the length of the light guide 122A.
- the light guides 122A described herein can further include one or more diverting features or “diverters” (not shown in Figure 1 ) within the light guide 122A that are configured to direct light to exit the light guide 122A toward a side surface e.g., at or near the guide distal end 122D of the light guide 122A, and toward the balloon wall 130.
- a diverting feature can include any feature of the system herein that diverts light from the light guide 122A away from its axial path toward a side surface of the light guide 122A.
- the light guides 122A can each include one or more light windows disposed along the longitudinal or axial surfaces of each light guide 122A and in optical communication with a diverting feature.
- the diverting features herein can be configured to direct light in the light guide 122A toward a side surface, e.g., at or near the guide distal end 122D, where the side surface is in optical communication with a light window.
- the light windows can include a portion of the light guide 122A that allows light to exit the light guide 122A from within the light guide 122A, such as a portion of the light guide 122A lacking a cladding material on or about the light guide 122A.
- Examples of the diverting features suitable for use herein include a reflecting element, a refracting element, and a fiber diffuser. Additionally, the diverting features suitable for focusing light away from the tip of the light guides 122A herein can include, but are not to be limited to, those having a convex surface, a gradient-index (GRIN) lens, and a mirror focus lens.
- the light is diverted within the light guide 122A to the photoacoustic transducer 154 that is in optical communication with a side surface of the light guide 122A.
- the photoacoustic transducer 154 then converts light energy into an acoustic wave that extends away from the side surface of the light guide 122A.
- the source manifold 136 can be positioned at or near the proximal portion 114 of the catheter system 100.
- the source manifold 136 can include one or more proximal end openings that can receive the plurality of light guides 122A of the light guide bundle 122, the guidewire 112, and/or an inflation conduit 140 that is coupled in fluid communication with the fluid pump 138.
- the catheter system 100 can also include the fluid pump 138 that is configured to inflate the inflatable balloon 104 with the balloon fluid 132, i.e. via the inflation conduit 140, as needed.
- the system console 123 includes one or more of the light source 124, the power source 125, the system controller 126, and the GUI 127.
- the system console 123 can include more components or fewer components than those specifically illustrated in Figure 1 .
- the system console 123 can be designed without the GUI 127.
- one or more of the light source 124, the power source 125, the system controller 126, and the GUI 127 can be provided within the catheter system 100 without the specific need for the system console 123.
- At least a portion of the electrical analyzer assembly 142 can also be positioned substantially within the system console 123. Alternatively, components of the electrical analyzer assembly 142 can be positioned in a different manner than what is specifically shown in Figure 1 .
- the system console 123 is operatively coupled to the catheter 102, the light guide bundle 122, and the remainder of the catheter system 100.
- the system console 123 can include a console connection aperture 148 (also sometimes referred to generally as a "socket") by which the light guide bundle 122 is mechanically coupled to the system console 123.
- the light guide bundle 122 can include a guide coupling housing 150 (also sometimes referred to generally as a "ferrule”) that houses a portion, e.g., the guide proximal end 122P, of each of the light guides 122A.
- the guide coupling housing 150 is configured to fit and be selectively retained within the console connection aperture 148 to provide the desired mechanical coupling between the light guide bundle 122 and the system console 123.
- the light guide bundle 122 can also include a guide bundler 152 (or "shell") that brings each of the individual light guides 122A closer together so that the light guides 122A and/or the light guide bundle 122 can be in a more compact form as it extends with the catheter 102 into the blood vessel 108 during use of the catheter system 100.
- a guide bundler 152 or "shell” that brings each of the individual light guides 122A closer together so that the light guides 122A and/or the light guide bundle 122 can be in a more compact form as it extends with the catheter 102 into the blood vessel 108 during use of the catheter system 100.
- the light source 124 can be selectively and/or alternatively coupled in optical communication with each of the light guides 122A, i.e. to the guide proximal end 122P of each of the light guides 122A, in the light guide bundle 122.
- the light source 124 is configured to generate light energy in the form of a source beam 124A, e.g., a pulsed source beam, that can be selectively and/or alternatively directed to and received by each of the light guides 122A in the light guide bundle 122 as an individual guide beam 124B.
- the catheter system 100 can include more than one light source 124.
- the catheter system 100 can include a separate light source 124 for each of the light guides 122A in the light guide bundle 122.
- the light source 124 can have any suitable design.
- the light source 124 can be configured to provide sub-millisecond pulses of light from the light source 124 that are focused onto a small spot in order to couple it into the guide proximal end 122P of the light guide 122A. Such pulses of light energy are then directed along the light guides 122A to a location within the inflatable balloon 104, thereby inducing plasma formation in the balloon fluid 132 within the balloon interior 146 of the inflatable balloon 104.
- the light energy emitted at the guide distal end 122D of the light guide 122A energizes the plasma generator to form the plasma within the balloon fluid 132 within the balloon interior 146.
- the sub-millisecond pulses of light from the light source 124 can be delivered to the treatment site 106 at a frequency of between approximately one hertz (Hz) and 5000 Hz. In some embodiments, the sub-millisecond pulses of light from the light source 124 can be delivered to the treatment site 106 at a frequency of between approximately 30 Hz and 1000 Hz. In other embodiments, the sub-millisecond pulses of light from the light source 124 can be delivered to the treatment site 106 at a frequency of between approximately ten Hz and 100 Hz.
- the sub-millisecond pulses of light from the light source 124 can be delivered to the treatment site 106 at a frequency of between approximately one Hz and 30 Hz.
- the sub-millisecond pulses of light can be delivered to the treatment site 106 at a frequency that can be greater than 5000 Hz.
- the light source 124 is typically utilized to provide pulses of light energy, the light source 124 can still be described as providing a single source beam 124A, i.e. a single pulsed source beam.
- the light sources 124 suitable for use herein can include various types of light sources including lasers and lamps. Alternatively, as noted above, the light sources 124, as referred to herein, can include any suitable type of energy source.
- Suitable lasers can include short pulse lasers on the sub-millisecond timescale.
- the light source 124 can include lasers on the nanosecond (ns) timescale.
- the lasers can also include short pulse lasers on the picosecond (ps), femtosecond (fs), and microsecond ( ⁇ s) timescales. It is appreciated that there are many combinations of laser wavelengths, pulse widths and energy levels that can be employed to achieve plasma in the balloon fluid 132 of the catheters 102 described herein.
- the pulse widths can include those falling within a range including from at least ten ns to 200 ns. In some embodiments, the pulse widths can include those falling within a range including from at least 20 ns to 100 ns. In other embodiments, the pulse widths can include those falling within a range including from at least one ns to 500 ns.
- exemplary nanosecond lasers can include those within the UV to IR spectrum, spanning wavelengths of about ten nanometers (nm) to one millimeter (mm).
- the light sources 124 suitable for use in the catheter systems 100 herein can include those capable of producing light at wavelengths of from at least 750 nm to 2000 nm.
- the light sources 124 can include those capable of producing light at wavelengths of from at least 700 nm to 3000 nm.
- the light sources 124 can include those capable of producing light at wavelengths of from at least 100 nm to ten micrometers ( ⁇ m).
- Nanosecond lasers can include those having repetition rates of up to 200 kHz.
- the laser can include a Q-switched thulium:yttrium-aluminum-garnet (Tm:YAG) laser.
- the laser can include a neodymium:yttrium-aluminum-garnet (Nd:YAG) laser, holmium:yttrium-aluminum-garnet (Ho:YAG) laser, erbium:yttrium-aluminum-garnet (Er:YAG) laser, excimer laser, helium-neon laser, carbon dioxide laser, as well as doped, pulsed, fiber lasers.
- Nd:YAG neodymium:yttrium-aluminum-garnet
- Ho:YAG holmium:yttrium-aluminum-garnet
- Er:YAG erbium:yttrium-aluminum-garnet
- excimer laser helium-neon laser
- carbon dioxide laser as well as doped, pulsed,
- the catheter systems 100 disclosed herein can generate pressure waves having maximum pressures in the range of at least one megapascal (MPa) to 100 MPa.
- MPa megapascal
- the maximum pressure generated by a particular catheter system 100 will depend on the light source 124, the absorbing material, the bubble expansion, the propagation medium, the balloon material, and other factors.
- the catheter systems 100 herein can generate pressure waves having maximum pressures in the range of at least two MPa to 50 MPa.
- the catheter systems 100 herein can generate pressure waves having maximum pressures in the range of at least two MPa to 30 MPa.
- the catheter systems 100 herein can generate pressure waves having maximum pressures in the range of at least 15 MPa to 25 MPa.
- the pressure waves described herein can be imparted upon the treatment site 106 from a distance within a range from at least 0.1 millimeters (mm) to 25 mm extending radially from the light guides 122A when the catheter 102 is placed at the treatment site 106. In some embodiments, the pressure waves can be imparted upon the treatment site 106 from a distance within a range from at least ten mm to 20 mm extending radially from the light guides 122A when the catheter 102 is placed at the treatment site 106.
- the pressure waves can be imparted upon the treatment site 106 from a distance within a range from at least one mm to ten mm extending radially from the light guides 122A when the catheter 102 is placed at the treatment site 106. In yet other embodiments, the pressure waves can be imparted upon the treatment site 106 from a distance within a range from at least 1.5 mm to four mm extending radially from the light guides 122A when the catheter 102 is placed at the treatment site 106. In some embodiments, the pressure waves can be imparted upon the treatment site 106 from a range of at least two MPa to 30 MPa at a distance from 0.1 mm to ten mm. In some embodiments, the pressure waves can be imparted upon the treatment site 106 from a range of at least two MPa to 25 MPa at a distance from 0.1 mm to ten mm.
- the power source 125 is electrically coupled to and is configured to provide necessary power to each of the light source 124, the system controller 126, the GUI 127, the handle assembly 128, and the electrical analyzer assembly 142.
- the power source 125 can have any suitable design for such purposes.
- the system controller 126 is electrically coupled to and receives power from the power source 125. Additionally, the system controller 126 is coupled to and is configured to control operation of each of the light source 124, the GUI 127 and the electrical analyzer assembly 142.
- the system controller 126 can include one or more processors or circuits for purposes of controlling the operation of at least the light source 124, the GUI 127 and the electrical analyzer assembly 142.
- the system controller 126 can control the light source 124 for generating pulses of light energy as desired, e.g., at any desired firing rate.
- the system controller 126 can control and/or operate in conjunction with the electrical analyzer assembly 142 to effectively provide real-time continuous monitoring of the performance, reliability and safety of the catheter system 100.
- system controller 126 can further be configured to control operation of other components of the catheter system 100, e.g., the positioning of the catheter 102 adjacent to the treatment site 106, the inflation of the inflatable balloon 104 with the balloon fluid 132, etc.
- catheter system 100 can include one or more additional controllers that can be positioned in any suitable manner for purposes of controlling the various operations of the catheter system 100.
- an additional controller and/or a portion of the system controller 126 can be positioned and/or incorporated within the handle assembly 128.
- the GUI 127 is accessible by the user or operator of the catheter system 100. Additionally, the GUI 127 is electrically connected to the system controller 126. With such design, the GUI 127 can be used by the user or operator to ensure that the catheter system 100 is employed as desired to impart pressure onto and induce fractures into the vascular lesions at the treatment site 106. Additionally, the GUI 127 can provide the user or operator with information that can be used before, during and after use of the catheter system 100. In one embodiment, the GUI 127 can provide static visual data and/or information to the user or operator. In addition, or in the alternative, the GUI 127 can provide dynamic visual data and/or information to the user or operator, such as video data or any other data that changes over time, e.g., during use of the catheter system 100.
- the GUI 127 can include one or more colors, different sizes, varying brightness, etc., that may act as alerts to the user or operator. Additionally, or in the alternative, the GUI 127 can provide audio data or information to the user or operator. It is appreciated that the specifics of the GUI 127 can vary depending upon the design requirements of the catheter system 100, or the specific needs, specifications and/or desires of the user or operator.
- the handle assembly 128 can be positioned at or near the proximal portion 114 of the catheter system 100, and/or near the source manifold 136. Additionally, in this embodiment, the handle assembly 128 is coupled to the inflatable balloon 104 and is positioned spaced apart from the inflatable balloon 104. Alternatively, the handle assembly 128 can be positioned at another suitable location.
- the handle assembly 128 is handled and used by the user or operator to operate, position and control the catheter 102.
- the design and specific features of the handle assembly 128 can vary to suit the design requirements of the catheter system 100.
- the handle assembly 128 is separate from, but in electrical and/or fluid communication with one or more of the system controller 126, the light source 124, the fluid pump 138, the GUI 127 and the electrical analyzer assembly 142.
- the handle assembly 128 can integrate and/or include at least a portion of the system controller 126 within an interior of the handle assembly 128.
- the handle assembly 128 can include circuitry 156 that can form at least a portion of the system controller 126.
- the circuitry 156 can receive electrical signals or data from the electrical analyzer assembly 142. Further, or in the alternative, the circuitry 156 can transmit such electrical signals or otherwise provide data to the system controller 126.
- the circuitry 156 can include a printed circuit board having one or more integrated circuits, or any other suitable circuitry.
- the circuitry 156 can be omitted, or can be included within the system controller 126, which in various embodiments can be positioned outside of the handle assembly 128, e.g., within the system console 123. It is understood that the handle assembly 128 can include fewer or additional components than those specifically illustrated and described herein.
- the electrical analyzer assembly 142 is configured to effectively monitor the performance, reliability and safety of the catheter system 100, in particular one that utilizes an energy source 124 to create a localized plasma which in turn induces a high energy bubble in the balloon fluid 132 within the balloon interior 146 of the inflatable balloon 104. More particularly, as described in detail herein, the electrical analyzer assembly 142 is specifically configured to effectively detect damage to, and/or rupturing or bursting of the inflatable balloon 104 during use of the catheter system 100.
- the generation of the localized plasma and the subsequent inducement of high energy bubbles in the balloon fluid 132 within the balloon interior 146 can cause the balloon fluid to heat up substantially, which, in addition to the pressure waves that are generated within the balloon interior 146, can put substantial stresses onto the balloon wall 130 of the inflatable balloon 104.
- the present invention is utilized to detect and/or identify when such stresses ultimately cause damage to the inflatable balloon 104, especially in the form of the potential rupturing or bursting of the inflatable balloon 104.
- the electrical analyzer assembly 142 provides an indication, e.g., to the system controller 126, that the inflatable balloon 104 has ruptured, it is important and necessary that the procedure be stopped immediately, as such a failure presents a substantial risk to the patient 109, including potential harms such as tissue burns.
- the rupture of the inflatable balloon 104 can be quickly and successfully detected, and an indicator or signal can be provided that is used to lock out the energy source 124. This provides a necessary safety interlock for a potentially hazardous condition in which the balloon fluid 132 is able to leak out.
- the design of the electrical analyzer assembly 142 can be varied to suit the specific requirements of the catheter system 100.
- the electrical analyzer assembly 142 can include one or more of a first electrode 158, a second electrode 160, and an impedance detector 162.
- the electrical analyzer assembly 142 can include more components or fewer components than what is specifically illustrated and described herein.
- the first electrode 158 can be positioned at any suitable location within the catheter system 100 so that it is in communication with the balloon fluid 132 that is positioned within the balloon interior 146 of the inflatable balloon 104.
- the first electrode 158 can be positioned within the balloon interior 146.
- the first electrode 158 can be positioned in another suitable location that is in communication with the balloon fluid 132 within the balloon interior 146.
- the first electrode 158 can be positioned within the handle assembly 128, within and/or adjacent to the inflation conduit 140, within and/or adjacent to the inflation lumen, and/or in another suitable location.
- the second electrode 160 can be positioned at any suitable location within the catheter system 100 so that it is in communication with the blood of the patient, i.e. so that no nonconductive materials of the catheter system 100 are positioned between the second electrode 160 and the blood of the patient 109.
- the second electrode 160 can be positioned inside the fluid channel within the guidewire lumen 118, on the guidewire 112, and/or in another suitable location.
- the first electrode 158 is in communication with the balloon fluid 132 within the balloon interior 146, during normal operation the first electrode 158 is not in communication with the blood of the patient 109 as at least the nonconductive materials of the inflatable balloon 104 are positioned therebetween.
- the second electrode 160 is in communication with the blood of the patient 109, during normal operation the second electrode 160 is not in communication with the balloon fluid 132 within the balloon interior 146 as at least the nonconductive materials of the inflatable balloon 104 are positioned therebetween.
- the impedance detector 162 is connected in electrical communication with each of the first electrode 158 and the second electrode 160. As such, the impedance detector 162 is configured to detect and thus provide real-time continuous monitoring of the impedance between the first electrode 158 and the second electrode 160. Impedance is the effective measurement of the degree a body resists the flow of electrical current, with the body's fluid and tissues acting as conductors of electrical current. It is appreciated that the impedance detector 162 can be electrically coupled to each of the first electrode 158 and the second electrode 160 via a wireless connection, or via a wired connection.
- the impedance detector 162 can be positioned in any suitable location where it can be in electrical communication with the first electrode 158 and the second electrode 160.
- the impedance detector 162 can be positioned substantially within the system console 123 and/or adjacent to the system controller 126.
- the impedance detector 162 can be positioned in another suitable location within the catheter system 100.
- the impedance detector 162 can be positioned within and/or adjacent to the handle assembly 128, inside the catheter 102, and/or in another suitable location.
- the impedance detector 162 is configured to detect the impedance between the first electrode 158 and the second electrode 160 during operation of the catheter system 100.
- the impedance detector 162 can then generate a detector signal or detector output, e.g., electrical signals regarding the detected impedance, and send the detector signal or detector output to the system controller 126 and/or the circuitry 156 within the handle assembly 128 for processing.
- the system controller 126 can then provide appropriate information to the user or operator, e.g., via the GUI 127, as to the status of operation of the catheter system 100, e.g., the potential rupturing of the inflatable balloon 104.
- the impedance detector 162 can be electrically connected to the system controller 126 via a wireless connection, or via a wired connection.
- the detected impedance would be very high, e.g., within an expected impedance range, since the first electrode 158 is insulated from the second electrode 160 by the nonconductive materials of the catheter 102. Additionally, the impedance detector 162 and/or the system controller 126 would process the detector signal to look for sudden drops in impedance between the electrodes 158, 160, which would indicate a rupture of the inflatable balloon 104, since a ruptured inflatable balloon 104 would remove the insulated barrier between the electrodes 158, 160.
- the present invention detects this failure and provides an indicator or signal that the system controller 126 could use to lock out the energy source 124.
- This provides a necessary safety interlock for a potentially hazardous condition in which the energy source 124 is able to leak out of the ruptured inflatable balloon 104.
- the signal could be used to indicate to the user or operator, e.g., via the GUI 127, to halt the procedure and remove the inflatable balloon 104 from the patient 109 under treatment.
- FIG. 2 is a schematic cross-sectional view of another embodiment of the catheter system 200 including another embodiment of the electrical analyzer assembly 242.
- the catheter system 200 can again include a catheter 202 including a catheter shaft 210, an inflatable balloon 204 having a balloon wall 230 that defines a balloon interior 246, a balloon proximal end 204P, and a balloon distal end 204D, a balloon fluid 232 that is retained substantially within the balloon interior 246, a guidewire 212, and a guidewire lumen 218 that extends into the balloon interior 246; an energy guide bundle 222 including one or more energy guides 222A; a source manifold 236; a fluid pump 238; a system console 223 including one or more of an energy source 224, a power source 225, a system controller 226, and a GUI 227; a handle assembly 228; and the electrical analyzer assembly 242.
- a catheter 202 including a catheter shaft 210, an inflatable balloon 204 having a balloon wall 230 that defines a balloon
- the catheter 202 including the catheter shaft 210, the inflatable balloon 204, the guidewire 212, and the guidewire lumen 218, is generally similar in design and operation to what has been described in detail herein above. Thus, such components will not be described in detail again in relation to the embodiment shown in Figure 2 .
- the inflatable balloon 204 is selectively movable between a collapsed configuration suitable for advancing the catheter 202 through a patient's vasculature, and an expanded configuration suitable for anchoring the catheter 202 in position relative to the treatment site 106.
- the balloon proximal end 204P can be coupled to the catheter shaft 210
- the balloon distal end 204D can be coupled to the guidewire lumen 218.
- the inflatable balloon 204 can be inflated with the balloon fluid 232, e.g., from the fluid pump 238, that is directed into the balloon interior 246 of the inflatable balloon 204 via the inflation conduit 240.
- the energy guide bundle 222 including the one or more energy guides 222A, and the system console 223 including one or more of the energy source 224, the power source 225, the system controller 226, and the GUI 227 are generally similar in design and operation to what has been described in detail herein above. Accordingly, such components will not be described in detail again in relation to the embodiment shown in Figure 2 .
- the handle assembly 228 is handled and used by the user or operator to operate, position and control the catheter 202. Additionally, as shown in the embodiment illustrated in Figure 2 , the handle assembly 228 can again include circuitry 256 that can form a portion of the system controller 226. Alternatively, the handle assembly 228 can be configured without the circuitry 256.
- the electrical analyzer assembly 242 is again configured to monitor the performance, reliability and safety of the catheter system 200. Additionally, the design of the electrical analyzer assembly 242 can be somewhat similar to what was illustrated and described herein above in relation to the embodiment shown in Figure 1 .
- the electrical analyzer assembly 242 can again include a first electrode 258, a second electrode 260, and an impedance detector 262 that is connected in electrical communication with the first electrode 258 and the second electrode 260 in order to effectively measure and/or detect the impedance between the first electrode 258 and the second electrode 260.
- one or more of the first electrode 258, the second electrode 260 and the impedance detector 262 can be positioned in a different manner than in the previous embodiment. More particularly, as shown in Figure 2 , in this embodiment, the first electrode 258 is again positioned within the balloon interior 246, and the impedance detector 262 is again positioned adjacent to and/or in electrical communication with the system controller 226, but the second electrode 260 is now positioned inside the fluid channel within the guidewire lumen 218.
- the impedance detector 262 in conjunction with the system controller 226 and/or the circuitry 256 in the handle assembly 228, is still configured to look for sudden drops in impedance between the electrodes 258, 260 as an indication of damage to and/or rupture of the inflatable balloon 204, which would necessitate that the procedure be immediately stopped and the catheter 202 removed from the patient 109.
- FIG. 3 is a schematic cross-sectional view of still another embodiment of the catheter system 300 including still another embodiment of the electrical analyzer assembly 342.
- the catheter system 300 can again include a catheter 302 including a catheter shaft 310, an inflatable balloon 304 having a balloon wall 330 that defines a balloon interior 346, a balloon proximal end 304P, and a balloon distal end 304D, a balloon fluid 332 that is retained substantially within the balloon interior 346, a guidewire 312, and a guidewire lumen 318 that extends into the balloon interior 346; an energy guide bundle 322 including one or more energy guides 322A; a source manifold 336; a fluid pump 338; a system console 323 including one or more of an energy source 324, a power source 325, a system controller 326, and a GUI 327; a handle assembly 328; and the electrical analyzer assembly 34
- the catheter 302 including the catheter shaft 310, the inflatable balloon 304, the guidewire 312, and the guidewire lumen 318, is generally similar in design and operation to what has been described in detail herein above. Thus, such components will not be described in detail again in relation to the embodiment shown in Figure 3 .
- the inflatable balloon 304 is selectively movable between a collapsed configuration suitable for advancing the catheter 302 through a patient's vasculature, and an expanded configuration suitable for anchoring the catheter 302 in position relative to the treatment site 106.
- the balloon proximal end 304P can be coupled to the catheter shaft 310
- the balloon distal end 304D can be coupled to the guidewire lumen 318.
- the inflatable balloon 304 can be inflated with the balloon fluid 332, e.g., from the fluid pump 338, that is directed into the balloon interior 346 of the inflatable balloon 304 via the inflation conduit 340.
- the energy guide bundle 322 including the one or more energy guides 322A, and the system console 323 including one or more of the energy source 324, the power source 325, the system controller 326, and the GUI 327 are generally similar in design and operation to what has been described in detail herein above. Accordingly, such components will not be described in detail again in relation to the embodiment shown in Figure 3 .
- the handle assembly 328 is handled and used by the user or operator to operate, position and control the catheter 302. Additionally, as shown in the embodiment illustrated in Figure 3 , the handle assembly 328 can again include circuitry 356 that can form a portion of the system controller 326. Alternatively, the handle assembly 328 can be configured without the circuitry 356.
- the electrical analyzer assembly 342 is again configured to monitor the performance, reliability and safety of the catheter system 300. Additionally, the design of the electrical analyzer assembly 342 can be somewhat similar to what was illustrated and described herein above in relation to the previous embodiments.
- the electrical analyzer assembly 342 can again include a first electrode 358, a second electrode 360, and an impedance detector 362 that is connected in electrical communication with the first electrode 358 and the second electrode 360 in order to effectively measure and/or detect the impedance between the first electrode 358 and the second electrode 360.
- one or more of the first electrode 358, the second electrode 360 and the impedance detector 362 can be positioned in a different manner than in the previous embodiments. More particularly, as shown in Figure 3 , in this embodiment, the first electrode 358 is again positioned within the balloon interior 346, and the impedance detector 362 is again positioned adjacent to and/or in electrical communication with the system controller 326, but the second electrode 360 is now positioned on and/or adjacent to the guidewire 312.
- the impedance detector 362 in conjunction with the system controller 326 and/or the circuitry 356 in the handle assembly 328, is still configured to look for sudden drops in impedance between the electrodes 358, 360 as an indication of damage to and/or rupture of the inflatable balloon 304, which would necessitate that the procedure be immediately stopped and the catheter 302 be removed from the patient 109.
- FIG. 4 is a schematic cross-sectional view of another embodiment of the catheter system 400 including another embodiment of the electrical analyzer assembly 442.
- the catheter system 400 can again include a catheter 402 including a catheter shaft 410, an inflatable balloon 404 having a balloon wall 430 that defines a balloon interior 446, a balloon proximal end 404P, and a balloon distal end 404D, a balloon fluid 432 that is retained substantially within the balloon interior 446, a guidewire 412, and a guidewire lumen 418 that extends into the balloon interior 446; an energy guide bundle 422 including one or more energy guides 422A; a source manifold 436; a fluid pump 438; a system console 423 including one or more of an energy source 424, a power source 425, a system controller 426, and a GUI 427; a handle assembly 428; and the electrical analyzer assembly 442.
- the catheter 402 including the catheter shaft 410, the inflatable balloon 404, the guidewire 412, and the guidewire lumen 418, is generally similar in design and operation to what has been described in detail herein above. Thus, such components will not be described in detail again in relation to the embodiment shown in Figure 4 .
- the inflatable balloon 404 is selectively movable between a collapsed configuration suitable for advancing the catheter 402 through a patient's vasculature, and an expanded configuration suitable for anchoring the catheter 402 in position relative to the treatment site 106.
- the balloon proximal end 404P can be coupled to the catheter shaft 410
- the balloon distal end 404D can be coupled to the guidewire lumen 418.
- the inflatable balloon 404 can be inflated with the balloon fluid 432, e.g., from the fluid pump 438, that is directed into the balloon interior 446 of the inflatable balloon 404 via the inflation conduit 440.
- the energy guide bundle 422 including the one or more energy guides 422A, and the system console 423 including one or more of the energy source 424, the power source 425, the system controller 426, and the GUI 427 are generally similar in design and operation to what has been described in detail herein above. Accordingly, such components will not be described in detail again in relation to the embodiment shown in Figure 4 .
- the handle assembly 428 is handled and used by the user or operator to operate, position and control the catheter 402. Additionally, as shown in the embodiment illustrated in Figure 4 , the handle assembly 428 can again include circuitry 456 that can form a portion of the system controller 426. Alternatively, the handle assembly 428 can be configured without the circuitry 456.
- the electrical analyzer assembly 442 is again configured to monitor the performance, reliability and safety of the catheter system 400. Additionally, the design of the electrical analyzer assembly 442 can be somewhat similar to what was illustrated and described herein above in relation to the previous embodiments.
- the electrical analyzer assembly 442 can again include a first electrode 458, a second electrode 460, and an impedance detector 462 that is connected in electrical communication with the first electrode 458 and the second electrode 460 in order to effectively measure and/or detect the impedance between the first electrode 458 and the second electrode 460.
- one or more of the first electrode 458, the second electrode 460 and the impedance detector 462 can be positioned in a different manner than in the previous embodiments. More particularly, as shown in Figure 4 , in this non-claimed embodiment, the second electrode 460 is again positioned on and/or adjacent to the skin 105 of the patient 109 (as in the embodiment shown in Figure 1 ), and the impedance detector 462 is again positioned adjacent to and/or in electrical communication with the system controller 426, but the first electrode 458 is now positioned within and/or adjacent to the inflation conduit 440 through which balloon fluid 432 is directed into the balloon interior 446 of the inflatable balloon 404.
- the impedance detector 462 in conjunction with the system controller 426 and/or the circuitry 456 in the handle assembly 428, is still configured to look for sudden drops in impedance between the electrodes 458, 460 as an indication of damage to and/or rupture of the inflatable balloon 404, which would necessitate that the procedure be immediately stopped and the catheter 402 be removed from the patient 109.
- FIG. 5 is a schematic cross-sectional view of yet another embodiment of the catheter system 500 including yet another embodiment of the electrical analyzer assembly 542.
- the catheter system 500 can again include a catheter 502 including a catheter shaft 510, an inflatable balloon 504 having a balloon wall 530 that defines a balloon interior 546, a balloon proximal end 504P, and a balloon distal end 504D, a balloon fluid 532 that is retained substantially within the balloon interior 546, a guidewire 512, and a guidewire lumen 518 that extends into the balloon interior 546; an energy guide bundle 522 including one or more energy guides 522A; a source manifold 536; a fluid pump 538; a system console 523 including one or more of an energy source 524, a power source 525, a system controller 526, and a GUI 527; a handle assembly 528; and the electrical analyzer assembly
- the catheter 502 including the catheter shaft 510, the inflatable balloon 504, the guidewire 512, and the guidewire lumen 518, is generally similar in design and operation to what has been described in detail herein above. Thus, such components will not be described in detail again in relation to the embodiment shown in Figure 5 .
- the inflatable balloon 504 is selectively movable between a collapsed configuration suitable for advancing the catheter 502 through a patient's vasculature, and an expanded configuration suitable for anchoring the catheter 502 in position relative to the treatment site 106.
- the balloon proximal end 504P can be coupled to the catheter shaft 510
- the balloon distal end 504D can be coupled to the guidewire lumen 518.
- the inflatable balloon 504 can be inflated with the balloon fluid 532, e.g., from the fluid pump 538, that is directed into the balloon interior 546 of the inflatable balloon 504 via the inflation conduit 540.
- the energy guide bundle 522 including the one or more energy guides 522A, and the system console 523 including one or more of the energy source 524, the power source 525, the system controller 526, and the GUI 527 are generally similar in design and operation to what has been described in detail herein above. Accordingly, such components will not be described in detail again in relation to the embodiment shown in Figure 5 .
- the handle assembly 528 is handled and used by the user or operator to operate, position and control the catheter 502. Additionally, as shown in the embodiment illustrated in Figure 5 , the handle assembly 528 can again include circuitry 556 that can form a portion of the system controller 526. Alternatively, the handle assembly 528 can be configured without the circuitry 556.
- the electrical analyzer assembly 542 is again configured to monitor the performance, reliability and safety of the catheter system 500. Additionally, the design of the electrical analyzer assembly 542 can be somewhat similar to what was illustrated and described herein above in relation to the previous embodiments.
- the electrical analyzer assembly 542 can again include a first electrode 558, a second electrode 560, and an impedance detector 562 that is connected in electrical communication with the first electrode 558 and the second electrode 560 in order to effectively measure and/or detect the impedance between the first electrode 558 and the second electrode 560.
- one or more of the first electrode 558, the second electrode 560 and the impedance detector 562 can be positioned in a different manner than in the previous embodiments. More particularly, as shown in Figure 5 , in this embodiment, the first electrode 558 is again positioned within and/or adjacent to the inflation conduit 540 through which balloon fluid 532 is directed into the balloon interior 546 of the inflatable balloon 504 (as in Figure 4 ), the second electrode 560 is again positioned within and/or adjacent to the guidewire lumen 518 (as in the embodiment shown in Figure 2 ), and the impedance detector 562 is again positioned adjacent to and/or in electrical communication with the system controller 526.
- the impedance detector 562 in conjunction with the system controller 526 and/or the circuitry 556 in the handle assembly 528, is still configured to look for sudden drops in impedance between the electrodes 558, 560 as an indication of damage to and/or rupture of the inflatable balloon 504, which would necessitate that the procedure be immediately stopped and the catheter 502 be removed from the patient 109.
- FIG. 6 is a schematic cross-sectional view of still yet another embodiment of the catheter system 600 including still yet another embodiment of the electrical analyzer assembly 642.
- the catheter system 600 can again include a catheter 602 including a catheter shaft 610, an inflatable balloon 604 having a balloon wall 630 that defines a balloon interior 646, a balloon proximal end 604P, and a balloon distal end 604D, a balloon fluid 632 that is retained substantially within the balloon interior 646, a guidewire 612, and a guidewire lumen 618 that extends into the balloon interior 646; an energy guide bundle 622 including one or more energy guides 622A; a source manifold 636; a fluid pump 638; a system console 623 including one or more of an energy source 624, a power source 625, a system controller 626, and a GUI 627; a handle assembly 628; and the electrical analyzer assembly
- the catheter 602 including the catheter shaft 610, the inflatable balloon 604, the guidewire 612, and the guidewire lumen 618, is generally similar in design and operation to what has been described in detail herein above. Thus, such components will not be described in detail again in relation to the embodiment shown in Figure 6 .
- the inflatable balloon 604 is selectively movable between a collapsed configuration suitable for advancing the catheter 602 through a patient's vasculature, and an expanded configuration suitable for anchoring the catheter 602 in position relative to the treatment site 106.
- the balloon proximal end 604P can be coupled to the catheter shaft 610
- the balloon distal end 604D can be coupled to the guidewire lumen 618.
- the inflatable balloon 604 can be inflated with the balloon fluid 632, e.g., from the fluid pump 638, that is directed into the balloon interior 646 of the inflatable balloon 604 via the inflation conduit 640.
- the energy guide bundle 622 including the one or more energy guides 622A, and the system console 623 including one or more of the energy source 624, the power source 625, the system controller 626, and the GUI 627 are generally similar in design and operation to what has been described in detail herein above. Accordingly, such components will not be described in detail again in relation to the embodiment shown in Figure 6 .
- the handle assembly 628 is handled and used by the user or operator to operate, position and control the catheter 602. Additionally, as shown in the embodiment illustrated in Figure 6 , the handle assembly 628 can again include circuitry 656 that can form a portion of the system controller 626. Alternatively, the handle assembly 628 can be configured without the circuitry 656.
- the electrical analyzer assembly 642 is again configured to monitor the performance, reliability and safety of the catheter system 600. Additionally, the design of the electrical analyzer assembly 642 can be somewhat similar to what was illustrated and described herein above in relation to the previous embodiments.
- the electrical analyzer assembly 642 can again include a first electrode 658, a second electrode 660, and an impedance detector 662 that is connected in electrical communication with the first electrode 658 and the second electrode 660 in order to effectively measure and/or detect the impedance between the first electrode 658 and the second electrode 660.
- one or more of the first electrode 658, the second electrode 660 and the impedance detector 662 can be positioned in a different manner than in the previous embodiments. More particularly, as shown in Figure 6 , in this embodiment, the first electrode 658 is again positioned within and/or adjacent to the inflation conduit 640 through which balloon fluid 632 is directed into the balloon interior 646 of the inflatable balloon 604 (as in Figure 4 ), the second electrode 660 is again positioned on and/or adjacent to the guidewire 612 (as in the embodiment shown in Figure 3 ), and the impedance detector 662 is again positioned adjacent to and/or in electrical communication with the system controller 626.
- the impedance detector 662 in conjunction with the system controller 626 and/or the circuitry 656 in the handle assembly 628, is still configured to look for sudden drops in impedance between the electrodes 658, 660 as an indication of damage to and/or rupture of the inflatable balloon 604, which would necessitate that the procedure be immediately stopped and the catheter 602 be removed from the patient 109.
- the electrical analyzer assembly of the present invention addresses several important challenges with the performance, reliability and safety of an intravascular lithotripsy catheter, in particular one that utilizes an energy source, e.g., a light source such as a laser source, to create a localized plasma which in turn induces a high energy bubble in the balloon fluid within the balloon interior of the balloon.
- an energy source e.g., a light source such as a laser source
- issues that are addressed by the present invention include, but are not limited to: 1) electrical detection of normal operation and/or balloon condition used within the catheter system, and 2) electrical detection of a failure of the balloon, e.g., damage to and/or rupture of the balloon, during use of the catheter system, which would necessitate shutting down of the catheter system and removal of the catheter from the body of the patient.
- the phrase “configured” describes a system, apparatus, or other structure that is constructed or configured to perform a particular task or adopt a particular configuration.
- the phrase “configured” can be used interchangeably with other similar phrases such as arranged and configured, constructed and arranged, constructed, manufactured and arranged, and the like.
Description
- Vascular lesions within vessels in the body can be associated with an increased risk for major adverse events, such as myocardial infarction, embolism, deep vein thrombosis, stroke, and the like. Severe vascular lesions can be difficult to treat and achieve patency for a physician in a clinical setting.
- Vascular lesions may be treated using interventions such as drug therapy, balloon angioplasty, atherectomy, stent placement, vascular graft bypass, to name a few. Such interventions may not always be ideal or may require subsequent treatment to address the lesion.
WO-A-2013/169807 discloses a catheter system for treating a treatment site within or adjacent to a vessel wall or heart valve within a body of a patient. -
EP-A-0119296 discloses an impedance based system for detection of balloon rupture. - The present invention provides a catheter system as defined in claim 1. The present invention is directed toward a catheter system used for treating a treatment site within or adjacent to the vessel wall. In various embodiments, the catheter system includes an energy source, a balloon, an energy guide, and an electrical analyzer assembly. The energy source generates energy. The balloon is positionable substantially adjacent to the treatment site. The balloon has a balloon wall that defines a balloon interior. The balloon interior receives a balloon fluid. The energy guide is configured to receive energy from the energy source and guide the energy into the balloon interior. The electrical analyzer assembly is configured to monitor a balloon condition during use of the catheter system. The electrical analyzer assembly includes a first electrode, a second electrode, and an impedance detector that is electrically coupled to the first electrode and the second electrode. The impedance detector is configured to detect impedance between the first electrode and the second electrode.
- In some embodiments, the electrical analyzer assembly analyzes an electrical signal and determines the balloon condition based at least in part on the electrical signal. For example, in certain such embodiments, the electrical analyzer assembly analyzes the electrical signal and determines a rupture of the balloon based at least in part on the electrical signal.
- In some embodiments, the first electrode is positioned in a manner to be in communication with the balloon fluid within the balloon interior; and the second electrode is positioned in a manner to not be in communication with the balloon fluid within the balloon interior. More particularly, the second electrode is positioned in a manner to be in communication with blood of the patient with no nonconductive materials positioned between the second electrode and the blood of the patient.
- In certain embodiments, the impedance detector generates a detector signal based at least in part on the detected impedance between the first electrode and the second electrode.
- In some embodiments, the catheter system further includes a system controller that is electrically coupled to the impedance detector. The system controller is configured to receive the detector signal from the impedance detector and to determine the balloon condition based at least in part on the detector signal. In alternative embodiments, the impedance detector can be electrically coupled to the system controller via a wired connection, or the impedance detector can be electrically coupled to the system controller via a wireless connection.
- In various embodiments, the system controller is configured to recognize a normal balloon condition based at least in part on the detector signal. Additionally, in certain embodiments, the system controller is configured to recognize a potential rupture of the balloon based at least in part on the detector signal. Further, in such embodiments, the system controller can be configured to automatically shut down operation of the catheter system upon recognition of the potential rupture of the balloon.
- In certain embodiments, the first electrode is positioned within the balloon interior. Alternatively, in other embodiments, the catheter system further includes an inflation conduit through which the balloon fluid is directed into the balloon interior; and the first electrode can be positioned within the inflation conduit.
- In some embodiments, the catheter system further includes a guidewire that is configured to guide positioning of the balloon substantially adjacent to the treatment site; and the second electrode can be positioned substantially adjacent to the guidewire. Still alternatively, in still other embodiments, the catheter system further includes a guidewire that is configured to guide positioning of the balloon substantially adjacent to the treatment site, and a guidewire lumen that is configured to move over the guidewire, the guidewire lumen being coupled to the balloon; and the second electrode can be positioned within the guidewire lumen.
- In certain embodiments, the energy source generates pulses of energy that are guided along the energy guide into the balloon interior to induce plasma formation in the balloon fluid within the balloon interior. Further, in such embodiments, the plasma formation can cause rapid bubble formation and imparts pressure waves upon the balloon wall adjacent to the treatment site.
- In some embodiments, the energy source is a laser source that provides pulses of laser energy.
- In certain embodiments, the energy guide includes an optical fiber.
- In various embodiments, the energy source is a high voltage energy source that provides pulses of high voltage.
- In certain embodiments, the energy guide can include an electrode pair including spaced apart electrodes that extend into the balloon interior; and pulses of high voltage from the energy source can be applied to the electrodes and form an electrical arc across the electrodes.
- The present disclosure is also directed toward a non-claimed method for treating a treatment site within or adjacent to a vessel wall within a body of a patient, the method including the steps of generating energy with an energy source; positioning a balloon substantially adjacent to the treatment site, the balloon having a balloon wall that defines a balloon interior that receives a balloon fluid; receiving energy from the energy source with an energy guide; guiding the energy with the energy guide into the balloon interior; and monitoring a balloon condition with an electrical analyzer assembly while energy is being guided into the balloon interior.
- This summary is an overview of some of the teachings of the present application and is not intended to be an exclusive or exhaustive treatment of the present subject matter. Further details are found in the detailed description and appended claims. Other aspects will be apparent to persons skilled in the art upon reading and understanding the following detailed description and viewing the drawings that form a part thereof, each of which is not to be taken in a limiting sense. The scope herein is defined by the appended claims.
-
WO 2013/169807 A1 discloses an angioplasty catheter system for treatment of lesions, particularly lesions which have calcified in the wall of an artery. The system comprises a balloon arranged about a carrier to receive a fluid that inflates the balloon, and a shock wave generator which forms rapidly expanding and collapsing bubbles which form mechanical shock waves within the balloon. These shock waves travel through the balloon to adjacent tissue, working to break up the calcified plaque. The formation of the rapidly expanding and collapsing bubble may include creating an electrical arc within the balloon by an electrical arc generator, or include generating a laser within the balloon. -
US 2018/333043 A1 discloses a balloon endoscope system having a selectively pressurizable interior volume and a selectably inflatable balloon located on an outer surface of the endoscope body and defining a balloon volume which communicates with the interior volume for selectable inflation of the balloon by selectable pressurization of the interior volume. Preferably, the invention includes a balloon inflation/deflation control system which operates to provide automatic leak testing of at least one of the selectively inflatably pressurizable interior volume and selectively inflatable balloon, based on pressure measurements. The automatic leak testing may comprise either a positive pressure leak testing mode or a negative pressure leak testing mode. -
US 2016/184023 A1 discloses a device for using laser-induced pressure waves to disrupt vascular blockages, characterised by a catheter comprising a sheath having a lumen, a proximal end and a distal end, one or more layers of optical fibers circumferentially arranged around or adjacent to the lumen, a balloon assembly circumferentially arranged around a portion of the sheath, at least one emitter coupled to the sheath and disposed within the balloon assembly, wherein said emitter is disposed proximate the distal end of the sheath, wherein said emitter is coupled to the one or more layers of optical fibers, and one or more liquid medium ports disposed about the sheath and within the balloon assembly. The activation of the at least one emitter within the balloon assembly to emit one or more pulses of light energy causes a reaction with the liquid medium and generates a plurality of propagating pressure waves that cause the balloon assembly to engage and disrupt at least a portion of the vascular obstruction. -
US 2011/257641 A1 discloses an apparatus for facilitating delivery of optical energy to a renal artery of a patient, characterised by a catheter configured for deployment relative to the renal artery, an optical fiber arrangement comprising a coupling for receiving laser light from a laser light source, and an optics arrangement comprising one or more optical elements arranged to receive the laser light and project optical energy to a desired depth within innervated tissue at or proximate an outer wall of the renal artery, the optical energy of sufficient power to ablate innervated tissue at or proximate the outer wall of the renal artery. - The novel features of this invention, as well as the invention itself, both as to its structure and its operation, will be best understood from the accompanying drawings, taken in conjunction with the accompanying description, in which similar reference characters refer to similar parts, and in which:
-
Figure 1 is a schematic cross-sectional view of an embodiment of a catheter system in accordance with various embodiments herein, the catheter system including an electrical analyzer assembly having features of the present invention; -
Figure 2 is a schematic cross-sectional view of another embodiment of the catheter system including another embodiment of the electrical analyzer assembly; -
Figure 3 is a schematic cross-sectional view of still another embodiment of the catheter system including still another embodiment of the electrical analyzer assembly; -
Figure 4 is a schematic cross-sectional view of another embodiment of the catheter system including another embodiment of the electrical analyzer assembly; -
Figure 5 is a schematic cross-sectional view of yet another embodiment of the catheter system including yet another embodiment of the electrical analyzer assembly; and -
Figure 6 is a schematic cross-sectional view of still yet another embodiment of the catheter system including still yet another embodiment of the electrical analyzer assembly. - While embodiments of the present invention are susceptible to various modifications and alternative forms, specifics thereof have been shown by way of example and drawings, and are described in detail herein. It is understood, however, that the scope herein is not limited to the particular embodiments described. On the contrary, the intention is to cover modifications, and alternatives falling within the scope of the apended claims.
- Treatment of vascular lesions (also sometimes referred to herein as "treatment sites") can reduce major adverse events or death in affected subjects. As referred to herein, a major adverse event is one that can occur anywhere within the body due to the presence of a vascular lesion. Major adverse events can include, but are not limited to, major adverse cardiac events, major adverse events in the peripheral or central vasculature, major adverse events in the brain, major adverse events in the musculature, or major adverse events in any of the internal organs.
- The catheter systems and related methods disclosed herein are configured to monitor the performance, reliability and safety of an intravascular lithotripsy catheter. In various embodiments, the catheter systems of the present invention utilize an energy source, e.g., a light source such as a laser source or another suitable energy source, which provides energy that is guided by an energy guide, e.g., a light guide, to create a localized plasma in a balloon fluid within a balloon interior of an inflatable balloon of the catheter. As such, the energy guide can sometimes be referred to as, or can be said to incorporate a "plasma generator" at or near a guide distal end of the energy guide that is positioned within the balloon interior. This localized plasma, in turn, induces a high energy bubble inside the balloon interior to create pressure waves to impart pressure onto and induce fractures in a treatment site, such as a calcified vascular lesion or a fibrous vascular lesion, at a treatment site within or adjacent to a blood vessel wall or a heart valve within a body of a patient.
- In particular, in various embodiments, the catheter systems can include a catheter configured to advance to the treatment site within or adjacent a blood vessel or heart valve within the body of the patient. The catheter includes a catheter shaft, and a balloon that is coupled and/or secured to the catheter shaft. The inflatable balloons herein can include a balloon wall that defines the balloon interior and can be configured to receive the balloon fluid within the balloon interior to expand from a collapsed configuration suitable for advancing the catheter through a patient's vasculature, to an expanded configuration suitable for anchoring the catheter in position relative to the treatment site. The catheter systems also include one or more energy guides, e.g., light guides, disposed along the catheter shaft and within the inflatable balloon. Each energy guide can be configured for generating pressure waves within the inflatable balloon for disrupting the treatment sites. The catheter systems utilize energy from an energy source, e.g., light energy from a light source, to generate the plasma, i.e. via the plasma generator, within the balloon fluid at or near a guide distal end of the energy guide disposed in the inflatable balloon located at the treatment site. The plasma formation can initiate a pressure wave and can initiate the rapid formation of one or more bubbles that can rapidly expand to a maximum size and then dissipate through a cavitation event that can launch a pressure wave upon collapse. The rapid expansion of the plasma-induced bubbles can generate one or more pressure waves within the balloon fluid retained within the inflatable balloon and thereby impart pressure waves upon the treatment site. In some embodiments, the energy source can be configured to provide sub-millisecond pulses of energy, e.g., light energy, from the energy source to initiate plasma formation in the balloon fluid within the inflatable balloon to cause rapid bubble formation and to impart pressure waves upon the balloon wall at the treatment site. Thus, the pressure waves can transfer mechanical energy through an incompressible balloon fluid to the treatment site to impart a fracture force on the vascular lesion.
- As used herein, the terms "intravascular lesion", "vascular lesion" and "treatment site" are used interchangeably unless otherwise noted. As such, the intravascular lesions and/or the vascular lesions are sometimes referred to herein simply as "lesions".
- Those of ordinary skill in the art will realize that the following detailed description of the present invention is illustrative only and is not intended to be in any way limiting. Other embodiments of the present invention will readily suggest themselves to such skilled persons having the benefit of this disclosure. Reference will now be made in detail to implementations of the present invention as illustrated in the accompanying drawings.
- In the interest of clarity, not all of the routine features of the implementations described herein are shown and described. It will, of course, be appreciated that in the development of any such actual implementation, numerous implementation-specific decisions must be made in order to achieve the developer's specific goals, such as compliance with application-related and business-related constraints, and that these specific goals will vary from one implementation to another and from one developer to another. Moreover, it is appreciated that such a development effort might be complex and time-consuming, but would nevertheless be a routine undertaking of engineering for those of ordinary skill in the art having the benefit of this disclosure.
- It is appreciated that the catheter systems disclosed herein can include many different forms. Referring now to
Figure 1 , a schematic cross-sectional view is shown of acatheter system 100 in accordance with various embodiments herein. As described herein, thecatheter system 100 is suitable for imparting pressure to induce fractures in one or more treatment sites within or adjacent a vessel wall of a blood vessel or a heart valve within a body of a patient. In the embodiment illustrated inFigure 1 , thecatheter system 100 can include one or more of acatheter 102, alight guide bundle 122 including one or more light guides 122A, asource manifold 136, afluid pump 138, asystem console 123 including one or more of alight source 124, apower source 125, asystem controller 126, and a graphic user interface 127 (a "GUI"), ahandle assembly 128, and anelectrical analyzer assembly 142. - The
catheter 102 is configured to move to atreatment site 106 within or adjacent to ablood vessel 108 within abody 107 of apatient 109. Thetreatment site 106 can include one or more vascular lesions such as calcified vascular lesions, for example. Additionally, or in the alternative, thetreatment site 106 can include vascular lesions such as fibrous vascular lesions. - The
catheter 102 can include an inflatable balloon 104 (sometimes referred to herein simply as a "balloon"), acatheter shaft 110 and aguidewire 112. Theinflatable balloon 104 can be coupled to thecatheter shaft 110. Theinflatable balloon 104 can include a balloonproximal end 104P and a balloondistal end 104D. Thecatheter shaft 110 can extend from aproximal portion 114 of thecatheter system 100 to adistal portion 116 of thecatheter system 100. Thecatheter shaft 110 can include alongitudinal axis 144. Thecatheter shaft 110 can also include aguidewire lumen 118 which is configured to move over theguidewire 112. Thecatheter shaft 110 can further include an inflation lumen (not shown). In some embodiments, thecatheter 102 can have adistal end opening 120 and can accommodate and be tracked over theguidewire 112 as thecatheter 102 is moved and positioned at or near thetreatment site 106. In some embodiments, the balloonproximal end 104P can be coupled to thecatheter shaft 110, and the balloondistal end 104D can be coupled to theguidewire lumen 118. - The
catheter shaft 110 of thecatheter 102 can be coupled to the one or more light guides 122A of thelight guide bundle 122 that are in optical communication with thelight source 124. The light guide(s) 122A can be disposed along thecatheter shaft 110 and within theinflatable balloon 104. In some embodiments, eachlight guide 122A can be an optical fiber and thelight source 124 can be a laser. Thelight source 124 can be in optical communication with the light guides 122A at theproximal portion 114 of thecatheter system 100. - In some embodiments, the
catheter shaft 110 can be coupled to multiplelight guides 122A such as a first light guide, a second light guide, a third light guide, etc., which can be disposed at any suitable positions about theguidewire lumen 118 and/or thecatheter shaft 110. For example, in certain non-exclusive embodiments, twolight guides 122A can be spaced apart by approximately 180 degrees about the circumference of theguidewire lumen 118 and/or thecatheter shaft 110; threelight guides 122A can be spaced apart by approximately 120 degrees about the circumference of theguidewire lumen 118 and/or thecatheter shaft 110; or fourlight guides 122A can be spaced apart by approximately 90 degrees about the circumference of theguidewire lumen 118 and/or thecatheter shaft 110. Still alternatively, multiplelight guides 122A need not be uniformly spaced apart from one another about the circumference of theguidewire lumen 118 and/or thecatheter shaft 110. More particularly, it is further appreciated that the light guides 122A described herein can be disposed uniformly or non-uniformly about theguidewire lumen 118 and/or thecatheter shaft 110 to achieve the desired effect in the desired locations. - The
inflatable balloon 104 can include aballoon wall 130 that defines aballoon interior 146, and can be inflated with aballoon fluid 132 to expand from a collapsed configuration suitable for advancing thecatheter 102 through a patient's vasculature, to an expanded configuration suitable for anchoring thecatheter 102 in position relative to thetreatment site 106. Stated in another manner, when theinflatable balloon 104 is in the expanded configuration, theballoon wall 130 of theinflatable balloon 104 is configured to be positioned substantially adjacent to thetreatment site 106. In some embodiments, thelight source 124 of thecatheter system 100 can be configured to provide sub-millisecond pulses of light from thelight source 124, along the light guides 122A, to a location within theballoon interior 146 of theinflatable balloon 104, thereby inducing plasma formation in theballoon fluid 132 within theballoon interior 146 of theinflatable balloon 104. The plasma formation causes rapid bubble formation, and imparts pressure waves upon thetreatment site 106. Exemplary plasma-induced bubbles are shown asbubbles 134 inFigure 1 . - It is appreciated that although the
catheter systems 100 illustrated herein are generally described as including alight source 124 and one or more light guides 122A, thecatheter system 100 can alternatively include any suitable energy source and energy guides for purposes of generating the desired plasma in theballoon fluid 132 within theballoon interior 146. For example, in one non-exclusive alternative embodiment, theenergy source 124 can be configured to provide high voltage pulses, and eachenergy guide 122A can include an electrode pair including spaced apart electrodes that extend into theballoon interior 146. In such embodiment, each pulse of high voltage is applied to the electrodes and forms an electrical arc across the electrodes, which, in turn, forms the pressure waves within theballoon fluid 132 that are utilized to provide the fracture force onto thetreatment site 106. Still alternatively, theenergy source 124 and/or the energy guides 122A can have another suitable design and/or configuration. - The
balloons 104 suitable for use in thecatheter systems 100 described in detail herein include those that can be passed through the vasculature of a patient when in the collapsed configuration. In some embodiments, theballoons 104 herein are made from silicone. In other embodiments, theballoons 104 herein are made from polydimethylsiloxane (PDMS), polyurethane, polymers such as PEBAX™ material available from Arkema, which has a location at King of Prussia, Pennsylvania, USA, nylon, and the like. In some embodiments, theballoons 104 can include those having diameters ranging from one millimeter (mm) to 25 mm in diameter. In some embodiments, theballoons 104 can include those having diameters ranging from at least 1.5 mm to 12 mm in diameter. In some embodiments, theballoons 104 can include those having diameters ranging from at least one mm to five mm in diameter. - Additionally, in some embodiments, the
balloons 104 herein can include those having a length ranging from at least five mm to 300 mm. More particularly, in some embodiments, theballoons 104 herein can include those having a length ranging from at least eight mm to 200 mm. It is appreciated thatballoons 104 of greater length can be positioned adjacent tolarger treatment sites 106, and, thus, may be usable for imparting pressure onto and inducing fractures in larger vascular lesions or multiple vascular lesions at precise locations at thetreatment site 106. - Further, the
balloons 104 herein can be inflated to inflation pressures of between approximately one atmosphere (atm) and 70 atm. In some embodiments, theballoons 104 herein can be inflated to inflation pressures of from at least 20 atm to 70 atm. In other embodiments, theballoons 104 herein can be inflated to inflation pressures of from at least six atm to 20 atm. In still other embodiments, theballoons 104 herein can be inflated to inflation pressures of from at least three atm to 20 atm. In yet other embodiments, theballoons 104 herein can be inflated to inflation pressures of from at least two atm to ten atm. - Still further, the
balloons 104 herein can include those having various shapes, including, but not to be limited to, a conical shape, a square shape, a rectangular shape, a spherical shape, a conical/square shape, a conical/spherical shape, an extended spherical shape, an oval shape, a tapered shape, a bone shape, a stepped diameter shape, an offset shape, or a conical offset shape. In some embodiments, theballoons 104 herein can include a drug eluting coating or a drug eluting stent structure. The drug eluting coating or drug eluting stent can include one or more therapeutic agents including anti-inflammatory agents, anti-neoplastic agents, anti-angiogenic agents, and the like. - The
balloon fluid 132 can be a liquid or a gas.Exemplary balloon fluids 132 suitable for use herein can include, but are not limited to one or more of water, saline, contrast medium, fluorocarbons, perfluorocarbons, gases, such as carbon dioxide, and the like. In some embodiments, theballoon fluids 132 described can be used as base inflation fluids. In some embodiments, theballoon fluids 132 include a mixture of saline to contrast medium in a volume ratio of 50:50. In other embodiments, theballoon fluids 132 include a mixture of saline to contrast medium in a volume ratio of 25:75. In still other embodiments, theballoon fluids 132 include a mixture of saline to contrast medium in a volume ratio of 75:25. Additionally, theballoon fluids 132 suitable for use herein can be tailored on the basis of composition, viscosity, and the like in order to manipulate the rate of travel of the pressure waves therein. In certain embodiments, theballoon fluids 132 suitable for use herein are biocompatible. A volume ofballoon fluid 132 can be tailored by the chosenlight source 124 and the type ofballoon fluid 132 used. - In some embodiments, the contrast agents used in the contrast media herein can include, but are not to be limited to, iodine-based contrast agents, such as ionic or non-ionic iodine-based contrast agents. Some non-limiting examples of ionic iodine-based contrast agents include diatrizoate, metrizoate, iothalamate, and ioxaglate. Some non-limiting examples of non-ionic iodine-based contrast agents include iopamidol, iohexol, ioxilan, iopromide, iodixanol, and ioversol. In other embodiments, non-iodine based contrast agents can be used. Suitable non-iodine containing contrast agents can include gadolinium (III)-based contrast agents. Suitable fluorocarbon and perfluorocarbon agents can include, but are not to be limited to, agents such as the perfluorocarbon dodecafluoropentane (DDFP, C5F12).
- Additionally, the
balloon fluids 132 herein can include those that include absorptive agents that can selectively absorb light in the ultraviolet region (e.g., at least ten nanometers (nm) to 400 nm), the visible region (e.g., at least 400 nm to 780 nm), or the near-infrared region (e.g., at least 780 nm to 2.5 µm) of the electromagnetic spectrum. Suitable absorptive agents can include those with absorption maxima along the spectrum from at least ten nm to 2.5 µm. Alternatively, theballoon fluids 132 can include those that include absorptive agents that can selectively absorb light in the mid-infrared region (e.g., at least 2.5 µm to 15 µm), or the far-infrared region (e.g., at least 15 µm to one mm) of the electromagnetic spectrum. In various embodiments, the absorptive agent can be those that have an absorption maximum matched with the emission maximum of the laser used in the catheter system. By way of non-limiting examples, various lasers described herein can include neodymium:yttrium-aluminum-garnet (Nd:YAG - emission maximum = 1064 nm) lasers, holmium:YAG (Ho:YAG - emission maximum = 2.1 µm) lasers, or erbium:YAG (Er:YAG - emission maximum = 2.94 µm) lasers. In some embodiments, the absorptive agents used herein can be water soluble. In other embodiments, the absorptive agents used herein are not water soluble. In some embodiments, the absorptive agents used in theballoon fluids 132 herein can be tailored to match the peak emission of thelight source 124. Variouslight sources 124 having emission wavelengths of at least ten nanometers to one millimeter are discussed elsewhere herein. - It is appreciated that the
catheter system 100 and/or thelight guide bundle 122 disclosed herein can include any number oflight guides 122A in optical communication with thelight source 124 at theproximal portion 114, and with theballoon fluid 132 within theballoon interior 146 of theinflatable balloon 104 at thedistal portion 116. For example, in some embodiments, thecatheter system 100 and/or thelight guide bundle 122 can include from onelight guide 122A to fivelight guides 122A. In other embodiments, thecatheter system 100 and/or thelight guide bundle 122 can include from fivelight guides 122A to fifteenlight guides 122A. In yet other embodiments, thecatheter system 100 and/or thelight guide bundle 122 can include from tenlight guides 122A to thirtylight guides 122A. Alternatively, in still other embodiments, thecatheter system 100 and/or thelight guide bundle 122 can include greater than 30light guides 122A. - The light guides 122A herein can include an optical fiber or flexible light pipe. The light guides 122A herein can be thin and flexible and can allow light signals to be sent with very little loss of strength. The light guides 122A herein can include a core surrounded by a cladding about its circumference. In some embodiments, the core can be a cylindrical core or a partially cylindrical core. The core and cladding of the light guides 122A can be formed from one or more materials, including but not limited to one or more types of glass, silica, or one or more polymers. The light guides 122A may also include a protective coating, such as a polymer. It is appreciated that the index of refraction of the core will be greater than the index of refraction of the cladding.
- Each
light guide 122A can guide light along its length from a proximal portion, i.e. a guideproximal end 122P, to a distal portion, i.e. a guidedistal end 122D, having at least one optical window (not shown) that is positioned within theballoon interior 146. The light guides 122A can create a light path as a portion of an optical network including thelight source 124. The light path within the optical network allows light to travel from one part of the network to another. Both the optical fiber and the flexible light pipe can provide a light path within the optical networks herein. - Further, the light guides 122A herein can assume many configurations about and/or relative to the
catheter shaft 110 of thecatheters 102 described herein. In some embodiments, the light guides 122A can run parallel to thelongitudinal axis 144 of thecatheter shaft 110. In some embodiments, the light guides 122A can be physically coupled to thecatheter shaft 110. In other embodiments, the light guides 122A can be disposed along a length of an outer diameter of thecatheter shaft 110. In yet other embodiments, the light guides 122A herein can be disposed within one or more light guide lumens within thecatheter shaft 110. - Additionally, it is further appreciated that the light guides 122A can be disposed at any suitable positions about the circumference of the
guidewire lumen 118 and/or thecatheter shaft 110, and the guidedistal end 122D of each of the light guides 122A can be disposed at any suitable longitudinal position relative to the length of theinflatable balloon 104 and/or relative to the length of theguidewire lumen 118. - Further, the light guides 122A herein can include one or more
photoacoustic transducers 154, where eachphotoacoustic transducer 154 can be in optical communication with thelight guide 122A within which it is disposed. In some embodiments, thephotoacoustic transducers 154 can be in optical communication with the guidedistal end 122D of thelight guide 122A. Additionally, in such embodiments, thephotoacoustic transducers 154 can have a shape that corresponds with and/or conforms to the guidedistal end 122D of thelight guide 122A. - The
photoacoustic transducer 154 is configured to convert light energy into an acoustic wave at or near the guidedistal end 122D of thelight guide 122A. It is appreciated that the direction of the acoustic wave can be tailored by changing an angle of the guidedistal end 122D of thelight guide 122A. - It is further appreciated that the
photoacoustic transducers 154 disposed at the guidedistal end 122D of thelight guide 122A herein can assume the same shape as the guidedistal end 122D of thelight guide 122A. For example, in certain non-exclusive embodiments, thephotoacoustic transducer 154 and/or the guidedistal end 122D can have a conical shape, a convex shape, a concave shape, a bulbous shape, a square shape, a stepped shape, a half-circle shape, an ovoid shape, and the like. It is also appreciated that thelight guide 122A can further include additionalphotoacoustic transducers 154 disposed along one or more side surfaces of the length of thelight guide 122A. - The light guides 122A described herein can further include one or more diverting features or "diverters" (not shown in
Figure 1 ) within thelight guide 122A that are configured to direct light to exit thelight guide 122A toward a side surface e.g., at or near the guidedistal end 122D of thelight guide 122A, and toward theballoon wall 130. A diverting feature can include any feature of the system herein that diverts light from thelight guide 122A away from its axial path toward a side surface of thelight guide 122A. Additionally, the light guides 122A can each include one or more light windows disposed along the longitudinal or axial surfaces of eachlight guide 122A and in optical communication with a diverting feature. Stated in another manner, the diverting features herein can be configured to direct light in thelight guide 122A toward a side surface, e.g., at or near the guidedistal end 122D, where the side surface is in optical communication with a light window. The light windows can include a portion of thelight guide 122A that allows light to exit thelight guide 122A from within thelight guide 122A, such as a portion of thelight guide 122A lacking a cladding material on or about thelight guide 122A. - Examples of the diverting features suitable for use herein include a reflecting element, a refracting element, and a fiber diffuser. Additionally, the diverting features suitable for focusing light away from the tip of the light guides 122A herein can include, but are not to be limited to, those having a convex surface, a gradient-index (GRIN) lens, and a mirror focus lens. Upon contact with the diverting feature, the light is diverted within the
light guide 122A to thephotoacoustic transducer 154 that is in optical communication with a side surface of thelight guide 122A. As noted, thephotoacoustic transducer 154 then converts light energy into an acoustic wave that extends away from the side surface of thelight guide 122A. - The source manifold 136 can be positioned at or near the
proximal portion 114 of thecatheter system 100. The source manifold 136 can include one or more proximal end openings that can receive the plurality oflight guides 122A of thelight guide bundle 122, theguidewire 112, and/or aninflation conduit 140 that is coupled in fluid communication with thefluid pump 138. Thecatheter system 100 can also include thefluid pump 138 that is configured to inflate theinflatable balloon 104 with theballoon fluid 132, i.e. via theinflation conduit 140, as needed. - As noted above, in the embodiment illustrated in
Figure 1 , thesystem console 123 includes one or more of thelight source 124, thepower source 125, thesystem controller 126, and theGUI 127. Alternatively, thesystem console 123 can include more components or fewer components than those specifically illustrated inFigure 1 . For example, in certain non-exclusive alternative embodiments, thesystem console 123 can be designed without theGUI 127. Still alternatively, one or more of thelight source 124, thepower source 125, thesystem controller 126, and theGUI 127 can be provided within thecatheter system 100 without the specific need for thesystem console 123. - Further, as illustrated in
Figure 1 , in certain embodiments, at least a portion of theelectrical analyzer assembly 142 can also be positioned substantially within thesystem console 123. Alternatively, components of theelectrical analyzer assembly 142 can be positioned in a different manner than what is specifically shown inFigure 1 . - Additionally, as shown, the
system console 123, and the components included therewith, is operatively coupled to thecatheter 102, thelight guide bundle 122, and the remainder of thecatheter system 100. For example, in some embodiments, as illustrated inFigure 1 , thesystem console 123 can include a console connection aperture 148 (also sometimes referred to generally as a "socket") by which thelight guide bundle 122 is mechanically coupled to thesystem console 123. In such embodiments, thelight guide bundle 122 can include a guide coupling housing 150 (also sometimes referred to generally as a "ferrule") that houses a portion, e.g., the guideproximal end 122P, of each of the light guides 122A. Theguide coupling housing 150 is configured to fit and be selectively retained within theconsole connection aperture 148 to provide the desired mechanical coupling between thelight guide bundle 122 and thesystem console 123. - Further, the
light guide bundle 122 can also include a guide bundler 152 (or "shell") that brings each of the individual light guides 122A closer together so that the light guides 122A and/or thelight guide bundle 122 can be in a more compact form as it extends with thecatheter 102 into theblood vessel 108 during use of thecatheter system 100. - As provided herein, the
light source 124 can be selectively and/or alternatively coupled in optical communication with each of the light guides 122A, i.e. to the guideproximal end 122P of each of the light guides 122A, in thelight guide bundle 122. In particular, thelight source 124 is configured to generate light energy in the form of asource beam 124A, e.g., a pulsed source beam, that can be selectively and/or alternatively directed to and received by each of the light guides 122A in thelight guide bundle 122 as anindividual guide beam 124B. Alternatively, thecatheter system 100 can include more than onelight source 124. For example, in one non-exclusive alternative embodiment, thecatheter system 100 can include a separatelight source 124 for each of the light guides 122A in thelight guide bundle 122. - The
light source 124 can have any suitable design. In certain embodiments, as noted above, thelight source 124 can be configured to provide sub-millisecond pulses of light from thelight source 124 that are focused onto a small spot in order to couple it into the guideproximal end 122P of thelight guide 122A. Such pulses of light energy are then directed along the light guides 122A to a location within theinflatable balloon 104, thereby inducing plasma formation in theballoon fluid 132 within theballoon interior 146 of theinflatable balloon 104. In particular, the light energy emitted at the guidedistal end 122D of thelight guide 122A energizes the plasma generator to form the plasma within theballoon fluid 132 within theballoon interior 146. The plasma formation causes rapid bubble formation, and imparts pressure waves upon thetreatment site 106. In such embodiments, the sub-millisecond pulses of light from thelight source 124 can be delivered to thetreatment site 106 at a frequency of between approximately one hertz (Hz) and 5000 Hz. In some embodiments, the sub-millisecond pulses of light from thelight source 124 can be delivered to thetreatment site 106 at a frequency of between approximately 30 Hz and 1000 Hz. In other embodiments, the sub-millisecond pulses of light from thelight source 124 can be delivered to thetreatment site 106 at a frequency of between approximately ten Hz and 100 Hz. In yet other embodiments, the sub-millisecond pulses of light from thelight source 124 can be delivered to thetreatment site 106 at a frequency of between approximately one Hz and 30 Hz. Alternatively, the sub-millisecond pulses of light can be delivered to thetreatment site 106 at a frequency that can be greater than 5000 Hz. - It is appreciated that although the
light source 124 is typically utilized to provide pulses of light energy, thelight source 124 can still be described as providing asingle source beam 124A, i.e. a single pulsed source beam. - The
light sources 124 suitable for use herein can include various types of light sources including lasers and lamps. Alternatively, as noted above, thelight sources 124, as referred to herein, can include any suitable type of energy source. - Suitable lasers can include short pulse lasers on the sub-millisecond timescale. In some embodiments, the
light source 124 can include lasers on the nanosecond (ns) timescale. The lasers can also include short pulse lasers on the picosecond (ps), femtosecond (fs), and microsecond (µs) timescales. It is appreciated that there are many combinations of laser wavelengths, pulse widths and energy levels that can be employed to achieve plasma in theballoon fluid 132 of thecatheters 102 described herein. In various embodiments, the pulse widths can include those falling within a range including from at least ten ns to 200 ns. In some embodiments, the pulse widths can include those falling within a range including from at least 20 ns to 100 ns. In other embodiments, the pulse widths can include those falling within a range including from at least one ns to 500 ns. - Additionally, exemplary nanosecond lasers can include those within the UV to IR spectrum, spanning wavelengths of about ten nanometers (nm) to one millimeter (mm). In some embodiments, the
light sources 124 suitable for use in thecatheter systems 100 herein can include those capable of producing light at wavelengths of from at least 750 nm to 2000 nm. In other embodiments, thelight sources 124 can include those capable of producing light at wavelengths of from at least 700 nm to 3000 nm. In still other embodiments, thelight sources 124 can include those capable of producing light at wavelengths of from at least 100 nm to ten micrometers (µm). Nanosecond lasers can include those having repetition rates of up to 200 kHz. In some embodiments, the laser can include a Q-switched thulium:yttrium-aluminum-garnet (Tm:YAG) laser. In other embodiments, the laser can include a neodymium:yttrium-aluminum-garnet (Nd:YAG) laser, holmium:yttrium-aluminum-garnet (Ho:YAG) laser, erbium:yttrium-aluminum-garnet (Er:YAG) laser, excimer laser, helium-neon laser, carbon dioxide laser, as well as doped, pulsed, fiber lasers. - The
catheter systems 100 disclosed herein can generate pressure waves having maximum pressures in the range of at least one megapascal (MPa) to 100 MPa. The maximum pressure generated by aparticular catheter system 100 will depend on thelight source 124, the absorbing material, the bubble expansion, the propagation medium, the balloon material, and other factors. In some embodiments, thecatheter systems 100 herein can generate pressure waves having maximum pressures in the range of at least two MPa to 50 MPa. In other embodiments, thecatheter systems 100 herein can generate pressure waves having maximum pressures in the range of at least two MPa to 30 MPa. In yet other embodiments, thecatheter systems 100 herein can generate pressure waves having maximum pressures in the range of at least 15 MPa to 25 MPa. - The pressure waves described herein can be imparted upon the
treatment site 106 from a distance within a range from at least 0.1 millimeters (mm) to 25 mm extending radially from the light guides 122A when thecatheter 102 is placed at thetreatment site 106. In some embodiments, the pressure waves can be imparted upon thetreatment site 106 from a distance within a range from at least ten mm to 20 mm extending radially from the light guides 122A when thecatheter 102 is placed at thetreatment site 106. In other embodiments, the pressure waves can be imparted upon thetreatment site 106 from a distance within a range from at least one mm to ten mm extending radially from the light guides 122A when thecatheter 102 is placed at thetreatment site 106. In yet other embodiments, the pressure waves can be imparted upon thetreatment site 106 from a distance within a range from at least 1.5 mm to four mm extending radially from the light guides 122A when thecatheter 102 is placed at thetreatment site 106. In some embodiments, the pressure waves can be imparted upon thetreatment site 106 from a range of at least two MPa to 30 MPa at a distance from 0.1 mm to ten mm. In some embodiments, the pressure waves can be imparted upon thetreatment site 106 from a range of at least two MPa to 25 MPa at a distance from 0.1 mm to ten mm. - The
power source 125 is electrically coupled to and is configured to provide necessary power to each of thelight source 124, thesystem controller 126, theGUI 127, thehandle assembly 128, and theelectrical analyzer assembly 142. Thepower source 125 can have any suitable design for such purposes. - As noted, the
system controller 126 is electrically coupled to and receives power from thepower source 125. Additionally, thesystem controller 126 is coupled to and is configured to control operation of each of thelight source 124, theGUI 127 and theelectrical analyzer assembly 142. Thesystem controller 126 can include one or more processors or circuits for purposes of controlling the operation of at least thelight source 124, theGUI 127 and theelectrical analyzer assembly 142. For example, thesystem controller 126 can control thelight source 124 for generating pulses of light energy as desired, e.g., at any desired firing rate. Additionally, thesystem controller 126 can control and/or operate in conjunction with theelectrical analyzer assembly 142 to effectively provide real-time continuous monitoring of the performance, reliability and safety of thecatheter system 100. - Additionally, the
system controller 126 can further be configured to control operation of other components of thecatheter system 100, e.g., the positioning of thecatheter 102 adjacent to thetreatment site 106, the inflation of theinflatable balloon 104 with theballoon fluid 132, etc. Further, or in the alternative, thecatheter system 100 can include one or more additional controllers that can be positioned in any suitable manner for purposes of controlling the various operations of thecatheter system 100. For example, in certain embodiments, an additional controller and/or a portion of thesystem controller 126 can be positioned and/or incorporated within thehandle assembly 128. - The
GUI 127 is accessible by the user or operator of thecatheter system 100. Additionally, theGUI 127 is electrically connected to thesystem controller 126. With such design, theGUI 127 can be used by the user or operator to ensure that thecatheter system 100 is employed as desired to impart pressure onto and induce fractures into the vascular lesions at thetreatment site 106. Additionally, theGUI 127 can provide the user or operator with information that can be used before, during and after use of thecatheter system 100. In one embodiment, theGUI 127 can provide static visual data and/or information to the user or operator. In addition, or in the alternative, theGUI 127 can provide dynamic visual data and/or information to the user or operator, such as video data or any other data that changes over time, e.g., during use of thecatheter system 100. Further, in various embodiments, theGUI 127 can include one or more colors, different sizes, varying brightness, etc., that may act as alerts to the user or operator. Additionally, or in the alternative, theGUI 127 can provide audio data or information to the user or operator. It is appreciated that the specifics of theGUI 127 can vary depending upon the design requirements of thecatheter system 100, or the specific needs, specifications and/or desires of the user or operator. - As shown in
Figure 1 , thehandle assembly 128 can be positioned at or near theproximal portion 114 of thecatheter system 100, and/or near thesource manifold 136. Additionally, in this embodiment, thehandle assembly 128 is coupled to theinflatable balloon 104 and is positioned spaced apart from theinflatable balloon 104. Alternatively, thehandle assembly 128 can be positioned at another suitable location. - The
handle assembly 128 is handled and used by the user or operator to operate, position and control thecatheter 102. The design and specific features of thehandle assembly 128 can vary to suit the design requirements of thecatheter system 100. In the embodiment illustrated inFigure 1 , thehandle assembly 128 is separate from, but in electrical and/or fluid communication with one or more of thesystem controller 126, thelight source 124, thefluid pump 138, theGUI 127 and theelectrical analyzer assembly 142. In some embodiments, thehandle assembly 128 can integrate and/or include at least a portion of thesystem controller 126 within an interior of thehandle assembly 128. For example, as shown, in certain such embodiments, thehandle assembly 128 can includecircuitry 156 that can form at least a portion of thesystem controller 126. Additionally, in some embodiments, thecircuitry 156 can receive electrical signals or data from theelectrical analyzer assembly 142. Further, or in the alternative, thecircuitry 156 can transmit such electrical signals or otherwise provide data to thesystem controller 126. - In one embodiment, the
circuitry 156 can include a printed circuit board having one or more integrated circuits, or any other suitable circuitry. In an alternative embodiment, thecircuitry 156 can be omitted, or can be included within thesystem controller 126, which in various embodiments can be positioned outside of thehandle assembly 128, e.g., within thesystem console 123. It is understood that thehandle assembly 128 can include fewer or additional components than those specifically illustrated and described herein. - As an overview, and as provided in greater detail herein, the
electrical analyzer assembly 142 is configured to effectively monitor the performance, reliability and safety of thecatheter system 100, in particular one that utilizes anenergy source 124 to create a localized plasma which in turn induces a high energy bubble in theballoon fluid 132 within theballoon interior 146 of theinflatable balloon 104. More particularly, as described in detail herein, theelectrical analyzer assembly 142 is specifically configured to effectively detect damage to, and/or rupturing or bursting of theinflatable balloon 104 during use of thecatheter system 100. - During use of the
catheter system 100, the generation of the localized plasma and the subsequent inducement of high energy bubbles in theballoon fluid 132 within theballoon interior 146 can cause the balloon fluid to heat up substantially, which, in addition to the pressure waves that are generated within theballoon interior 146, can put substantial stresses onto theballoon wall 130 of theinflatable balloon 104. Thus, the present invention is utilized to detect and/or identify when such stresses ultimately cause damage to theinflatable balloon 104, especially in the form of the potential rupturing or bursting of theinflatable balloon 104. As provided herein, if theelectrical analyzer assembly 142 provides an indication, e.g., to thesystem controller 126, that theinflatable balloon 104 has ruptured, it is important and necessary that the procedure be stopped immediately, as such a failure presents a substantial risk to thepatient 109, including potential harms such as tissue burns. Thus, with the invention described herein, the rupture of theinflatable balloon 104 can be quickly and successfully detected, and an indicator or signal can be provided that is used to lock out theenergy source 124. This provides a necessary safety interlock for a potentially hazardous condition in which theballoon fluid 132 is able to leak out. - The design of the
electrical analyzer assembly 142 can be varied to suit the specific requirements of thecatheter system 100. In various embodiments, as described herein, theelectrical analyzer assembly 142 can include one or more of afirst electrode 158, asecond electrode 160, and animpedance detector 162. Alternatively, theelectrical analyzer assembly 142 can include more components or fewer components than what is specifically illustrated and described herein. - The
first electrode 158 can be positioned at any suitable location within thecatheter system 100 so that it is in communication with theballoon fluid 132 that is positioned within theballoon interior 146 of theinflatable balloon 104. For example, in some embodiments, as shown inFigure 1 , thefirst electrode 158 can be positioned within theballoon interior 146. Alternatively, thefirst electrode 158 can be positioned in another suitable location that is in communication with theballoon fluid 132 within theballoon interior 146. For example, in certain non-exclusive alternative embodiments, thefirst electrode 158 can be positioned within thehandle assembly 128, within and/or adjacent to theinflation conduit 140, within and/or adjacent to the inflation lumen, and/or in another suitable location. - Additionally, the
second electrode 160 can be positioned at any suitable location within thecatheter system 100 so that it is in communication with the blood of the patient, i.e. so that no nonconductive materials of thecatheter system 100 are positioned between thesecond electrode 160 and the blood of thepatient 109. For example, in certain non-exclusive alternative embodiments, thesecond electrode 160 can be positioned inside the fluid channel within theguidewire lumen 118, on theguidewire 112, and/or in another suitable location. - It is appreciated that with the general design of the
electrical analyzer assembly 142 described herein, while thefirst electrode 158 is in communication with theballoon fluid 132 within theballoon interior 146, during normal operation thefirst electrode 158 is not in communication with the blood of thepatient 109 as at least the nonconductive materials of theinflatable balloon 104 are positioned therebetween. Similarly, it is further appreciated that while thesecond electrode 160 is in communication with the blood of thepatient 109, during normal operation thesecond electrode 160 is not in communication with theballoon fluid 132 within theballoon interior 146 as at least the nonconductive materials of theinflatable balloon 104 are positioned therebetween. - As noted above, the
impedance detector 162 is connected in electrical communication with each of thefirst electrode 158 and thesecond electrode 160. As such, theimpedance detector 162 is configured to detect and thus provide real-time continuous monitoring of the impedance between thefirst electrode 158 and thesecond electrode 160. Impedance is the effective measurement of the degree a body resists the flow of electrical current, with the body's fluid and tissues acting as conductors of electrical current. It is appreciated that theimpedance detector 162 can be electrically coupled to each of thefirst electrode 158 and thesecond electrode 160 via a wireless connection, or via a wired connection. - The
impedance detector 162 can be positioned in any suitable location where it can be in electrical communication with thefirst electrode 158 and thesecond electrode 160. For example, in some embodiments, as shown inFigure 1 , theimpedance detector 162 can be positioned substantially within thesystem console 123 and/or adjacent to thesystem controller 126. Alternatively, theimpedance detector 162 can be positioned in another suitable location within thecatheter system 100. For example, in certain non-exclusive alternative embodiments, theimpedance detector 162 can be positioned within and/or adjacent to thehandle assembly 128, inside thecatheter 102, and/or in another suitable location. - As provided herein, the
impedance detector 162 is configured to detect the impedance between thefirst electrode 158 and thesecond electrode 160 during operation of thecatheter system 100. Theimpedance detector 162 can then generate a detector signal or detector output, e.g., electrical signals regarding the detected impedance, and send the detector signal or detector output to thesystem controller 126 and/or thecircuitry 156 within thehandle assembly 128 for processing. Thesystem controller 126 can then provide appropriate information to the user or operator, e.g., via theGUI 127, as to the status of operation of thecatheter system 100, e.g., the potential rupturing of theinflatable balloon 104. It is appreciated that theimpedance detector 162 can be electrically connected to thesystem controller 126 via a wireless connection, or via a wired connection. - Under normal operating circumstances, the detected impedance would be very high, e.g., within an expected impedance range, since the
first electrode 158 is insulated from thesecond electrode 160 by the nonconductive materials of thecatheter 102. Additionally, theimpedance detector 162 and/or thesystem controller 126 would process the detector signal to look for sudden drops in impedance between theelectrodes inflatable balloon 104, since a rupturedinflatable balloon 104 would remove the insulated barrier between theelectrodes - Thus, in summary, if the
inflatable balloon 104 ruptures, the procedure must be stopped immediately. The present invention detects this failure and provides an indicator or signal that thesystem controller 126 could use to lock out theenergy source 124. This provides a necessary safety interlock for a potentially hazardous condition in which theenergy source 124 is able to leak out of the rupturedinflatable balloon 104. Moreover, the signal could be used to indicate to the user or operator, e.g., via theGUI 127, to halt the procedure and remove theinflatable balloon 104 from thepatient 109 under treatment. -
Figure 2 is a schematic cross-sectional view of another embodiment of thecatheter system 200 including another embodiment of theelectrical analyzer assembly 242. The design of thecatheter system 200 is substantially similar to the embodiment illustrated and described herein above. In particular, in the embodiment shown inFigure 2 , thecatheter system 200 can again include acatheter 202 including acatheter shaft 210, aninflatable balloon 204 having aballoon wall 230 that defines aballoon interior 246, a balloonproximal end 204P, and a balloondistal end 204D, aballoon fluid 232 that is retained substantially within theballoon interior 246, aguidewire 212, and aguidewire lumen 218 that extends into theballoon interior 246; anenergy guide bundle 222 including one ormore energy guides 222A; asource manifold 236; afluid pump 238; asystem console 223 including one or more of anenergy source 224, apower source 225, asystem controller 226, and aGUI 227; ahandle assembly 228; and theelectrical analyzer assembly 242. Alternatively, in other embodiments, thecatheter system 200 can include more components or fewer components than what is specifically illustrated and described herein. - The
catheter 202, including thecatheter shaft 210, theinflatable balloon 204, theguidewire 212, and theguidewire lumen 218, is generally similar in design and operation to what has been described in detail herein above. Thus, such components will not be described in detail again in relation to the embodiment shown inFigure 2 . - As above, the
inflatable balloon 204 is selectively movable between a collapsed configuration suitable for advancing thecatheter 202 through a patient's vasculature, and an expanded configuration suitable for anchoring thecatheter 202 in position relative to thetreatment site 106. In some embodiments, the balloonproximal end 204P can be coupled to thecatheter shaft 210, and the balloondistal end 204D can be coupled to theguidewire lumen 218. Additionally, theinflatable balloon 204 can be inflated with theballoon fluid 232, e.g., from thefluid pump 238, that is directed into theballoon interior 246 of theinflatable balloon 204 via theinflation conduit 240. - Additionally, the
energy guide bundle 222 including the one or more energy guides 222A, and thesystem console 223 including one or more of theenergy source 224, thepower source 225, thesystem controller 226, and theGUI 227, are generally similar in design and operation to what has been described in detail herein above. Accordingly, such components will not be described in detail again in relation to the embodiment shown inFigure 2 . - Further, as above, the
handle assembly 228 is handled and used by the user or operator to operate, position and control thecatheter 202. Additionally, as shown in the embodiment illustrated inFigure 2 , thehandle assembly 228 can again includecircuitry 256 that can form a portion of thesystem controller 226. Alternatively, thehandle assembly 228 can be configured without thecircuitry 256. - As with the previous embodiment, the
electrical analyzer assembly 242 is again configured to monitor the performance, reliability and safety of thecatheter system 200. Additionally, the design of theelectrical analyzer assembly 242 can be somewhat similar to what was illustrated and described herein above in relation to the embodiment shown inFigure 1 . For example, theelectrical analyzer assembly 242 can again include afirst electrode 258, asecond electrode 260, and animpedance detector 262 that is connected in electrical communication with thefirst electrode 258 and thesecond electrode 260 in order to effectively measure and/or detect the impedance between thefirst electrode 258 and thesecond electrode 260. - However, in the embodiment shown in
Figure 2 , one or more of thefirst electrode 258, thesecond electrode 260 and theimpedance detector 262 can be positioned in a different manner than in the previous embodiment. More particularly, as shown inFigure 2 , in this embodiment, thefirst electrode 258 is again positioned within theballoon interior 246, and theimpedance detector 262 is again positioned adjacent to and/or in electrical communication with thesystem controller 226, but thesecond electrode 260 is now positioned inside the fluid channel within theguidewire lumen 218. - It is appreciated that with such design, during normal operation, the
first electrode 258 is still in communication with theballoon fluid 232 within theballoon interior 246, but not in communication with the blood of thepatient 109; and thesecond electrode 260 is still in communication with the blood of thepatient 109, but not in communication with theballoon fluid 232 within theballoon interior 246. Additionally, it is further appreciated that with such design, theimpedance detector 262, in conjunction with thesystem controller 226 and/or thecircuitry 256 in thehandle assembly 228, is still configured to look for sudden drops in impedance between theelectrodes inflatable balloon 204, which would necessitate that the procedure be immediately stopped and thecatheter 202 removed from thepatient 109. -
Figure 3 is a schematic cross-sectional view of still another embodiment of thecatheter system 300 including still another embodiment of theelectrical analyzer assembly 342. The design of thecatheter system 300 is substantially similar to the embodiments illustrated and described herein above. In particular, in the embodiment shown inFigure 3 , thecatheter system 300 can again include acatheter 302 including acatheter shaft 310, aninflatable balloon 304 having aballoon wall 330 that defines aballoon interior 346, a balloonproximal end 304P, and a balloondistal end 304D, aballoon fluid 332 that is retained substantially within theballoon interior 346, aguidewire 312, and aguidewire lumen 318 that extends into theballoon interior 346; anenergy guide bundle 322 including one ormore energy guides 322A; asource manifold 336; afluid pump 338; asystem console 323 including one or more of anenergy source 324, apower source 325, asystem controller 326, and aGUI 327; ahandle assembly 328; and theelectrical analyzer assembly 342. Alternatively, in other embodiments, thecatheter system 300 can include more components or fewer components than what is specifically illustrated and described herein. - The
catheter 302, including thecatheter shaft 310, theinflatable balloon 304, theguidewire 312, and theguidewire lumen 318, is generally similar in design and operation to what has been described in detail herein above. Thus, such components will not be described in detail again in relation to the embodiment shown inFigure 3 . - As above, the
inflatable balloon 304 is selectively movable between a collapsed configuration suitable for advancing thecatheter 302 through a patient's vasculature, and an expanded configuration suitable for anchoring thecatheter 302 in position relative to thetreatment site 106. In some embodiments, the balloonproximal end 304P can be coupled to thecatheter shaft 310, and the balloondistal end 304D can be coupled to theguidewire lumen 318. Additionally, theinflatable balloon 304 can be inflated with theballoon fluid 332, e.g., from thefluid pump 338, that is directed into theballoon interior 346 of theinflatable balloon 304 via theinflation conduit 340. - Additionally, the
energy guide bundle 322 including the one or more energy guides 322A, and thesystem console 323 including one or more of theenergy source 324, thepower source 325, thesystem controller 326, and theGUI 327, are generally similar in design and operation to what has been described in detail herein above. Accordingly, such components will not be described in detail again in relation to the embodiment shown inFigure 3 . - Further, as above, the
handle assembly 328 is handled and used by the user or operator to operate, position and control thecatheter 302. Additionally, as shown in the embodiment illustrated inFigure 3 , thehandle assembly 328 can again includecircuitry 356 that can form a portion of thesystem controller 326. Alternatively, thehandle assembly 328 can be configured without thecircuitry 356. - As with the previous embodiments, the
electrical analyzer assembly 342 is again configured to monitor the performance, reliability and safety of thecatheter system 300. Additionally, the design of theelectrical analyzer assembly 342 can be somewhat similar to what was illustrated and described herein above in relation to the previous embodiments. For example, theelectrical analyzer assembly 342 can again include afirst electrode 358, asecond electrode 360, and animpedance detector 362 that is connected in electrical communication with thefirst electrode 358 and thesecond electrode 360 in order to effectively measure and/or detect the impedance between thefirst electrode 358 and thesecond electrode 360. - However, in the embodiment shown in
Figure 3 , one or more of thefirst electrode 358, thesecond electrode 360 and theimpedance detector 362 can be positioned in a different manner than in the previous embodiments. More particularly, as shown inFigure 3 , in this embodiment, thefirst electrode 358 is again positioned within theballoon interior 346, and theimpedance detector 362 is again positioned adjacent to and/or in electrical communication with thesystem controller 326, but thesecond electrode 360 is now positioned on and/or adjacent to theguidewire 312. - It is appreciated that with such design, during normal operation, the
first electrode 358 is still in communication with theballoon fluid 332 within theballoon interior 346, but not in communication with the blood of thepatient 109; and thesecond electrode 360 is still in communication with the blood of thepatient 109, but not in communication with theballoon fluid 332 within theballoon interior 346. Additionally, it is further appreciated that with such design, theimpedance detector 362, in conjunction with thesystem controller 326 and/or thecircuitry 356 in thehandle assembly 328, is still configured to look for sudden drops in impedance between theelectrodes inflatable balloon 304, which would necessitate that the procedure be immediately stopped and thecatheter 302 be removed from thepatient 109. -
Figure 4 is a schematic cross-sectional view of another embodiment of thecatheter system 400 including another embodiment of theelectrical analyzer assembly 442. The design of thecatheter system 400 is substantially similar to the embodiments illustrated and described herein above. In particular, in the embodiment shown inFigure 4 , thecatheter system 400 can again include acatheter 402 including acatheter shaft 410, aninflatable balloon 404 having aballoon wall 430 that defines aballoon interior 446, a balloonproximal end 404P, and a balloondistal end 404D, aballoon fluid 432 that is retained substantially within theballoon interior 446, aguidewire 412, and aguidewire lumen 418 that extends into theballoon interior 446; anenergy guide bundle 422 including one ormore energy guides 422A; asource manifold 436; afluid pump 438; asystem console 423 including one or more of anenergy source 424, apower source 425, asystem controller 426, and aGUI 427; ahandle assembly 428; and theelectrical analyzer assembly 442. Alternatively, in other embodiments, thecatheter system 400 can include more components or fewer components than what is specifically illustrated and described herein. - The
catheter 402, including thecatheter shaft 410, theinflatable balloon 404, theguidewire 412, and theguidewire lumen 418, is generally similar in design and operation to what has been described in detail herein above. Thus, such components will not be described in detail again in relation to the embodiment shown inFigure 4 . - As above, the
inflatable balloon 404 is selectively movable between a collapsed configuration suitable for advancing thecatheter 402 through a patient's vasculature, and an expanded configuration suitable for anchoring thecatheter 402 in position relative to thetreatment site 106. In some embodiments, the balloonproximal end 404P can be coupled to thecatheter shaft 410, and the balloondistal end 404D can be coupled to theguidewire lumen 418. Additionally, theinflatable balloon 404 can be inflated with theballoon fluid 432, e.g., from thefluid pump 438, that is directed into theballoon interior 446 of theinflatable balloon 404 via theinflation conduit 440. - Additionally, the
energy guide bundle 422 including the one or more energy guides 422A, and thesystem console 423 including one or more of theenergy source 424, thepower source 425, thesystem controller 426, and theGUI 427, are generally similar in design and operation to what has been described in detail herein above. Accordingly, such components will not be described in detail again in relation to the embodiment shown inFigure 4 . - Further, as above, the
handle assembly 428 is handled and used by the user or operator to operate, position and control thecatheter 402. Additionally, as shown in the embodiment illustrated inFigure 4 , thehandle assembly 428 can again includecircuitry 456 that can form a portion of thesystem controller 426. Alternatively, thehandle assembly 428 can be configured without thecircuitry 456. - As with the previous embodiments, the
electrical analyzer assembly 442 is again configured to monitor the performance, reliability and safety of thecatheter system 400. Additionally, the design of theelectrical analyzer assembly 442 can be somewhat similar to what was illustrated and described herein above in relation to the previous embodiments. For example, theelectrical analyzer assembly 442 can again include afirst electrode 458, asecond electrode 460, and animpedance detector 462 that is connected in electrical communication with thefirst electrode 458 and thesecond electrode 460 in order to effectively measure and/or detect the impedance between thefirst electrode 458 and thesecond electrode 460. - However, in the embodiment shown in
Figure 4 , one or more of thefirst electrode 458, thesecond electrode 460 and theimpedance detector 462 can be positioned in a different manner than in the previous embodiments. More particularly, as shown inFigure 4 , in this non-claimed embodiment, thesecond electrode 460 is again positioned on and/or adjacent to theskin 105 of the patient 109 (as in the embodiment shown inFigure 1 ), and theimpedance detector 462 is again positioned adjacent to and/or in electrical communication with thesystem controller 426, but thefirst electrode 458 is now positioned within and/or adjacent to theinflation conduit 440 through whichballoon fluid 432 is directed into theballoon interior 446 of theinflatable balloon 404. - It is appreciated that with such design, during normal operation, the
first electrode 458 is still in communication with theballoon fluid 432 within theballoon interior 446, but not in communication with the blood of thepatient 109; and thesecond electrode 460 is still in communication with the blood of thepatient 109, but not in communication with theballoon fluid 432 within theballoon interior 446. Additionally, it is further appreciated that with such design, theimpedance detector 462, in conjunction with thesystem controller 426 and/or thecircuitry 456 in thehandle assembly 428, is still configured to look for sudden drops in impedance between theelectrodes inflatable balloon 404, which would necessitate that the procedure be immediately stopped and thecatheter 402 be removed from thepatient 109. -
Figure 5 is a schematic cross-sectional view of yet another embodiment of thecatheter system 500 including yet another embodiment of theelectrical analyzer assembly 542. The design of thecatheter system 500 is substantially similar to the embodiments illustrated and described herein above. In particular, in the embodiment shown inFigure 5 , thecatheter system 500 can again include acatheter 502 including acatheter shaft 510, aninflatable balloon 504 having aballoon wall 530 that defines aballoon interior 546, a balloonproximal end 504P, and a balloondistal end 504D, aballoon fluid 532 that is retained substantially within theballoon interior 546, aguidewire 512, and aguidewire lumen 518 that extends into theballoon interior 546; anenergy guide bundle 522 including one ormore energy guides 522A; asource manifold 536; afluid pump 538; asystem console 523 including one or more of anenergy source 524, apower source 525, asystem controller 526, and aGUI 527; ahandle assembly 528; and theelectrical analyzer assembly 542. Alternatively, in other embodiments, thecatheter system 500 can include more components or fewer components than what is specifically illustrated and described herein. - The
catheter 502, including thecatheter shaft 510, theinflatable balloon 504, theguidewire 512, and theguidewire lumen 518, is generally similar in design and operation to what has been described in detail herein above. Thus, such components will not be described in detail again in relation to the embodiment shown inFigure 5 . - As above, the
inflatable balloon 504 is selectively movable between a collapsed configuration suitable for advancing thecatheter 502 through a patient's vasculature, and an expanded configuration suitable for anchoring thecatheter 502 in position relative to thetreatment site 106. In some embodiments, the balloonproximal end 504P can be coupled to thecatheter shaft 510, and the balloondistal end 504D can be coupled to theguidewire lumen 518. Additionally, theinflatable balloon 504 can be inflated with theballoon fluid 532, e.g., from thefluid pump 538, that is directed into theballoon interior 546 of theinflatable balloon 504 via theinflation conduit 540. - Additionally, the
energy guide bundle 522 including the one or more energy guides 522A, and thesystem console 523 including one or more of theenergy source 524, thepower source 525, thesystem controller 526, and theGUI 527, are generally similar in design and operation to what has been described in detail herein above. Accordingly, such components will not be described in detail again in relation to the embodiment shown inFigure 5 . - Further, as above, the
handle assembly 528 is handled and used by the user or operator to operate, position and control thecatheter 502. Additionally, as shown in the embodiment illustrated inFigure 5 , thehandle assembly 528 can again includecircuitry 556 that can form a portion of thesystem controller 526. Alternatively, thehandle assembly 528 can be configured without thecircuitry 556. - As with the previous embodiments, the
electrical analyzer assembly 542 is again configured to monitor the performance, reliability and safety of thecatheter system 500. Additionally, the design of theelectrical analyzer assembly 542 can be somewhat similar to what was illustrated and described herein above in relation to the previous embodiments. For example, theelectrical analyzer assembly 542 can again include afirst electrode 558, asecond electrode 560, and animpedance detector 562 that is connected in electrical communication with thefirst electrode 558 and thesecond electrode 560 in order to effectively measure and/or detect the impedance between thefirst electrode 558 and thesecond electrode 560. - However, in the embodiment shown in
Figure 5 , one or more of thefirst electrode 558, thesecond electrode 560 and theimpedance detector 562 can be positioned in a different manner than in the previous embodiments. More particularly, as shown inFigure 5 , in this embodiment, thefirst electrode 558 is again positioned within and/or adjacent to theinflation conduit 540 through whichballoon fluid 532 is directed into theballoon interior 546 of the inflatable balloon 504 (as inFigure 4 ), thesecond electrode 560 is again positioned within and/or adjacent to the guidewire lumen 518 (as in the embodiment shown inFigure 2 ), and theimpedance detector 562 is again positioned adjacent to and/or in electrical communication with thesystem controller 526. - It is appreciated that with such design, during normal operation, the
first electrode 558 is still in communication with theballoon fluid 532 within theballoon interior 546, but not in communication with the blood of thepatient 109; and thesecond electrode 560 is still in communication with the blood of thepatient 109, but not in communication with theballoon fluid 532 within theballoon interior 546. Additionally, it is further appreciated that with such design, theimpedance detector 562, in conjunction with thesystem controller 526 and/or thecircuitry 556 in thehandle assembly 528, is still configured to look for sudden drops in impedance between theelectrodes inflatable balloon 504, which would necessitate that the procedure be immediately stopped and thecatheter 502 be removed from thepatient 109. -
Figure 6 is a schematic cross-sectional view of still yet another embodiment of thecatheter system 600 including still yet another embodiment of theelectrical analyzer assembly 642. The design of thecatheter system 600 is substantially similar to the embodiments illustrated and described herein above. In particular, in the embodiment shown inFigure 6 , thecatheter system 600 can again include acatheter 602 including acatheter shaft 610, aninflatable balloon 604 having aballoon wall 630 that defines aballoon interior 646, a balloonproximal end 604P, and a balloondistal end 604D, aballoon fluid 632 that is retained substantially within theballoon interior 646, aguidewire 612, and aguidewire lumen 618 that extends into theballoon interior 646; anenergy guide bundle 622 including one ormore energy guides 622A; asource manifold 636; afluid pump 638; asystem console 623 including one or more of anenergy source 624, apower source 625, asystem controller 626, and aGUI 627; ahandle assembly 628; and theelectrical analyzer assembly 642. Alternatively, in other embodiments, thecatheter system 600 can include more components or fewer components than what is specifically illustrated and described herein. - The
catheter 602, including thecatheter shaft 610, theinflatable balloon 604, theguidewire 612, and theguidewire lumen 618, is generally similar in design and operation to what has been described in detail herein above. Thus, such components will not be described in detail again in relation to the embodiment shown inFigure 6 . - As above, the
inflatable balloon 604 is selectively movable between a collapsed configuration suitable for advancing thecatheter 602 through a patient's vasculature, and an expanded configuration suitable for anchoring thecatheter 602 in position relative to thetreatment site 106. In some embodiments, the balloonproximal end 604P can be coupled to thecatheter shaft 610, and the balloondistal end 604D can be coupled to theguidewire lumen 618. Additionally, theinflatable balloon 604 can be inflated with theballoon fluid 632, e.g., from thefluid pump 638, that is directed into theballoon interior 646 of theinflatable balloon 604 via theinflation conduit 640. - Additionally, the
energy guide bundle 622 including the one or more energy guides 622A, and thesystem console 623 including one or more of theenergy source 624, thepower source 625, thesystem controller 626, and theGUI 627, are generally similar in design and operation to what has been described in detail herein above. Accordingly, such components will not be described in detail again in relation to the embodiment shown inFigure 6 . - Further, as above, the
handle assembly 628 is handled and used by the user or operator to operate, position and control thecatheter 602. Additionally, as shown in the embodiment illustrated inFigure 6 , thehandle assembly 628 can again includecircuitry 656 that can form a portion of thesystem controller 626. Alternatively, thehandle assembly 628 can be configured without thecircuitry 656. - As with the previous embodiments, the
electrical analyzer assembly 642 is again configured to monitor the performance, reliability and safety of thecatheter system 600. Additionally, the design of theelectrical analyzer assembly 642 can be somewhat similar to what was illustrated and described herein above in relation to the previous embodiments. For example, theelectrical analyzer assembly 642 can again include afirst electrode 658, asecond electrode 660, and animpedance detector 662 that is connected in electrical communication with thefirst electrode 658 and thesecond electrode 660 in order to effectively measure and/or detect the impedance between thefirst electrode 658 and thesecond electrode 660. - However, in the embodiment shown in
Figure 6 , one or more of thefirst electrode 658, thesecond electrode 660 and theimpedance detector 662 can be positioned in a different manner than in the previous embodiments. More particularly, as shown inFigure 6 , in this embodiment, thefirst electrode 658 is again positioned within and/or adjacent to theinflation conduit 640 through whichballoon fluid 632 is directed into theballoon interior 646 of the inflatable balloon 604 (as inFigure 4 ), thesecond electrode 660 is again positioned on and/or adjacent to the guidewire 612 (as in the embodiment shown inFigure 3 ), and theimpedance detector 662 is again positioned adjacent to and/or in electrical communication with thesystem controller 626. - It is appreciated that with such design, during normal operation, the
first electrode 658 is still in communication with theballoon fluid 632 within theballoon interior 646, but not in communication with the blood of thepatient 109; and thesecond electrode 660 is still in communication with the blood of thepatient 109, but not in communication with theballoon fluid 632 within theballoon interior 646. Additionally, it is further appreciated that with such design, theimpedance detector 662, in conjunction with thesystem controller 626 and/or thecircuitry 656 in thehandle assembly 628, is still configured to look for sudden drops in impedance between theelectrodes inflatable balloon 604, which would necessitate that the procedure be immediately stopped and thecatheter 602 be removed from thepatient 109. - As noted above, the electrical analyzer assembly of the present invention addresses several important challenges with the performance, reliability and safety of an intravascular lithotripsy catheter, in particular one that utilizes an energy source, e.g., a light source such as a laser source, to create a localized plasma which in turn induces a high energy bubble in the balloon fluid within the balloon interior of the balloon. For example, as noted above, issues that are addressed by the present invention include, but are not limited to: 1) electrical detection of normal operation and/or balloon condition used within the catheter system, and 2) electrical detection of a failure of the balloon, e.g., damage to and/or rupture of the balloon, during use of the catheter system, which would necessitate shutting down of the catheter system and removal of the catheter from the body of the patient.
- It should be noted that, as used in this specification and the appended claims, the singular forms "a," "an," and "the" include plural referents unless the content and/or context clearly dictates otherwise. It should also be noted that the term "or" is generally employed in its sense including "and/or" unless the content or context clearly dictates otherwise.
- It should also be noted that, as used in this specification and the appended claims, the phrase "configured" describes a system, apparatus, or other structure that is constructed or configured to perform a particular task or adopt a particular configuration. The phrase "configured" can be used interchangeably with other similar phrases such as arranged and configured, constructed and arranged, constructed, manufactured and arranged, and the like.
- The headings used herein provide organizational cues. These headings shall not be viewed to limit or characterize the invention(s) set out in any claims that may issue from this disclosure. As an example, a description of a technology in the "Background" is not an admission that technology is prior art to any invention(s) in this disclosure. Neither is the "Summary" or "Abstract" to be considered as a characterization of the invention(s) set forth in issued claims.
- The embodiments described herein are not intended to be exhaustive or to limit the invention to the precise forms disclosed in the detailed description provided herein. Rather, the embodiments are chosen and described so that others skilled in the art can appreciate and understand the principles and practices. As such, aspects have been described with reference to various specific and preferred embodiments and techniques. However, it should be understood that many variations and modifications may be made while remaining within the scope of the apended claims.
- It is understood that although a number of different embodiments of the catheter systems have been illustrated and described herein, one or more features of any one embodiment can be combined with one or more features of one or more of the other embodiments, provided that such combination satisfies the intent of the present invention.
- While a number of exemplary aspects and embodiments of the catheter systems have been discussed above, those of skill in the art will recognize certain modifications, permutations, additions and sub-combinations thereof.
Claims (13)
- A catheter system (100) for treating a treatment site (106) within or adjacent to a vessel wall or heart valve within a body of a patient, the catheter system (100) comprising:an energy source (124) that generates energy;a balloon (104) that is positionable substantially adjacent to the treatment site (106), the balloon having a balloon wall (130) that defines a balloon interior (146), the balloon interior (146) being configured to receive a balloon fluid (132);an energy guide (122A) that is configured to receive energy from the energy source (124) and guide the energy into the balloon interior (146); andan electrical analyzer assembly (142) that is configured to monitor a condition of the balloon during use of the catheter system (100), wherein the electrical analyzer assembly (142) includes (i) a first electrode (158), (ii) a second electrode (160) positioned in a manner to, in use, be in fluid communication with blood of the patient (109), and (iii) an impedance detector (162), the impedance detector (162) being electrically coupled to the first electrode (158) and the second electrode (160), the impedance detector (162) being configured to detect an impedance between the first electrode (158) and the second electrode (162).
- The catheter system (100) of claim 1 wherein when a rupture in the balloon has not occurred, the first electrode (158) is in fluid communication with the balloon fluid (132) in the balloon interior (146), and the second electrode (160) is not in fluid communication with the balloon fluid (132) in the balloon interior (146).
- The catheter system (100) of any of claims 1-2 wherein the impedance detector (162) generates a detector signal based at least in part on the detected impedance between the first electrode (158) and the second electrode (160).
- The catheter system (100) of claim 3 4- further comprising a system controller (126) that is electrically coupled to the impedance detector (162), the system controller (126) being configured to receive the detector signal from the impedance detector (162) and determine the condition of the balloon (104) based at least in part on the detector signal.
- The catheter system (100) of claim 4 wherein the impedance detector (162) is electrically coupled to the system controller (126) via a wired connection.
- The catheter system (100) of claim 4 wherein the impedance detector (162) is electrically coupled to the system controller (126) via a wireless connection.
- The catheter system (100) of any of claims 4-6 wherein the system controller (126) is configured to recognize a normal condition of the balloon (104) based at least in part on the detector signal.
- The catheter system (100) of any of claims 4-7 wherein the system controller (126) is configured to recognize a potential rupture of the balloon (104) based at least in part on the detector signal.
- The catheter system (100) of claim 8 wherein the system controller (126) is configured to automatically shut down operation of the catheter system (100) upon recognition of the potential rupture of the balloon (104).
- The catheter system (100) of any of claims 1-9 wherein the first electrode (158) is positioned within the balloon interior (146).
- The catheter system (100) of any of claims 1-9 further comprising an inflation conduit (140) through which the balloon fluid (132) is directed into the balloon interior (146); and wherein the first electrode (158) is positioned within the inflation conduit (140).
- The catheter system (100) of any of claims 1-10 further comprising a guidewire (112) that is configured to guide positioning of the balloon (104) substantially adjacent to the treatment site (106); and wherein the second electrode (160) is positioned substantially adjacent to the guidewire (112).
- The catheter system (100) of any of claims 1-10 further comprising a guidewire (112) that is configured to guide positioning of the balloon (104) substantially adjacent to the treatment site (106), and a guidewire lumen that is configured to move over the guidewire, the guidewire lumen (118) being coupled to the balloon (104); and wherein the second electrode (160) is positioned within the guidewire lumen (118).
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063004977P | 2020-04-03 | 2020-04-03 | |
US17/211,150 US11707323B2 (en) | 2020-04-03 | 2021-03-24 | Electrical analyzer assembly for intravascular lithotripsy device |
PCT/US2021/024216 WO2021202248A1 (en) | 2020-04-03 | 2021-03-25 | Electrical analyzer assembly for intravascular lithotripsy device |
Publications (3)
Publication Number | Publication Date |
---|---|
EP4125665A1 EP4125665A1 (en) | 2023-02-08 |
EP4125665C0 EP4125665C0 (en) | 2024-02-21 |
EP4125665B1 true EP4125665B1 (en) | 2024-02-21 |
Family
ID=77921732
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP21719784.7A Active EP4125665B1 (en) | 2020-04-03 | 2021-03-25 | Intravascular lithotripsy device with electrical analyzer assembly |
Country Status (3)
Country | Link |
---|---|
US (2) | US11707323B2 (en) |
EP (1) | EP4125665B1 (en) |
WO (1) | WO2021202248A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020256898A1 (en) | 2019-06-19 | 2020-12-24 | Boston Scientific Scimed, Inc. | Balloon surface photoacoustic pressure wave generation to disrupt vascular lesions |
US11717139B2 (en) | 2019-06-19 | 2023-08-08 | Bolt Medical, Inc. | Plasma creation via nonaqueous optical breakdown of laser pulse energy for breakup of vascular calcium |
US11660427B2 (en) | 2019-06-24 | 2023-05-30 | Boston Scientific Scimed, Inc. | Superheating system for inertial impulse generation to disrupt vascular lesions |
US11517713B2 (en) | 2019-06-26 | 2022-12-06 | Boston Scientific Scimed, Inc. | Light guide protection structures for plasma system to disrupt vascular lesions |
US11583339B2 (en) | 2019-10-31 | 2023-02-21 | Bolt Medical, Inc. | Asymmetrical balloon for intravascular lithotripsy device and method |
US11672599B2 (en) | 2020-03-09 | 2023-06-13 | Bolt Medical, Inc. | Acoustic performance monitoring system and method within intravascular lithotripsy device |
US20210290286A1 (en) | 2020-03-18 | 2021-09-23 | Bolt Medical, Inc. | Optical analyzer assembly and method for intravascular lithotripsy device |
US11707323B2 (en) | 2020-04-03 | 2023-07-25 | Bolt Medical, Inc. | Electrical analyzer assembly for intravascular lithotripsy device |
WO2023235665A1 (en) * | 2022-06-01 | 2023-12-07 | Fastwave Medical Inc. | Intravascular lithotripsy |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0119296A1 (en) * | 1983-02-18 | 1984-09-26 | Baylor College of Medicine | An apparatus for intra-aortic balloon monitoring and leak detection |
Family Cites Families (432)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1453853A (en) | 1966-04-06 | 1966-07-22 | Advanced device for crushing stones in the bladder | |
DE3038445A1 (en) | 1980-10-11 | 1982-05-27 | Dornier Gmbh, 7990 Friedrichshafen | Pressure wave generator for diagnosis and therapy - has spark gap in inflatable balloon at end of catheter |
US4649924A (en) | 1984-08-14 | 1987-03-17 | Consiglio Nazionale Delle Ricerche | Method for the detection of intracardiac electrical potential fields |
US4799479A (en) | 1984-10-24 | 1989-01-24 | The Beth Israel Hospital Association | Method and apparatus for angioplasty |
US20020045811A1 (en) | 1985-03-22 | 2002-04-18 | Carter Kittrell | Laser ablation process and apparatus |
US5034010A (en) | 1985-03-22 | 1991-07-23 | Massachusetts Institute Of Technology | Optical shield for a laser catheter |
US4913142A (en) | 1985-03-22 | 1990-04-03 | Massachusetts Institute Of Technology | Catheter for laser angiosurgery |
US4699147A (en) | 1985-09-25 | 1987-10-13 | Cordis Corporation | Intraventricular multielectrode cardial mapping probe and method for using same |
US4994059A (en) | 1986-05-09 | 1991-02-19 | Gv Medical, Inc. | Laser catheter feedback system |
JPS62275446A (en) | 1986-05-21 | 1987-11-30 | オリンパス光学工業株式会社 | Discharge stone crushing apparatus |
US4744366A (en) | 1986-09-10 | 1988-05-17 | Jang G David | Concentric independently inflatable/deflatable multiple diameter balloon angioplasty catheter systems and method of use |
JPS63158064A (en) | 1986-12-23 | 1988-07-01 | テルモ株式会社 | Blood vessel dilating catheter |
DE3728814A1 (en) | 1987-08-28 | 1989-03-30 | Lentia Gmbh | SOLUTION FOR USE AS A RINSING LIQUID IN THE DESTRUCTION OF NON-BODY DEPOSITS IN HUMAN AND ANIMAL TISSUES OR BODIES |
US5372138A (en) | 1988-03-21 | 1994-12-13 | Boston Scientific Corporation | Acousting imaging catheters and the like |
US5200838A (en) | 1988-05-27 | 1993-04-06 | The University Of Connecticut | Lateral effect imaging system |
DE3836337A1 (en) | 1988-10-25 | 1990-04-26 | Meessen Stephan Dr B | Method and device for recording intracorporally generated, laser-induced shock waves |
DE3842916C1 (en) | 1988-12-21 | 1990-02-01 | Messerschmitt-Boelkow-Blohm Gmbh, 8012 Ottobrunn, De | |
WO1990007303A1 (en) | 1989-01-06 | 1990-07-12 | Angioplasty Systems, Inc. | Electrosurgical catheter for resolving atherosclerotic plaque |
WO1990007904A1 (en) | 1989-01-23 | 1990-07-26 | Medilase, Incorporated | Acoustic monitoring and controlling of laser angioplasty |
DE3913027A1 (en) | 1989-04-20 | 1990-10-25 | Hohla Kristian | Shock wave transmission through optical fibre - sheathed in casing to prevent destruction at shock wave exit |
DE3933613C2 (en) | 1989-10-07 | 1998-10-08 | Laser & Med Tech Gmbh | Device for generating laser-induced shock waves |
JP2514087Y2 (en) | 1990-05-25 | 1996-10-16 | 幸三 牧田 | Balloon with detachable double-sided check valve |
CA2089656A1 (en) | 1990-08-21 | 1992-02-22 | Robert J. Crowley | Acoustic imaging catheter and the like |
US5428658A (en) | 1994-01-21 | 1995-06-27 | Photoelectron Corporation | X-ray source with flexible probe |
US5104391A (en) | 1990-10-30 | 1992-04-14 | Advanced Cardiovascular Systems | Optical fiber breakage detection system |
US5275594A (en) | 1990-11-09 | 1994-01-04 | C. R. Bard, Inc. | Angioplasty system having means for identification of atherosclerotic plaque |
US5152768A (en) | 1991-02-26 | 1992-10-06 | Bhatta Krishna M | Electrohydraulic lithotripsy |
US5116227A (en) | 1991-03-01 | 1992-05-26 | Endo Technic Corporation | Process for cleaning and enlarging passages |
US5173049A (en) | 1991-03-01 | 1992-12-22 | Endo Technic Corporation | Removing a post embedded in a tooth |
EP0558297B1 (en) | 1992-02-25 | 1997-04-16 | Japan Crescent Inc. | Heated balloon catheter |
US5290277A (en) | 1992-04-03 | 1994-03-01 | Angeion Corporation | Multi-fiber linear array laser catheter connector |
EP0574686A2 (en) | 1992-05-13 | 1993-12-22 | The Spectranetics Corporation | Linear scan method and system for cloupling energy into an optical fiber bundle |
EP0571306A1 (en) | 1992-05-22 | 1993-11-24 | LASER MEDICAL TECHNOLOGY, Inc. | Apparatus and method for removal of deposits from the walls of body passages |
US5662108A (en) | 1992-09-23 | 1997-09-02 | Endocardial Solutions, Inc. | Electrophysiology mapping system |
JP3581888B2 (en) | 1992-09-23 | 2004-10-27 | エンドカーディアル・セラピューティクス・インコーポレーテッド | Endocardial mapping system |
WO1994007446A1 (en) | 1992-10-05 | 1994-04-14 | Boston Scientific Corporation | Device and method for heating tissue |
CA2114988A1 (en) | 1993-02-05 | 1994-08-06 | Matthew O'boyle | Ultrasonic angioplasty balloon catheter |
US5772609A (en) | 1993-05-11 | 1998-06-30 | Target Therapeutics, Inc. | Guidewire with variable flexibility due to polymeric coatings |
US6939309B1 (en) | 1993-09-23 | 2005-09-06 | Endocardial Solutions, Inc. | Electrophysiology mapping system |
US6139510A (en) | 1994-05-11 | 2000-10-31 | Target Therapeutics Inc. | Super elastic alloy guidewire |
US5944697A (en) | 1994-05-31 | 1999-08-31 | Universal Medical Instrument Corp. | Percutaneous catheter introducer |
US5509917A (en) | 1994-06-28 | 1996-04-23 | Ceramoptec Industries, Inc. | Lensed caps for radial medical laser delivery devices |
US6572609B1 (en) | 1999-07-14 | 2003-06-03 | Cardiofocus, Inc. | Phototherapeutic waveguide apparatus |
US6423055B1 (en) | 1999-07-14 | 2002-07-23 | Cardiofocus, Inc. | Phototherapeutic wave guide apparatus |
US5562657A (en) | 1994-09-19 | 1996-10-08 | Griffin; Stephen E. | Side fire laser catheter method and apparatus |
US5718241A (en) | 1995-06-07 | 1998-02-17 | Biosense, Inc. | Apparatus and method for treating cardiac arrhythmias with no discrete target |
US5824005A (en) | 1995-08-22 | 1998-10-20 | Board Of Regents, The University Of Texas System | Maneuverable electrophysiology catheter for percutaneous or intraoperative ablation of cardiac arrhythmias |
US5729583A (en) | 1995-09-29 | 1998-03-17 | The United States Of America As Represented By The Secretary Of Commerce | Miniature x-ray source |
US5598494A (en) | 1995-10-23 | 1997-01-28 | The United States Of America As Represented By The Secretary Of The Army | Multi-channel fiber optic connector |
US5697377A (en) | 1995-11-22 | 1997-12-16 | Medtronic, Inc. | Catheter mapping system and method |
US5891135A (en) | 1996-01-19 | 1999-04-06 | Ep Technologies, Inc. | Stem elements for securing tubing and electrical wires to expandable-collapsible electrode structures |
US7189209B1 (en) | 1996-03-29 | 2007-03-13 | Sanuwave, Inc. | Method for using acoustic shock waves in the treatment of a diabetic foot ulcer or a pressure sore |
US6464660B2 (en) | 1996-09-05 | 2002-10-15 | Pharmasonics, Inc. | Balloon catheters having ultrasonically driven interface surfaces and methods for their use |
DE19718512C1 (en) | 1997-05-02 | 1998-06-25 | Hmt Ag | Production of shock waves for medical applications using spark discharge in water |
DE19718513C5 (en) | 1997-05-02 | 2010-06-02 | Sanuwave, Inc., | Device for generating acoustic shock waves, in particular for medical use |
US6024740A (en) | 1997-07-08 | 2000-02-15 | The Regents Of The University Of California | Circumferential ablation device assembly |
US6652515B1 (en) | 1997-07-08 | 2003-11-25 | Atrionix, Inc. | Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall |
US6500174B1 (en) | 1997-07-08 | 2002-12-31 | Atrionix, Inc. | Circumferential ablation device assembly and methods of use and manufacture providing an ablative circumferential band along an expandable member |
US6514249B1 (en) | 1997-07-08 | 2003-02-04 | Atrionix, Inc. | Positioning system and method for orienting an ablation element within a pulmonary vein ostium |
US6013072A (en) | 1997-07-09 | 2000-01-11 | Intraluminal Therapeutics, Inc. | Systems and methods for steering a catheter through body tissue |
US5906611A (en) | 1997-07-28 | 1999-05-25 | Dodick; Jack Murray | Surgical instrument with laser target |
US6538739B1 (en) | 1997-09-30 | 2003-03-25 | The Regents Of The University Of California | Bubble diagnostics |
CA2306867A1 (en) | 1997-10-21 | 1999-04-29 | The Regents Of The University Of California | Photoacoustic removal of occlusions from blood vessels |
US6123923A (en) | 1997-12-18 | 2000-09-26 | Imarx Pharmaceutical Corp. | Optoacoustic contrast agents and methods for their use |
US6368318B1 (en) | 1998-01-23 | 2002-04-09 | The Regents Of The University Of California | Opto-acoustic recanilization delivery system |
US6210404B1 (en) | 1998-10-28 | 2001-04-03 | John H. Shadduck | Microjoule electrical discharge catheter for thrombolysis in stroke patients |
US6210400B1 (en) | 1998-07-22 | 2001-04-03 | Endovasix, Inc. | Flexible flow apparatus and method for the disruption of occlusions |
US6547779B2 (en) | 1998-07-22 | 2003-04-15 | Endovasix, Inc. | Flexible flow apparatus and method for the disruption of occlusions |
US6607502B1 (en) | 1998-11-25 | 2003-08-19 | Atrionix, Inc. | Apparatus and method incorporating an ultrasound transducer onto a delivery member |
US6203537B1 (en) | 1999-02-04 | 2001-03-20 | Sorin Adrian | Laser-driven acoustic ablation catheter |
US20050010095A1 (en) | 1999-04-05 | 2005-01-13 | Medtronic, Inc. | Multi-purpose catheter apparatus and method of use |
US6339470B1 (en) | 1999-04-26 | 2002-01-15 | Endovasix, Inc. | Apparatus and method for aligning an energy beam |
US7527622B2 (en) | 1999-08-23 | 2009-05-05 | Cryocath Technologies Inc. | Endovascular cryotreatment catheter |
US6524251B2 (en) | 1999-10-05 | 2003-02-25 | Omnisonics Medical Technologies, Inc. | Ultrasonic device for tissue ablation and sheath for use therewith |
US6652547B2 (en) | 1999-10-05 | 2003-11-25 | Omnisonics Medical Technologies, Inc. | Apparatus and method of removing occlusions using ultrasonic medical device operating in a transverse mode |
US20040249401A1 (en) | 1999-10-05 | 2004-12-09 | Omnisonics Medical Technologies, Inc. | Apparatus and method for an ultrasonic medical device with a non-compliant balloon |
US20040097996A1 (en) | 1999-10-05 | 2004-05-20 | Omnisonics Medical Technologies, Inc. | Apparatus and method of removing occlusions using an ultrasonic medical device operating in a transverse mode |
US6610007B2 (en) | 2000-04-03 | 2003-08-26 | Neoguide Systems, Inc. | Steerable segmented endoscope and method of insertion |
US6635054B2 (en) | 2000-07-13 | 2003-10-21 | Transurgical, Inc. | Thermal treatment methods and apparatus with focused energy application |
US6638246B1 (en) | 2000-11-28 | 2003-10-28 | Scimed Life Systems, Inc. | Medical device for delivery of a biologically active material to a lumen |
US20020082553A1 (en) | 2000-12-22 | 2002-06-27 | Advanced Cardiovascular Systems, Inc. | Balloon designs for angioplasty |
DE10100974B4 (en) | 2001-01-11 | 2004-07-08 | Hmt High Medical Technologies Ag | Device for generating shock waves |
US6514203B2 (en) | 2001-02-12 | 2003-02-04 | Sonata Technologies Ltd. | Method for ultrasonic coronary thrombolysis |
US6879851B2 (en) | 2001-06-07 | 2005-04-12 | Lightlab Imaging, Llc | Fiber optic endoscopic gastrointestinal probe |
US7141044B2 (en) | 2001-12-11 | 2006-11-28 | Ekos Corporation | Alternate site gene therapy |
US6740107B2 (en) | 2001-12-19 | 2004-05-25 | Trimedyne, Inc. | Device for treatment of atrioventricular valve regurgitation |
US7087061B2 (en) | 2002-03-12 | 2006-08-08 | Lithotech Medical Ltd | Method for intracorporeal lithotripsy fragmentation and apparatus for its implementation |
US6773447B2 (en) | 2002-07-02 | 2004-08-10 | Sentient Engineering & Technology, Llc | Balloon catheter and treatment apparatus |
US7037319B2 (en) | 2002-10-15 | 2006-05-02 | Scimed Life Systems, Inc. | Nanotube paper-based medical device |
US6847848B2 (en) | 2003-01-07 | 2005-01-25 | Mmtc, Inc | Inflatable balloon catheter structural designs and methods for treating diseased tissue of a patient |
FR2851153B1 (en) | 2003-02-14 | 2005-04-08 | Alain Lebet | GENERATING DEVICE OF A SHOCK WAVE WAVE. |
US7470240B2 (en) | 2004-10-22 | 2008-12-30 | General Patent, Llc | Pressure pulse/shock wave therapy methods and an apparatus for conducting the therapeutic methods |
US20040162508A1 (en) | 2003-02-19 | 2004-08-19 | Walter Uebelacker | Shock wave therapy method and device |
US9603545B2 (en) | 2003-02-21 | 2017-03-28 | 3Dt Holdings, Llc | Devices, systems, and methods for removing targeted lesions from vessels |
US7867178B2 (en) | 2003-02-26 | 2011-01-11 | Sanuwave, Inc. | Apparatus for generating shock waves with piezoelectric fibers integrated in a composite |
DE10311659B4 (en) | 2003-03-14 | 2006-12-21 | Sws Shock Wave Systems Ag | Apparatus and method for optimized electrohydraulic pressure pulse generation |
US6849994B1 (en) | 2003-06-30 | 2005-02-01 | Healthtronics Surgical Services, Inc. | Electrode assembly for lithotripters |
WO2005025661A2 (en) | 2003-09-11 | 2005-03-24 | Cook Incorporated | Catheter having an overmolded hub |
US20050080396A1 (en) | 2003-10-03 | 2005-04-14 | Michael Rontal | Method and apparatus for the ultrasonic cleaning of biofilm coated surfaces |
JP4391221B2 (en) | 2003-12-22 | 2009-12-24 | 有限会社日本エレクテル | High frequency heating balloon catheter |
WO2005065563A1 (en) | 2003-12-31 | 2005-07-21 | Biosense Webster, Inc | Circumferential ablation device assembly with an expandable member |
US20050171437A1 (en) | 2004-01-14 | 2005-08-04 | Neptec Optical Solutions, Inc. | Optical switching system for catheter-based analysis and treatment |
WO2005094283A2 (en) | 2004-03-25 | 2005-10-13 | Hauser David L | Vascular filter device |
DE102004021754A1 (en) | 2004-04-30 | 2005-11-24 | Reinhardt Thyzel | Device for removing epithelial cells from a lens capsular bag of a human or animal eye |
US7758572B2 (en) | 2004-05-20 | 2010-07-20 | Boston Scientific Scimed, Inc. | Medical devices and methods including cooling balloons having nanotubes |
WO2005117737A2 (en) | 2004-06-04 | 2005-12-15 | The Regents Of The University Of Michigan | Electromagnetic flow sensor device |
US20050277839A1 (en) | 2004-06-10 | 2005-12-15 | Honeywell International, Inc. | Wireless flow measurement in arterial stent |
US20070299392A1 (en) | 2004-07-14 | 2007-12-27 | By-Pass, Inc. | Material Delivery System |
US7435077B2 (en) | 2004-08-13 | 2008-10-14 | Boston Scientific Scimed, Inc. | Catheter balloon molding device |
US7309324B2 (en) | 2004-10-15 | 2007-12-18 | Futuremed Interventional, Inc. | Non-compliant medical balloon having an integral woven fabric layer |
US8050746B2 (en) | 2005-02-02 | 2011-11-01 | Voyage Medical, Inc. | Tissue visualization device and method variations |
WO2006089246A2 (en) | 2005-02-16 | 2006-08-24 | Transoma Medical, Inc. | Impedance based sensor for monitoring leakage in aaa stent graft |
US20060241524A1 (en) | 2005-03-11 | 2006-10-26 | Qi Yu | Intravascular ultrasound catheter device and method for ablating atheroma |
US7595615B2 (en) | 2005-04-05 | 2009-09-29 | Texas Instruments Incorporated | Systems and methods for providing over-current protection in a switching power supply |
US20060241733A1 (en) | 2005-04-25 | 2006-10-26 | Cardiac Pacemakers, Inc. | Atrial pacing lead |
US9468500B2 (en) | 2005-04-26 | 2016-10-18 | Tea Time Partners, L.P. | Image-guided laser catheter |
US20060270976A1 (en) | 2005-05-31 | 2006-11-30 | Prorhythm, Inc. | Steerable catheter |
US8162859B2 (en) | 2005-06-09 | 2012-04-24 | General Patent , LLC | Shock wave treatment device and method of use |
EP1909884A1 (en) | 2005-06-17 | 2008-04-16 | Abbott Laboratories | Method of reducing rigidity of angioplasty balloon sections |
EP1895927A4 (en) | 2005-06-20 | 2011-03-09 | Medtronic Ablation Frontiers | Ablation catheter |
US8657814B2 (en) | 2005-08-22 | 2014-02-25 | Medtronic Ablation Frontiers Llc | User interface for tissue ablation system |
US7918870B2 (en) | 2005-09-12 | 2011-04-05 | Bridgepoint Medical, Inc. | Endovascular devices and methods |
US8057408B2 (en) | 2005-09-22 | 2011-11-15 | The Regents Of The University Of Michigan | Pulsed cavitational ultrasound therapy |
US20070088380A1 (en) | 2005-10-14 | 2007-04-19 | Endocross Ltd. | Balloon catheter system for treating vascular occlusions |
EP1946712B1 (en) | 2005-11-01 | 2012-08-29 | Japan Electel Inc. | Balloon catheter system |
US20070118057A1 (en) | 2005-11-18 | 2007-05-24 | Moshe Ein-Gal | Acoustic wave energy delivery device |
US7599588B2 (en) | 2005-11-22 | 2009-10-06 | Vascular Imaging Corporation | Optical imaging probe connector |
US20080108867A1 (en) | 2005-12-22 | 2008-05-08 | Gan Zhou | Devices and Methods for Ultrasonic Imaging and Ablation |
US7810395B2 (en) | 2005-12-22 | 2010-10-12 | Total Wire Corporation | Ultrasonic pressure sensor and method of operating the same |
US9629567B2 (en) | 2006-01-12 | 2017-04-25 | Biosense Webster, Inc. | Mapping of complex fractionated atrial electrogram |
WO2007087560A2 (en) | 2006-01-26 | 2007-08-02 | The Board Of Trustees Of The University Of Illinois | Stroke inducing and monitoring system and method for using the same |
US20070239082A1 (en) | 2006-01-27 | 2007-10-11 | General Patent, Llc | Shock Wave Treatment Device |
US20070179496A1 (en) | 2006-01-31 | 2007-08-02 | Medtronic, Inc. | Flexible catheter for ablation therapy |
DE102006012204A1 (en) | 2006-03-16 | 2007-09-20 | Switech Medical Ag | Fluid medium`s electrical discharge producing device for use in e.g. therapeutic application, has electrodes formed from metallic material including titanium alloy with hardness, where electrical voltage is applied to electrodes in medium |
US20070255270A1 (en) | 2006-04-27 | 2007-11-01 | Medtronic Vascular, Inc. | Intraluminal guidance system using bioelectric impedance |
US7976873B2 (en) | 2006-05-10 | 2011-07-12 | Medtronic Xomed, Inc. | Extracellular polysaccharide solvating system for treatment of bacterial ear conditions |
JP2009537222A (en) | 2006-05-16 | 2009-10-29 | ウィルソン−クック・メディカル・インコーポレーテッド | Balloon cuff |
US20080097251A1 (en) | 2006-06-15 | 2008-04-24 | Eilaz Babaev | Method and apparatus for treating vascular obstructions |
US8108030B2 (en) | 2006-10-20 | 2012-01-31 | Board Of Regents, The University Of Texas System | Method and apparatus to identify vulnerable plaques with thermal wave imaging of heated nanoparticles |
KR100840771B1 (en) | 2006-11-02 | 2008-06-23 | 조성찬 | Apparatus for generating shock wave using piezoelectric element |
US8246643B2 (en) | 2006-11-07 | 2012-08-21 | Flowcardia, Inc. | Ultrasound catheter having improved distal end |
US7896822B2 (en) | 2006-11-30 | 2011-03-01 | Scoseria Jose P | Multiple lithotripter electrode |
US8206349B2 (en) | 2007-03-01 | 2012-06-26 | Medtronic Xomed, Inc. | Systems and methods for biofilm removal, including a biofilm removal endoscope for use therewith |
US20100241178A1 (en) | 2008-06-02 | 2010-09-23 | Loma Vista Medical, Inc. | Inflatable medical devices |
DE102007018841B4 (en) | 2007-04-20 | 2017-07-20 | MTS Medical UG (haftungsbeschränkt) | Device for generating shock waves, method for determining the state of consumption of the electrodes in a device for generating shock waves and method for generating shock waves by means of an underwater spark discharge |
US20090054881A1 (en) | 2007-06-14 | 2009-02-26 | Yosef Krespi | Mammalian biofilm treatment processes and instruments |
EP2170452B1 (en) | 2007-07-09 | 2013-02-13 | Cook Medical Technologies LLC | Balloon catheter with deflation mechanism |
US20100191089A1 (en) | 2007-07-09 | 2010-07-29 | Sis Medical Ag | Method and system to detect neointima coverage of a stent |
DE102007046902A1 (en) | 2007-09-28 | 2009-04-09 | Hochschule Konstanz Technik, Wirtschaft Und Gestaltung | Impulse generator for shock-wave therapy device, has capacitors charged by charging units comprising switch such that charging voltages developed at capacitors are partially compensated based on polarity of capacitors by series connection |
FR2922308B1 (en) | 2007-10-11 | 2012-03-16 | Mauna Kea Technologies | MODULAR IMAGING DEVICE, MODULE FOR THIS DEVICE AND METHOD IMPLEMENTED BY SAID DEVICE |
WO2009053839A2 (en) | 2007-10-22 | 2009-04-30 | Endocross Ltd. | Balloons and balloon catheter systems for treating vascular occlusions |
US8166825B2 (en) | 2007-10-30 | 2012-05-01 | Tea Time Partners, L.P. | Method and apparatus for noise reduction in ultrasound detection |
US9066742B2 (en) | 2007-11-09 | 2015-06-30 | The Spectranetics Corporation | Intra-vascular device with pressure detection capabilities using pressure sensitive material |
EP2249691B1 (en) | 2008-01-24 | 2013-07-03 | Boston Scientific Scimed, Inc. | Structure for use as part of a medical device |
DE102008011811B3 (en) | 2008-02-29 | 2009-10-15 | Anton Dr. Kasenbacher | Dental laser processing device for processing dental material |
US20090247933A1 (en) | 2008-03-27 | 2009-10-01 | The Regents Of The University Of California; Angiodynamics, Inc. | Balloon catheter method for reducing restenosis via irreversible electroporation |
CN102057422B (en) | 2008-04-14 | 2013-09-25 | 阿夫纳·斯佩科特 | Automatic adjustable voltage to stabilize pressure for shockwave medical therapy device |
US20100036294A1 (en) | 2008-05-07 | 2010-02-11 | Robert Mantell | Radially-Firing Electrohydraulic Lithotripsy Probe |
US8496652B2 (en) | 2008-06-06 | 2013-07-30 | Ethicon, Inc. | Balloon catheter systems and methods for treating uterine disorders |
US8192368B2 (en) | 2008-06-09 | 2012-06-05 | Gentera Holdings, Llc | Pressure sensing catheter |
US20130030431A1 (en) | 2008-06-13 | 2013-01-31 | Adams John M | Shock wave balloon catheter system with off center shock wave generator |
US10702293B2 (en) | 2008-06-13 | 2020-07-07 | Shockwave Medical, Inc. | Two-stage method for treating calcified lesions within the wall of a blood vessel |
US9072534B2 (en) | 2008-06-13 | 2015-07-07 | Shockwave Medical, Inc. | Non-cavitation shockwave balloon catheter system |
US8956371B2 (en) | 2008-06-13 | 2015-02-17 | Shockwave Medical, Inc. | Shockwave balloon catheter system |
JP2011526529A (en) | 2008-07-02 | 2011-10-13 | アンジオスライド リミテッド | Balloon catheter system and method of use thereof |
US20100016862A1 (en) | 2008-07-16 | 2010-01-21 | Daniel Hawkins | Method of providing embolic protection and shockwave angioplasty therapy to a vessel |
DE102008034702A1 (en) | 2008-07-25 | 2010-01-28 | Siemens Aktiengesellschaft | Ultrasonic-shock wave head for patient during therapy i.e. lithotripsy, with shock waves, has electromagnetic shock wave source including electrical conductor arrangement having electrical conductor constructed from carbon-nano particles |
EP2326264B1 (en) | 2008-07-27 | 2017-11-15 | Pi-R-Squared Ltd. | Fracturing calcifications in heart valves |
DE102008038214B4 (en) | 2008-08-18 | 2013-12-05 | Siemens Aktiengesellschaft | Method and shockwave head for generating focused ultrasound shockwaves |
US8097926B2 (en) | 2008-10-07 | 2012-01-17 | Mc10, Inc. | Systems, methods, and devices having stretchable integrated circuitry for sensing and delivering therapy |
EP2349440B1 (en) | 2008-10-07 | 2019-08-21 | Mc10, Inc. | Catheter balloon having stretchable integrated circuitry and sensor array |
US9119533B2 (en) | 2008-10-07 | 2015-09-01 | Mc10, Inc. | Systems, methods, and devices having stretchable integrated circuitry for sensing and delivering therapy |
US8821486B2 (en) | 2009-11-13 | 2014-09-02 | Hermes Innovations, LLC | Tissue ablation systems and methods |
WO2010051488A1 (en) | 2008-10-30 | 2010-05-06 | R4 Vascular, Inc. | Rupture-resistant compliant radiopaque catheter balloon and methods for use of same in an intravascular surgical procedure |
US9180280B2 (en) | 2008-11-04 | 2015-11-10 | Shockwave Medical, Inc. | Drug delivery shockwave balloon catheter system |
US9044618B2 (en) | 2008-11-05 | 2015-06-02 | Shockwave Medical, Inc. | Shockwave valvuloplasty catheter system |
CA2743992A1 (en) | 2008-11-17 | 2010-05-20 | Minnow Medical, Inc. | Selective accumulation of energy with or without knowledge of tissue topography |
DE202008016760U1 (en) | 2008-12-18 | 2009-03-12 | Switech Medical Ag | Device for generating shockwaves |
US20100160903A1 (en) | 2008-12-22 | 2010-06-24 | Yosef Krespi | Process and system for treating a vascular occlusion or other endoluminal structure |
US20100168572A1 (en) | 2008-12-30 | 2010-07-01 | Sliwa John W | Apparatus and Methods for Acoustic Monitoring of Ablation Procedures |
US20100179632A1 (en) | 2009-01-12 | 2010-07-15 | Medtronic Vascular, Inc. | Robotic Fenestration Device Having Impedance Measurement |
DE202009001238U1 (en) | 2009-02-02 | 2010-06-24 | Storz Medical Ag | Pressure wave treatment device with parameter setting |
US9131949B2 (en) | 2009-03-31 | 2015-09-15 | Guys And St. Thomas's Nhs Foundation Trust | System and method for assessing lithotripsy |
DE102009016102A1 (en) | 2009-04-03 | 2010-10-14 | Storz Medical Ag | Method for preparing a device for treating the human or animal body with mechanical pressure waves |
US8644927B2 (en) | 2009-04-21 | 2014-02-04 | Incube Labs, Llc | Apparatus and method for the detection and treatment of atrial fibrillation |
ES2717268T3 (en) | 2009-07-08 | 2019-06-20 | Sanuwave Inc | Use of intracorporeal pressure shock waves in medicine |
US20150313732A1 (en) | 2009-08-13 | 2015-11-05 | Quadra Endovascular, Inc. | Method and Device for Treating a Target Site in a Vascular Body Channel |
WO2011041638A2 (en) | 2009-10-02 | 2011-04-07 | Cardiofocus, Inc. | Cardiac ablation system with automatic safety shut-off feature |
US20130345617A1 (en) | 2009-10-06 | 2013-12-26 | Michael P. Wallace | Methods and devices for removal of tissue, blood clots and liquids from the patient |
US9375223B2 (en) | 2009-10-06 | 2016-06-28 | Cardioprolific Inc. | Methods and devices for endovascular therapy |
US11039845B2 (en) | 2009-10-06 | 2021-06-22 | Cardioprolific Inc. | Methods and devices for endovascular therapy |
US20110082534A1 (en) | 2009-10-06 | 2011-04-07 | Wallace Michael P | Ultrasound-enhanced stenosis therapy |
US20110144502A1 (en) | 2009-12-15 | 2011-06-16 | Tea Time Partners, L.P. | Imaging guidewire |
US20110263921A1 (en) | 2009-12-31 | 2011-10-27 | Anthony Vrba | Patterned Denervation Therapy for Innervated Renal Vasculature |
WO2011091020A2 (en) | 2010-01-19 | 2011-07-28 | The Board Of Regents Of The University Of Texas System | Apparatuses and systems for generating high-frequency shockwaves, and methods of use |
DE202010001176U1 (en) | 2010-01-19 | 2011-05-26 | Storz Medical Ag | Medical pressure wave device |
JP5448885B2 (en) | 2010-01-28 | 2014-03-19 | 富士フイルム株式会社 | Medical equipment and endoscope device |
WO2011094379A1 (en) | 2010-01-28 | 2011-08-04 | Cook Medical Technologies Llc | Apparatus and method for destruction of vascular thrombus |
US9743980B2 (en) | 2010-02-24 | 2017-08-29 | Safepass Vascular Ltd | Method and system for assisting a wire guide to cross occluded ducts |
WO2011105631A1 (en) | 2010-02-26 | 2011-09-01 | 学校法人慶應義塾 | Catheter performing photodynamic ablation of cardiac muscle tissue by photochemical reaction |
CA3030244C (en) | 2010-03-09 | 2021-04-27 | Smart Medical Systems Ltd | Balloon endoscope and methods of manufacture and use thereof |
US20120071867A1 (en) | 2010-03-18 | 2012-03-22 | Metalase, Inc. | Diode laser systems and methods for endoscopic treatment of tissue |
CN103068330B (en) | 2010-04-09 | 2016-06-29 | Vessix血管股份有限公司 | Power for treating tissue occurs and controls device |
US20110257641A1 (en) | 2010-04-14 | 2011-10-20 | Roger Hastings | Phototherapy for renal denervation |
EP2588013B1 (en) | 2010-07-01 | 2016-05-04 | Zimmer, Inc. | Multi-locking external fixation clamp |
DE202010009899U1 (en) | 2010-07-06 | 2010-10-14 | Zimmer Medizinsysteme Gmbh | Shock wave apparatus for generating mechanical shockwaves and shockwave device |
WO2012025833A2 (en) | 2010-08-27 | 2012-03-01 | Socpra- Sciences Et Génie, S.E.C. | Mechanical wave generator and method thereof |
US20120095371A1 (en) | 2010-10-18 | 2012-04-19 | CardioSonic Ltd. | Ultrasound transducer and cooling thereof |
US20130218054A1 (en) | 2010-10-18 | 2013-08-22 | CardioSonic Ltd. | Separation device for ultrasound element |
TW201221174A (en) | 2010-10-25 | 2012-06-01 | Medtronic Ardian Luxembourg | Microwave catheter apparatuses, systems, and methods for renal neuromodulation |
US9060755B2 (en) | 2010-10-26 | 2015-06-23 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation cryotherapeutic devices and associated systems and methods |
WO2012064404A1 (en) | 2010-11-09 | 2012-05-18 | Daniel Hawkins | Shockwave valvuloplasty device with guidewire and debris basket |
US20120232409A1 (en) * | 2010-12-15 | 2012-09-13 | Stahmann Jeffrey E | System and method for renal artery occlusion during renal denervation therapy |
KR102291972B1 (en) | 2011-01-19 | 2021-08-23 | 프랙틸 헬쓰, 인코포레이티드 | Devices and methods for the treatment of tissue |
CA2825033C (en) | 2011-02-01 | 2018-08-28 | Channel Medsystems, Inc. | Methods and apparatus for cryogenic treatment of a body cavity or lumen |
US20120203255A1 (en) | 2011-02-04 | 2012-08-09 | Daniel Hawkins | High pressure balloon shockwave catheter and method |
TWI558702B (en) | 2011-02-21 | 2016-11-21 | 普雷辛肯公司 | Solid forms of a pharmaceutically active substance |
KR101879012B1 (en) | 2011-02-25 | 2018-07-16 | 마이크로벤션, 인코포레이티드 | Reinforced balloon catheter |
WO2012120495A2 (en) | 2011-03-04 | 2012-09-13 | Rainbow Medical Ltd. | Tissue treatment and monitoring by application of energy |
AU2012246722B9 (en) | 2011-04-22 | 2015-06-04 | Topera, Inc. | Basket style cardiac mapping catheter having spline bends for detection of cardiac rhythm disorders |
JP5839031B2 (en) | 2011-05-19 | 2016-01-06 | コニカミノルタ株式会社 | Optical connector plug, optical probe and optical system |
WO2012162186A1 (en) | 2011-05-20 | 2012-11-29 | Boston Scientific Scimed, Inc. | Balloon catheter with improved pushability |
US10016579B2 (en) | 2011-06-23 | 2018-07-10 | W.L. Gore & Associates, Inc. | Controllable inflation profile balloon cover apparatus |
EP2726140B1 (en) | 2011-07-01 | 2020-12-16 | Coloplast A/S | A catheter with a balloon |
GB201113066D0 (en) | 2011-07-29 | 2011-09-14 | Univ Bristol | Optical device |
US20130041355A1 (en) | 2011-08-11 | 2013-02-14 | Tammo Heeren | Reducing Damage From A Dielectric Breakdown in Surgical Applications |
US20130053792A1 (en) | 2011-08-24 | 2013-02-28 | Ablative Solutions, Inc. | Expandable catheter system for vessel wall injection and muscle and nerve fiber ablation |
US9808605B2 (en) | 2011-10-06 | 2017-11-07 | W. L. Gore & Associates, Inc. | Controlled porosity devices for tissue treatments, methods of use, and methods of manufacture |
CN102429701A (en) | 2011-11-01 | 2012-05-02 | 福州施可瑞光电科技有限公司 | Ultrasonic stone crushing method and ultrasonic stone crushing pincers |
US8574247B2 (en) | 2011-11-08 | 2013-11-05 | Shockwave Medical, Inc. | Shock wave valvuloplasty device with moveable shock wave generator |
WO2013119662A1 (en) | 2012-02-06 | 2013-08-15 | Cornell University | Catheter based system and method for thrombus removal using time reversal acoustics |
US9381039B2 (en) | 2012-03-21 | 2016-07-05 | Medtronic, Inc. | Filling methods and apparatus for implanted medical therapy delivery devices |
ES2566940T3 (en) | 2012-04-26 | 2016-04-18 | Dornier Medtech Laser Gmbh | Lithotripter with shaped laser pulses |
WO2013169807A1 (en) | 2012-05-07 | 2013-11-14 | Djt, Llc. | Non-cavitation shockwave balloon catheter system |
EP2858553A1 (en) | 2012-06-08 | 2015-04-15 | Koninklijke Philips N.V. | Distributed sensing device for referencing of physiological features |
US9198825B2 (en) | 2012-06-22 | 2015-12-01 | Sanuwave, Inc. | Increase electrode life in devices used for extracorporeal shockwave therapy (ESWT) |
US9642673B2 (en) | 2012-06-27 | 2017-05-09 | Shockwave Medical, Inc. | Shock wave balloon catheter with multiple shock wave sources |
US9955946B2 (en) | 2014-03-12 | 2018-05-01 | Cibiem, Inc. | Carotid body ablation with a transvenous ultrasound imaging and ablation catheter |
DE102012106017A1 (en) | 2012-07-05 | 2014-05-08 | A.R.C. Laser Gmbh | Applicator and device for cell treatment |
EP2879605A4 (en) | 2012-07-30 | 2016-04-06 | Fractyl Lab Inc | Electrical energy ablation systems, devices and methods for the treatment of tissue |
WO2014022867A1 (en) | 2012-08-03 | 2014-02-06 | Alumend, Llc | Endovascular multi-balloon cathethers with optical diffuser for treatment of vascular stenoses |
EP2879595B1 (en) | 2012-08-03 | 2019-04-10 | Muffin Incorporated | Weeping balloon catheter with ultrasound element |
WO2014025397A1 (en) | 2012-08-06 | 2014-02-13 | Shockwave Medical, Inc. | Low profile electrodes for an angioplasty shock wave catheter |
EP2879597B1 (en) | 2012-08-06 | 2016-09-21 | Shockwave Medical, Inc. | Shockwave catheter |
CA2881211A1 (en) | 2012-08-08 | 2014-02-13 | Shockwave Medical, Inc. | Shockwave valvuloplasty with multiple balloons |
US9237984B2 (en) | 2012-08-10 | 2016-01-19 | Shockwave Medical, Inc. | Shockwave nerve therapy system and method |
US9277957B2 (en) | 2012-08-15 | 2016-03-08 | Ethicon Endo-Surgery, Inc. | Electrosurgical devices and methods |
US9138249B2 (en) | 2012-08-17 | 2015-09-22 | Shockwave Medical, Inc. | Shock wave catheter system with arc preconditioning |
US20140052146A1 (en) | 2012-08-17 | 2014-02-20 | Chip Curtis | Electrohydraulic Lithotripsy Probe and Electrical Source for an Electrohydraulic Lithotripsy Probe |
US11253732B2 (en) | 2012-08-22 | 2022-02-22 | Energize Medical Llc | Therapeutic energy systems |
US9522012B2 (en) | 2012-09-13 | 2016-12-20 | Shockwave Medical, Inc. | Shockwave catheter system with energy control |
US9333000B2 (en) | 2012-09-13 | 2016-05-10 | Shockwave Medical, Inc. | Shockwave catheter system with energy control |
US9801721B2 (en) | 2012-10-12 | 2017-10-31 | St. Jude Medical, Cardiology Division, Inc. | Sizing device and method of positioning a prosthetic heart valve |
US8992817B2 (en) | 2012-12-10 | 2015-03-31 | Abbott Cardiovascular Systems, Inc. | Process of making a medical balloon |
US20140180126A1 (en) | 2012-12-20 | 2014-06-26 | Volcano Corporation | Catheter with balloon and imaging |
US20140180069A1 (en) | 2012-12-21 | 2014-06-26 | Volcano Corporation | Intraluminal imaging system |
EP2934321A4 (en) | 2012-12-21 | 2016-07-20 | Paul Hoseit | Imaging catheter for imaging from within balloon |
CN105188830B (en) | 2012-12-28 | 2019-06-07 | 巴德血管外围设备公司 | Pass through the drug delivery of mechanical oscillation sacculus |
JP5819387B2 (en) | 2013-01-09 | 2015-11-24 | 富士フイルム株式会社 | Photoacoustic image generating apparatus and insert |
DE102013201928A1 (en) | 2013-02-06 | 2014-08-07 | Richard Wolf Gmbh | Electroacoustic transducer for producing acoustic waves e.g. shock waves in medical field, has piezoelectric elements whose one side is provided with electrode which is electrical insulated in relation to piezoelectric elements |
US20140228829A1 (en) | 2013-02-13 | 2014-08-14 | St. Jude Medical, Cardiology Division, Inc. | Laser-based devices and methods for renal denervation |
CA2898879C (en) | 2013-03-08 | 2023-05-02 | Limflow Gmbh | Methods and systems for providing or maintaining fluid flow through body passages |
US10835767B2 (en) | 2013-03-08 | 2020-11-17 | Board Of Regents, The University Of Texas System | Rapid pulse electrohydraulic (EH) shockwave generator apparatus and methods for medical and cosmetic treatments |
WO2014140715A2 (en) | 2013-03-11 | 2014-09-18 | Northgate Technologies Inc. | Unfocused electrohydraulic lithotripter |
US20160184022A1 (en) | 2013-03-13 | 2016-06-30 | The Spectranetics Corporation | Laser-induced pressure wave emitting catheter sheath |
US9320530B2 (en) | 2013-03-13 | 2016-04-26 | The Spectranetics Corporation | Assisted cutting balloon |
US10842567B2 (en) | 2013-03-13 | 2020-11-24 | The Spectranetics Corporation | Laser-induced fluid filled balloon catheter |
US10201387B2 (en) | 2013-03-13 | 2019-02-12 | The Spectranetics Corporation | Laser-induced fluid filled balloon catheter |
CN106178294B (en) | 2013-03-14 | 2018-11-20 | 瑞蔻医药有限公司 | A kind of endovascular ablation system based on ultrasound |
WO2014144070A1 (en) | 2013-03-15 | 2014-09-18 | Hunter William L | Stent monitoring assembly and method of use thereof |
EP3884859A1 (en) | 2013-06-27 | 2021-09-29 | Potrero Medical, Inc. | Sensing foley catheter |
US9867629B2 (en) | 2013-07-31 | 2018-01-16 | Shockwave Medical, Inc. | Angioplasty balloon |
JP2015073197A (en) | 2013-10-02 | 2015-04-16 | ソニー株式会社 | Transmitter and transmitting method, receiver and receiving method and computer program |
US9687166B2 (en) | 2013-10-14 | 2017-06-27 | Boston Scientific Scimed, Inc. | High resolution cardiac mapping electrode array catheter |
US9770606B2 (en) | 2013-10-15 | 2017-09-26 | Boston Scientific Scimed, Inc. | Ultrasound ablation catheter with cooling infusion and centering basket |
WO2015056662A1 (en) | 2013-10-15 | 2015-04-23 | ニプロ株式会社 | Ablation system and ablation device |
ES2758676T3 (en) | 2013-10-15 | 2020-05-06 | Nipro Corp | Ablation system and ablation device |
GB2519302B (en) | 2013-10-15 | 2016-04-20 | Gloucestershire Hospitals Nhs Foundation Trust | Apparatus for artificial cardiac stimulation and method of using the same |
US10390881B2 (en) | 2013-10-25 | 2019-08-27 | Denervx LLC | Cooled microwave denervation catheter with insertion feature |
JP6517832B2 (en) | 2013-11-18 | 2019-05-22 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | Guided thrombus dispersion catheter |
WO2015097255A2 (en) | 2013-12-23 | 2015-07-02 | Eric Chevalier | A versatile vascular access device |
WO2015099786A1 (en) | 2013-12-27 | 2015-07-02 | Empire Technology Development Llc | Devices and techniques for ablative treatment |
US9555267B2 (en) | 2014-02-17 | 2017-01-31 | Moshe Ein-Gal | Direct contact shockwave transducer |
CN105960200B (en) | 2014-02-25 | 2019-08-30 | 圣犹达医疗用品心脏病学部门有限公司 | The system and method classified for using electro physiology property to arrhythmia cordis source |
JP6560244B2 (en) | 2014-02-26 | 2019-08-14 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | System for performing intraluminal histotripsy and method of operation thereof |
JP6141234B2 (en) | 2014-03-26 | 2017-06-07 | フロンティア・ラボ株式会社 | Gas phase component analyzer |
US20160000590A1 (en) | 2014-04-07 | 2016-01-07 | Washington University | Intravascular Device |
US9730715B2 (en) | 2014-05-08 | 2017-08-15 | Shockwave Medical, Inc. | Shock wave guide wire |
US20150359432A1 (en) | 2014-06-11 | 2015-12-17 | Sympara Medical, Inc. | Methods and devices for detecting nerve activity |
JP6543628B2 (en) | 2014-07-16 | 2019-07-10 | テルモ株式会社 | Treatment device |
WO2017004432A1 (en) | 2015-07-01 | 2017-01-05 | Fractyl Laboratories, Inc. | Systems, devices and methods for performing medical procedures in the intestine |
US9784922B2 (en) | 2014-07-18 | 2017-10-10 | Biosense Webster (Israel) Ltd | Electro-optical connector with hot electrical contact protection |
EP3182930B1 (en) | 2014-08-18 | 2020-09-23 | St. Jude Medical, Cardiology Division, Inc. | Sensors for prosthetic heart devices |
US11246659B2 (en) | 2014-08-25 | 2022-02-15 | The Spectranetics Corporation | Liquid laser-induced pressure wave emitting catheter sheath |
US20170119470A1 (en) | 2014-08-31 | 2017-05-04 | Lithotech Medical Ltd. | Device and method for fragmenting organo-mineral concretions |
WO2016077627A1 (en) | 2014-11-14 | 2016-05-19 | Shockwave Medical, Inc. | Shock wave valvuloplasty device and methods |
JP6790316B2 (en) | 2014-11-25 | 2020-11-25 | 460メディカル・インコーポレイテッド460Medical, Inc. | Visualization catheter |
US20190069949A1 (en) | 2014-12-03 | 2019-03-07 | Metavention, Inc. | Systems and methods for modulatng nerves or other tissue |
WO2016089683A1 (en) | 2014-12-03 | 2016-06-09 | C.R. Bard, Inc. | Electro-hydraulically actuated lithotripters and related methods |
EP3240600B1 (en) | 2014-12-30 | 2019-05-08 | The Spectranetics Corporation | Electrically-induced pressure wave emitting catheter sheath |
WO2016109737A1 (en) | 2014-12-30 | 2016-07-07 | The Spectranetics Corporation | Electrically-induced fluid filled balloon catheter |
EP4193939A1 (en) | 2015-03-26 | 2023-06-14 | Vensica Medical Ltd. | Ultrasonic urinary bladder drug delivery |
US20180092763A1 (en) | 2015-03-30 | 2018-04-05 | Enopace Biomedical Ltd. | Antenna for use with an intravascular device |
CA2983655C (en) | 2015-04-24 | 2022-01-25 | Les Solutions Medicales Soundbite Inc. | Method and system for generating mechanical pulses |
EP3270776B1 (en) | 2015-05-12 | 2020-05-27 | St. Jude Medical, Cardiology Division, Inc. | Systems and methods for orientation independent sensing |
WO2017087195A1 (en) | 2015-11-18 | 2017-05-26 | Shockwave Medical, Inc. | Shock wave electrodes |
US9894756B2 (en) | 2015-12-08 | 2018-02-13 | Kardium Inc. | Circuits for flexible structures |
WO2017120167A1 (en) | 2016-01-04 | 2017-07-13 | Alcyone Lifesciences, Inc. | Methods and devices for treating stroke |
US10368884B2 (en) | 2016-01-11 | 2019-08-06 | Boston Scientific Scimed, Inc. | Irrigation devices, methods, and systems |
US20190388002A1 (en) | 2016-04-11 | 2019-12-26 | Sensome SAS | Medical device making treatment recommendations based on sensed characteristics of a lesion |
US10226265B2 (en) | 2016-04-25 | 2019-03-12 | Shockwave Medical, Inc. | Shock wave device with polarity switching |
EP3454718A4 (en) | 2016-05-05 | 2020-02-26 | Brown, Joe Denton | Protective caps or tips for surgical laser fibers |
WO2017194557A1 (en) | 2016-05-13 | 2017-11-16 | Cryotherapeutics Gmbh | Balloon catheter |
CN114191067A (en) | 2016-05-19 | 2022-03-18 | 圣安娜技术有限公司 | Integrated cooled ablation catheter |
CN109561929A (en) | 2016-06-06 | 2019-04-02 | 纽乌罗有限公司 | Device for far field bipolar ablation |
JP6968146B2 (en) | 2016-07-25 | 2021-11-17 | ザ スペクトラネティックス コーポレイション | Catheter sheath that radiates liquid laser-induced pressure waves |
EP3522812B1 (en) | 2016-07-25 | 2021-12-01 | The Spectranetics Corporation | Laser-induced pressure wave emitting catheter sheath |
US10405923B2 (en) | 2016-08-12 | 2019-09-10 | Boston Scientific Scimed, Inc. | Systems, devices, and related methods for laser lithotripsy |
US10646240B2 (en) | 2016-10-06 | 2020-05-12 | Shockwave Medical, Inc. | Aortic leaflet repair using shock wave applicators |
WO2018075924A1 (en) | 2016-10-20 | 2018-04-26 | Retrovascular, Inc. | Method and device for enhanced composition delivery |
EP3534808A4 (en) | 2016-11-04 | 2020-06-10 | Les Solutions Médicales Soundbite Inc. | Device for delivering mechanical waves through a balloon catheter |
EP3318204B1 (en) | 2016-11-08 | 2020-02-12 | Enraf Nonius B.V. | Shockwave generator |
US10284732B2 (en) | 2016-11-30 | 2019-05-07 | Microsoft Technology Licensing, Llc | Masking latency in USB photo capture |
US10357264B2 (en) | 2016-12-06 | 2019-07-23 | Shockwave Medical, Inc. | Shock wave balloon catheter with insertable electrodes |
EP4272818A3 (en) | 2017-01-24 | 2024-02-14 | Boston Scientific Scimed, Inc. | Thrombolytic agent for the treatment of thromboembolism |
WO2018175322A1 (en) | 2017-03-20 | 2018-09-27 | Precise Light Surgical, Inc. | Soft tissue selective ablation surgical systems |
EP3600070A4 (en) * | 2017-03-24 | 2020-09-30 | Robert J. Cottone | Systems and methods for tissue displacement |
EP3600181A4 (en) | 2017-03-31 | 2020-12-16 | Boston Scientific Scimed, Inc. | Cryogenic balloon pressure sensor assembly |
US10470748B2 (en) | 2017-04-03 | 2019-11-12 | C. R. Bard, Inc. | Ultrasonic endovascular catheter with expandable portion |
US10441300B2 (en) | 2017-04-19 | 2019-10-15 | Shockwave Medical, Inc. | Drug delivery shock wave balloon catheter system |
WO2018194980A1 (en) | 2017-04-21 | 2018-10-25 | Boston Scientific Scimed, Inc. | Lithotripsy angioplasty devices and methods |
US10561428B2 (en) | 2017-04-21 | 2020-02-18 | Boston Scientific Scimed, Inc. | Lithotripsy angioplasty devices and methods |
WO2018194894A1 (en) | 2017-04-21 | 2018-10-25 | Boston Scientific Scimed, Inc. | Lithotripsy angioplasty devices and methods |
US11020135B1 (en) | 2017-04-25 | 2021-06-01 | Shockwave Medical, Inc. | Shock wave device for treating vascular plaques |
US10966737B2 (en) | 2017-06-19 | 2021-04-06 | Shockwave Medical, Inc. | Device and method for generating forward directed shock waves |
NL2019807B1 (en) | 2017-10-26 | 2019-05-06 | Boston Scient Scimed Inc | Shockwave generating device |
US11350954B2 (en) | 2017-07-28 | 2022-06-07 | Philips Image Guided Therapy Corporation | Intravascular ultrasound (IVUS) and flow guided embolism therapy devices systems and methods |
EP3668416A1 (en) | 2017-08-17 | 2020-06-24 | Koninklijke Philips N.V. | Temporary occlusion balloon devices, systems and methods for preventing flow through a vascular perforation |
US11071557B2 (en) | 2017-10-19 | 2021-07-27 | Medtronic Vascular, Inc. | Catheter for creating pulse wave within vasculature |
US11737778B2 (en) | 2017-11-15 | 2023-08-29 | Pavel V. Efremkin | Devices and methods for intrabody surgery |
US10709462B2 (en) | 2017-11-17 | 2020-07-14 | Shockwave Medical, Inc. | Low profile electrodes for a shock wave catheter |
US20190175111A1 (en) | 2017-12-04 | 2019-06-13 | 4C Medical Technologies, Inc. | Devices and methods for atrial mapping, sensing and treating cardiac arrhythmia |
CA3084738A1 (en) | 2017-12-12 | 2019-06-20 | Alcon Inc. | Thermally robust laser probe assembly |
US11779427B2 (en) | 2017-12-12 | 2023-10-10 | Alcon Inc. | Multiple-input-coupled illuminated multi-spot laser probe |
US11213661B2 (en) | 2018-01-05 | 2022-01-04 | Cook Medical Technologies Llc | Expandable medical device and method of use thereof |
US11006996B2 (en) | 2018-01-16 | 2021-05-18 | Daniel Ezra Walzman | Torus balloon with energy emitters for intravascular lithotripsy |
US10758735B2 (en) | 2018-02-01 | 2020-09-01 | Pacesetter, Inc. | Implantable medical device having an electrode and antenna provided with a ceramic header |
US11103262B2 (en) | 2018-03-14 | 2021-08-31 | Boston Scientific Scimed, Inc. | Balloon-based intravascular ultrasound system for treatment of vascular lesions |
US20190282250A1 (en) | 2018-03-14 | 2019-09-19 | Boston Scientific Scimed, Inc. | Treatment of vascular lesions |
WO2019200201A1 (en) | 2018-04-12 | 2019-10-17 | The Regents Of The University Of Michigan | System for effecting and controlling oscillatory pressure within balloon catheters for fatigue fracture of calculi |
JP7104177B2 (en) | 2018-04-26 | 2022-07-20 | セント・ジュード・メディカル,カーディオロジー・ディヴィジョン,インコーポレイテッド | Systems and methods for mapping arrhythmia driver sites |
JP7114699B2 (en) | 2018-05-10 | 2022-08-08 | オリンパス株式会社 | Ablation instrument controller and ablation system |
US11395700B2 (en) | 2018-05-16 | 2022-07-26 | Optical Integrity, Inc. | Fiber tip protective structure with scale indicator |
WO2019222843A1 (en) | 2018-05-22 | 2019-11-28 | Interface Biologics, Inc. | Compositions and methods for delivering drugs to a vessel wall |
US11123135B2 (en) | 2018-05-30 | 2021-09-21 | Biosense Webster (Israel) Ltd. | Enhanced large-diameter balloon catheter |
CN112367934A (en) | 2018-06-21 | 2021-02-12 | 冲击波医疗公司 | System for treating an occlusion in a body lumen |
WO2019246469A1 (en) | 2018-06-22 | 2019-12-26 | Avava, Inc. | Feedback detection for a treament device |
US20200061931A1 (en) | 2018-08-21 | 2020-02-27 | Optical Integrity, Inc. | Method of welding a protective structure to an optical fiber tip |
CN109223100A (en) | 2018-09-03 | 2019-01-18 | 沛嘉医疗科技(苏州)有限公司 | It is a kind of for treating the device and its application method of heart valve and angiosteosis |
JP2022511318A (en) | 2018-09-11 | 2022-01-31 | アクア、ハート、インコーポレイテッド | Heated steam ablation system and method for treating heart disease |
CN112789014B (en) | 2018-10-05 | 2023-08-29 | 爱尔康公司 | Occlusion Sensing in Ophthalmic Laser Probes |
EP3863707A4 (en) | 2018-10-09 | 2022-07-13 | LimFlow GmbH | Devices and methods for catheter alignment |
US11622779B2 (en) | 2018-10-24 | 2023-04-11 | Boston Scientific Scimed, Inc. | Photoacoustic pressure wave generation for intravascular calcification disruption |
US11266817B2 (en) | 2018-10-25 | 2022-03-08 | Medtronic Vascular, Inc. | Cavitation catheter |
US11357958B2 (en) | 2018-10-25 | 2022-06-14 | Medtronic Vascular, Inc. | Devices and techniques for cardiovascular intervention |
CN113195114B (en) | 2018-10-26 | 2022-11-18 | 阿普劳德医疗公司 | Ultrasonic device for use with synthetic cavitation nuclei |
WO2020089876A1 (en) | 2018-11-02 | 2020-05-07 | Med-Innov Sas | Devices for treating calcified heart valves |
FR3091409B1 (en) | 2018-12-31 | 2020-12-25 | Adm28 S Ar L | Pulse electric discharge device |
US10770047B2 (en) | 2019-01-15 | 2020-09-08 | Bose Corporation | Electric musical instrument having rear mounted speaker |
MX2021015569A (en) | 2019-06-18 | 2022-01-26 | Bard Inc C R | Ultrasonic system and method having improved occlusion engagement during crossing and atherectomy procedures. |
WO2020256898A1 (en) | 2019-06-19 | 2020-12-24 | Boston Scientific Scimed, Inc. | Balloon surface photoacoustic pressure wave generation to disrupt vascular lesions |
CA3144246C (en) | 2019-06-19 | 2024-03-05 | Boston Scientific Scimed, Inc. | Plasma creation via nonaqueous optical breakdown of laser pulse energy for breakup of vascular calcium |
US11717139B2 (en) | 2019-06-19 | 2023-08-08 | Bolt Medical, Inc. | Plasma creation via nonaqueous optical breakdown of laser pulse energy for breakup of vascular calcium |
US11660427B2 (en) | 2019-06-24 | 2023-05-30 | Boston Scientific Scimed, Inc. | Superheating system for inertial impulse generation to disrupt vascular lesions |
US11517713B2 (en) | 2019-06-26 | 2022-12-06 | Boston Scientific Scimed, Inc. | Light guide protection structures for plasma system to disrupt vascular lesions |
CN110638501A (en) | 2019-09-10 | 2020-01-03 | 丁·奥利弗 | Ultrasonic balloon catheter system for cardiovascular lithotripsy |
JP2022549269A (en) | 2019-09-24 | 2022-11-24 | ショックウェーブ メディカル, インコーポレイテッド | Thin electrodes for shockwave catheters |
JP2022548977A (en) | 2019-09-24 | 2022-11-22 | ショックウェーブ メディカル, インコーポレイテッド | Translesion shock wave catheter |
EP4034006A1 (en) | 2019-09-24 | 2022-08-03 | Shockwave Medical, Inc. | System for treating thrombus in body lumens |
US20220346650A1 (en) | 2019-10-02 | 2022-11-03 | Blaze Bioscience, Inc. | Systems and methods for vascular and structural imaging |
US11583339B2 (en) | 2019-10-31 | 2023-02-21 | Bolt Medical, Inc. | Asymmetrical balloon for intravascular lithotripsy device and method |
US20210137598A1 (en) | 2019-11-13 | 2021-05-13 | Bolt Medical, Inc. | Dynamic lithoplasty device with movable energy guide |
US20210153939A1 (en) | 2019-11-22 | 2021-05-27 | Bolt Medical, Inc. | Energy manifold for directing and concentrating energy within a lithoplasty device |
US20210369348A1 (en) | 2019-12-18 | 2021-12-02 | Bolt Medical, Inc. | Optical valve multiplexer for laser-driven pressure wave device |
US20210186613A1 (en) | 2019-12-18 | 2021-06-24 | Bolt Medical, Inc. | Multiplexer for laser-driven intravascular lithotripsy device |
US20210220052A1 (en) | 2020-01-22 | 2021-07-22 | Bolt Medical, Inc. | Lithoplasty device with advancing energy wavefront |
US20210244473A1 (en) | 2020-02-10 | 2021-08-12 | Bolt Medical, Inc. | System and method for pressure monitoring within a catheter system |
US20210267685A1 (en) | 2020-02-27 | 2021-09-02 | Bolt Medical, Inc. | Fluid recirculation system for intravascular lithotripsy device |
US20210275249A1 (en) | 2020-03-09 | 2021-09-09 | Boston Scientific Scimed, Inc. | Laser pulse shaping to enhance conversion efficiency and protect fiber optic delivery system for disruption of vascular calcium |
US11672599B2 (en) | 2020-03-09 | 2023-06-13 | Bolt Medical, Inc. | Acoustic performance monitoring system and method within intravascular lithotripsy device |
US20210290286A1 (en) | 2020-03-18 | 2021-09-23 | Bolt Medical, Inc. | Optical analyzer assembly and method for intravascular lithotripsy device |
US11707323B2 (en) | 2020-04-03 | 2023-07-25 | Bolt Medical, Inc. | Electrical analyzer assembly for intravascular lithotripsy device |
US20210353359A1 (en) | 2020-05-12 | 2021-11-18 | Bolt Medical, Inc. | Active alignment system and method for optimizing optical coupling of multiplexer for laser-driven intravascular lithotripsy device |
US20210378743A1 (en) | 2020-06-03 | 2021-12-09 | Boston Scientific Scimed, Inc. | System and method for maintaining balloon integrity within intravascular lithotripsy device with plasma generator |
US20210386479A1 (en) | 2020-06-15 | 2021-12-16 | Daniel Frank Massimini | Spectroscopic tissue identification for balloon intravascular lithotripsy guidance |
US11896249B2 (en) | 2020-07-02 | 2024-02-13 | Gyrus Acmi, Inc. | Lithotripsy system having a drill and lateral emitter |
WO2022007490A1 (en) | 2020-07-06 | 2022-01-13 | 上海鑫律通生命科技有限公司 | System for treating arrhythmias using pulsed electric field ablation technology |
DE102020117713A1 (en) | 2020-07-06 | 2022-01-13 | Karl Storz Se & Co. Kg | Lithotripsy device and method of operating a lithotripsy device |
US20220008130A1 (en) | 2020-07-09 | 2022-01-13 | Boston Scientific Scimed, Inc. | Acoustic tissue identification for balloon intravascular lithotripsy guidance |
US20220071704A1 (en) | 2020-09-09 | 2022-03-10 | Bolt Medical, Inc. | Valvuloplasty treatment system and method |
US20220183738A1 (en) | 2020-12-11 | 2022-06-16 | Bolt Medical, Inc. | Catheter system for valvuloplasty procedure |
WO2022125525A1 (en) | 2020-12-11 | 2022-06-16 | Bolt Medical, Inc. | Catheter system for valvuloplasty procedure |
CN113951972A (en) | 2020-12-16 | 2022-01-21 | 深圳市赛禾医疗技术有限公司 | Pressure wave sacculus pipe |
CN113951973A (en) | 2020-12-16 | 2022-01-21 | 深圳市赛禾医疗技术有限公司 | Pressure wave sacculus pipe |
CN215384399U (en) | 2021-01-06 | 2022-01-04 | 苏州中荟医疗科技有限公司 | Shock wave generating device for cardiovascular stenosis |
EP4277548A1 (en) | 2021-01-12 | 2023-11-22 | Bolt Medical, Inc. | Balloon assembly for valvuloplasty catheter system |
US11672585B2 (en) | 2021-01-12 | 2023-06-13 | Bolt Medical, Inc. | Balloon assembly for valvuloplasty catheter system |
WO2022173719A1 (en) | 2021-02-10 | 2022-08-18 | Bolt Medical, Inc. | Optical assemblies to improve energy coupling to pressure wave generator of an intravascular lithotripsy device |
US20220249165A1 (en) | 2021-02-10 | 2022-08-11 | Bolt Medical, Inc. | Optical assemblies to improve energy coupling to pressure wave generator of an intravascular lithotripsy device |
US20220273324A1 (en) | 2021-03-01 | 2022-09-01 | Bolt Medical, Inc. | Valvuloplasty treatment assembly and method using directed bubble energy |
WO2022187058A1 (en) | 2021-03-01 | 2022-09-09 | Bolt Medical, Inc. | Valvuloplasty treatment assembly and method using directed bubble energy |
CN215651484U (en) | 2021-03-24 | 2022-01-28 | 上海微创旋律医疗科技有限公司 | Electrode balloon catheter and high-voltage generation treatment device |
WO2022216488A1 (en) | 2021-04-06 | 2022-10-13 | Bolt Medical, Inc. | Intravascular lithotripsy balloon |
US11648057B2 (en) | 2021-05-10 | 2023-05-16 | Bolt Medical, Inc. | Optical analyzer assembly with safety shutdown system for intravascular lithotripsy device |
WO2022240674A1 (en) | 2021-05-10 | 2022-11-17 | Bolt Medical, Inc. | Optical analyzer assembly with safety shutdown system for intravascular lithotripsy device |
CN215651393U (en) | 2021-05-21 | 2022-01-28 | 上海微创心通医疗科技有限公司 | Medical catheter and medical device |
CN215386905U (en) | 2021-06-04 | 2022-01-04 | 乐普(北京)医疗器械股份有限公司 | Shock wave auxiliary medicine perfusion balloon catheter and medical equipment |
US11806075B2 (en) | 2021-06-07 | 2023-11-07 | Bolt Medical, Inc. | Active alignment system and method for laser optical coupling |
WO2022260932A1 (en) | 2021-06-07 | 2022-12-15 | Bolt Medical, Inc. | Active alignment system for laser optical coupling |
CN215458400U (en) | 2021-06-23 | 2022-01-11 | 苏州中荟医疗科技有限公司 | Shock wave generating system |
CN215458401U (en) | 2021-06-23 | 2022-01-11 | 苏州中荟医疗科技有限公司 | Shock wave generating device for angiostenosis lesion |
CN215653328U (en) | 2021-06-30 | 2022-01-28 | 苏州中荟医疗科技有限公司 | Shock wave generating device for angiostenosis lesion |
CN215537694U (en) | 2021-07-07 | 2022-01-18 | 苏州中荟医疗科技有限公司 | Seismic wave guide pipe system |
CN215606068U (en) | 2021-07-30 | 2022-01-25 | 苏州中荟医疗科技有限公司 | Shock wave generation conduit |
CN215651394U (en) | 2021-08-13 | 2022-01-28 | 苏州中荟医疗科技有限公司 | Catheter and shock wave generation system |
CN215584286U (en) | 2021-08-13 | 2022-01-21 | 苏州中荟医疗科技有限公司 | Device for treating occlusive lesions |
CN215534803U (en) | 2021-08-24 | 2022-01-18 | 江苏朴芃医疗科技有限公司 | A stent system for endovascular calcification plaque treatment |
CN215505065U (en) | 2021-08-25 | 2022-01-14 | 苏州中荟医疗科技有限公司 | Balloon catheter |
CN113974765B (en) | 2021-10-22 | 2022-09-06 | 北京荷清和创医疗科技有限公司 | Intervention type thrombus removal device and thrombolysis promoting module |
CN113974826A (en) | 2021-10-29 | 2022-01-28 | 深圳微量医疗科技有限公司 | High-adaptability interventional catheter |
CN113877044A (en) | 2021-11-03 | 2022-01-04 | 上海微创旋律医疗科技有限公司 | Medical device |
CN113907838B (en) | 2021-11-18 | 2023-03-21 | 郑州大学第一附属医院 | Urological calculus smashing and sucking device |
-
2021
- 2021-03-24 US US17/211,150 patent/US11707323B2/en active Active
- 2021-03-25 WO PCT/US2021/024216 patent/WO2021202248A1/en active Application Filing
- 2021-03-25 EP EP21719784.7A patent/EP4125665B1/en active Active
-
2023
- 2023-04-26 US US18/139,624 patent/US20230255688A1/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0119296A1 (en) * | 1983-02-18 | 1984-09-26 | Baylor College of Medicine | An apparatus for intra-aortic balloon monitoring and leak detection |
Also Published As
Publication number | Publication date |
---|---|
EP4125665A1 (en) | 2023-02-08 |
EP4125665C0 (en) | 2024-02-21 |
WO2021202248A1 (en) | 2021-10-07 |
US20210307828A1 (en) | 2021-10-07 |
US11707323B2 (en) | 2023-07-25 |
US20230255688A1 (en) | 2023-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4117563B1 (en) | Acoustic performance monitoring system within intravascular lithotripsy device | |
US20210244473A1 (en) | System and method for pressure monitoring within a catheter system | |
EP4125665B1 (en) | Intravascular lithotripsy device with electrical analyzer assembly | |
EP4051154B1 (en) | Asymmetrical balloon for lithoplasty device | |
US11903642B2 (en) | Optical analyzer assembly and method for intravascular lithotripsy device | |
US20220008130A1 (en) | Acoustic tissue identification for balloon intravascular lithotripsy guidance | |
US20210267685A1 (en) | Fluid recirculation system for intravascular lithotripsy device | |
CN115103643A (en) | Energy manifold for directing and concentrating energy within lithotripsy devices | |
US20230255635A1 (en) | Manifold integrated handle assembly for intravascular lithotripsy device | |
US20240032995A1 (en) | Routing assembly for intravascular lithotripsy catheter system | |
US20240065712A1 (en) | Optical emitter housing assembly for intravascular lithotripsy device | |
WO2023154327A1 (en) | Manifold integrated handle assembly for intravascular lithotripsy device | |
WO2024026322A1 (en) | Routing assembly for intravascular lithotripsy catheter system | |
CA3201972A1 (en) | Optical emitter housing assembly for intravascular lithotripsy device | |
WO2023113922A1 (en) | Optical emitter housing assembly for intravascular lithotripsy device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20220930 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61B 18/22 20060101ALN20230907BHEP Ipc: A61B 17/00 20060101ALN20230907BHEP Ipc: A61B 18/12 20060101ALN20230907BHEP Ipc: A61B 18/00 20060101ALN20230907BHEP Ipc: A61B 90/00 20160101ALN20230907BHEP Ipc: A61N 1/05 20060101ALI20230907BHEP Ipc: A61B 18/14 20060101ALI20230907BHEP Ipc: A61B 18/04 20060101ALI20230907BHEP Ipc: A61B 18/26 20060101AFI20230907BHEP |
|
INTG | Intention to grant announced |
Effective date: 20230922 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602021009637 Country of ref document: DE |
|
U01 | Request for unitary effect filed |
Effective date: 20240312 |